BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769-2778. [PMID: 29050646 DOI: 10.1016/s0140-6736(17)32448-0] [Cited by in Crossref: 1450] [Cited by in F6Publishing: 1907] [Article Influence: 290.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou YF, Zhang GL, Sun N, Wang ZQ, Ye XY, Xiong J, Deng XD, Lin X, Zhang P, Zheng H, Zhang Y, Yang K, Gao ZD, Sun RR, Liang FR. Acupuncture for emotional disorders in patients with inflammatory bowel disease: a systematic review protocol. BMJ Open 2022;12:e058568. [PMID: 36167375 DOI: 10.1136/bmjopen-2021-058568] [Reference Citation Analysis]
2 Luo J, Zhong J, Li H, Zhang S, Zhang L, Hou JT, Ke J, Li H, Liu F, Chen XL. Translation and evaluation of the simplified Chinese version of the rating form of IBD patient concerns. BMC Gastroenterol 2022;22:426. [PMID: 36138341 DOI: 10.1186/s12876-022-02503-7] [Reference Citation Analysis]
3 Masanetz RK, Winkler J, Winner B, Günther C, Süß P. The Gut–Immune–Brain Axis: An Important Route for Neuropsychiatric Morbidity in Inflammatory Bowel Disease. IJMS 2022;23:11111. [DOI: 10.3390/ijms231911111] [Reference Citation Analysis]
4 Zhang J, Liang F, Chen Z, Chen Y, Yuan J, Xiong Q, Hou S, Huang S, Liu C, Liang J. Vitexin Protects against Dextran Sodium Sulfate-Induced Colitis in Mice and Its Potential Mechanisms. J Agric Food Chem 2022. [PMID: 36124900 DOI: 10.1021/acs.jafc.2c05177] [Reference Citation Analysis]
5 Qiu Y, Li Q, Wu D, Zhang Y, Cheng J, Cao Z, Zhou Y. Altered mean apparent propagator-based microstructure and the corresponding functional connectivity of the parahippocampus and thalamus in Crohn’s disease. Front Neurosci 2022;16:985190. [DOI: 10.3389/fnins.2022.985190] [Reference Citation Analysis]
6 Wang Z, Wang X, Zhao X, Hu Z, Sun D, Wu D, Xing Y. Causal relationship between bipolar disorder and inflammatory bowel disease: A bidirectional two-sample mendelian randomization study. Front Genet 2022;13:970933. [DOI: 10.3389/fgene.2022.970933] [Reference Citation Analysis]
7 Abdel-rahman LIH, Morgan XC. Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izac194] [Reference Citation Analysis]
8 Liu C, Yu R, Zhang J, Wei S, Xue F, Guo Y, He P, Shang L, Dong W. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Front Immunol 2022;13:972079. [DOI: 10.3389/fimmu.2022.972079] [Reference Citation Analysis]
9 Yang F, Ni B, Liu Q, He F, Li L, Zhong X, Zheng X, Lu J, Chen X, Lin H, Xu R, He Y, Zhang Q, Zou X, Chen W. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-03118-1] [Reference Citation Analysis]
10 Adriano A, Thompson DM, Mcmullan C, Price M, Moore D, Booth L, Mathers J. Peer support for carers and patients with inflammatory bowel disease: a systematic review. Syst Rev 2022;11. [DOI: 10.1186/s13643-022-02064-6] [Reference Citation Analysis]
11 Li S, Kern I, Manuwald U, Kugler J, Rothe U. Application of the capture–recapture method to ascertain the completeness of the Saxon pediatric IBD registry in Germany. J Public Health (Berl ). [DOI: 10.1007/s10389-022-01749-5] [Reference Citation Analysis]
12 Wu L, Lv Z, Lai L, Zhou P. Assessment of influencing factors of hospitalization expenses for Crohn's disease patients: Based on LASSO and linear mixed model. Front Public Health 2022;10:925616. [DOI: 10.3389/fpubh.2022.925616] [Reference Citation Analysis]
13 Zhang T, Zhang B, Tian W, Wang F, Zhang J, Ma X, Wei Y, Tang X. Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021. Front Pharmacol 2022;13:951004. [DOI: 10.3389/fphar.2022.951004] [Reference Citation Analysis]
14 Xie D, Zhou X, Xiao B, Duan L, Zhu Z. Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis. Biomolecules 2022;12:1263. [DOI: 10.3390/biom12091263] [Reference Citation Analysis]
15 Liu D, Chen Y, Li Q, Xu M, Liao J, Wang B. Integrative bioinformatics analysis to identify the effects of circadian rhythm on Crohn’s disease. Front Mol Biosci 2022;9:961481. [DOI: 10.3389/fmolb.2022.961481] [Reference Citation Analysis]
16 Ha R, Keynan Y, Rueda ZV. Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy. Front Cell Infect Microbiol 2022;12:980868. [DOI: 10.3389/fcimb.2022.980868] [Reference Citation Analysis]
17 Yang Z, Lin S, Feng W, Liu Y, Song Z, Pan G, Zhang Y, Dai X, Ding X, Chen L, Wang Y. A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization. Front Pharmacol 2022;13:999179. [DOI: 10.3389/fphar.2022.999179] [Reference Citation Analysis]
18 Alrubia S, Mao J, Chen Y, Barber J, Rostami-Hodjegan A. Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs. Clin Pharmacokinet 2022. [PMID: 36056298 DOI: 10.1007/s40262-022-01169-4] [Reference Citation Analysis]
19 Huang C, Wang Y, Lin X, Chan TF, Lai KP, Li R. Uncovering the functions of plasma proteins in ulcerative colitis and identifying biomarkers for BPA-induced severe ulcerative colitis: A plasma proteome analysis. Ecotoxicol Environ Saf 2022;242:113897. [PMID: 35999755 DOI: 10.1016/j.ecoenv.2022.113897] [Reference Citation Analysis]
20 Narkis B, Hadar E, Barbash-Hazan S, Houri O, Shay V, Ollech JE, Yanai H, Dotan I, Avni-Biron I. Peripartum Infections Among Women With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac185. [PMID: 36049022 DOI: 10.1093/ibd/izac185] [Reference Citation Analysis]
21 Zhang S, Jin W, Zhang W, Ren F, Wang P, Liu N. Pea Albumin Attenuates Dextran Sulfate Sodium-Induced Colitis by Regulating NF-κB Signaling and the Intestinal Microbiota in Mice. Nutrients 2022;14:3611. [DOI: 10.3390/nu14173611] [Reference Citation Analysis]
22 Eom J, Choi S, Kim H, Kim D, Bae J, Kwon G, Lee D, Hwang J, Kim D, Baek M, Cho Y. Hemp-Derived Nanovesicles Protect Leaky Gut and Liver Injury in Dextran Sodium Sulfate-Induced Colitis. IJMS 2022;23:9955. [DOI: 10.3390/ijms23179955] [Reference Citation Analysis]
23 Manu P, Rogozea LM, Dumitraşcu DL. Pharmacological Management of Inflammatory Bowel Disease: a Century of Expert Opinions in Cecil Textbook of Medicine. Am J Ther 2022. [PMID: 36048564 DOI: 10.1097/MJT.0000000000001555] [Reference Citation Analysis]
24 Rajbhandari R, Blakemore S, Gupta N, Mannan S, Nikolli K, Yih A, Drown L, Bukhman G. Crohn's Disease Among the Poorest Billion: Burden of Crohn's Disease in Low- and Lower-Middle-Income Countries. Dig Dis Sci 2022. [PMID: 36044105 DOI: 10.1007/s10620-022-07675-6] [Reference Citation Analysis]
25 Marabotto E, Kayali S, Buccilli S, Levo F, Bodini G, Giannini EG, Savarino V, Savarino EV. Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review. Cancers 2022;14:4254. [DOI: 10.3390/cancers14174254] [Reference Citation Analysis]
26 He C, Chen Z, Huang J, Gan R, Wang J, Wang L, Li D, Yao J, Hussain T. Interleukin-22 Ameliorates Dextran Sulfate Sodium-Induced Colitis through the Upregulation of lncRNA-UCL to Accelerate Claudin-1 Expression via Sequestering miR-568 in Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/8543720] [Reference Citation Analysis]
27 Li J, Guo Y, Zhou H, Yue T, Wang F, Sun F, Wang W. Arginine metabolism regulates the pathogenesis of inflammatory bowel disease. Nutrition Reviews 2022. [DOI: 10.1093/nutrit/nuac070] [Reference Citation Analysis]
28 Zhang J, Ou A, Tang X, Wang R, Fan Y, Fang Y, Zhao Y, Zhao P, Chen D, Wang B, Huang Y. "Two-birds-one-stone" colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis. J Nanobiotechnology 2022;20:389. [PMID: 36042499 DOI: 10.1186/s12951-022-01598-0] [Reference Citation Analysis]
29 Li Q, Sun X, Yu K, Lv J, Miao C, Yang J, Wang S, Fu Z, Sun Y, Zhang H, Zhang ZS, Keller ET, Yao Z, Wang Q. Enterobacter ludwigii protects DSS-induced colitis through choline-mediated immune tolerance. Cell Rep 2022;40:111308. [PMID: 36044853 DOI: 10.1016/j.celrep.2022.111308] [Reference Citation Analysis]
30 Zhu S, Han M, Liu S, Fan L, Shi H, Li P. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients. Front Cell Infect Microbiol 2022;12:953962. [DOI: 10.3389/fcimb.2022.953962] [Reference Citation Analysis]
31 Rajabnia M, Hajimirzaei SM, Hatamnejad MR, Shahrokh S, Ghavami SB, Farmani M, Salarieh N, Ebrahimi N, Kazemifard N, Farahanie A, Sherkat G, Aghdaei HA. Obesity, a challenge in the management of inflammatory bowel diseases. Immunol Res. [DOI: 10.1007/s12026-022-09315-7] [Reference Citation Analysis]
32 Lu Q, Li J, Ding P, Mao T, Shi L, Sun Z, Tan X, Jiang H, Dong J, Li Y, Yang X, Shi R, Liao Z. Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization In Vitro and In Vivo. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/9427076] [Reference Citation Analysis]
33 Li F, Liu Y, Wang Z, Zhao Q, Li Y, Tang T. A mendelian randomization study with populations of European ancestry rules out a causal relationship between inflammatory bowel disease and colorectal cancer. Front Genet 2022;13:949325. [DOI: 10.3389/fgene.2022.949325] [Reference Citation Analysis]
34 Bauer N, Löffler C, Öznur Ö, Uecker C, Keil T, Langhorst J. Mind-body-medicine and comprehensive lifestyle-modification in patients with Crohn's disease—Feasibility of a randomized controlled trial under pandemic circumstances. Front Integr Neurosci 2022;16:960301. [DOI: 10.3389/fnint.2022.960301] [Reference Citation Analysis]
35 Zhu Y, Qin H, Sun C, Shao B, Li G, Qin Y, Kong D, Ren S, Wang H, Wang Z, Zhang J, Wang H, Li XK. Endometrial Regenerative Cell-Derived Exosomes Attenuate Experimental Colitis through Downregulation of Intestine Ferroptosis. Stem Cells International 2022;2022:1-15. [DOI: 10.1155/2022/3014123] [Reference Citation Analysis]
36 Brown S, Wall CL, Frampton C, Gearry RB, Day AS. Dietary Nutrient Intake and Blood Micronutrient Status of Children with Crohn's Disease Compared with Their Shared-Home Environment, Healthy Siblings. Nutrients 2022;14:3425. [PMID: 36014931 DOI: 10.3390/nu14163425] [Reference Citation Analysis]
37 Katsandegwaza B, Horsnell W, Smith K. Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. Int J Mol Sci 2022;23:9344. [PMID: 36012618 DOI: 10.3390/ijms23169344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Shi Y, Feng S, Yan M, Wei S, Yang K, Feng Y. Inflammatory bowel disease and celiac disease: A bidirectional Mendelian randomization study. Front Genet 2022;13:928944. [DOI: 10.3389/fgene.2022.928944] [Reference Citation Analysis]
39 Dong L, Zhang R, Huang Q, Shen Y, Li H, Yu S, Wu Q. Construction, bioinformatics analysis, and validation of competitive endogenous RNA networks in ulcerative colitis. Front Genet 2022;13:951243. [DOI: 10.3389/fgene.2022.951243] [Reference Citation Analysis]
40 Jacobs JP, Goudarzi M, Lagishetty V, Li D, Mak T, Tong M, Ruegger P, Haritunians T, Landers C, Fleshner P, Vasiliauskas E, Ippoliti A, Melmed G, Shih D, Targan S, Borneman J, Fornace AJ Jr, McGovern DPB, Braun J. Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome. Genome Med 2022;14:91. [PMID: 35971134 DOI: 10.1186/s13073-022-01099-7] [Reference Citation Analysis]
41 Cassol OS, Zabot GP, Saad-Hossne R, Padoin A. Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil. World J Gastroenterol 2022; 28(30): 4174-4181 [DOI: 10.3748/wjg.v28.i30.4174] [Reference Citation Analysis]
42 Huang C, Huang Z, Ding L, Fu Y, Fan J, Mei Q, Lou L, Wang J, Yin N, Lu Y, Guo S, Zeng Y. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis. J Transl Med 2022;20:354. [PMID: 35962454 DOI: 10.1186/s12967-022-03569-3] [Reference Citation Analysis]
43 Jiang K, Wang D, Su L, Liu X, Yue Q, Li B, Li K, Zhang S, Zhao L. Structural characteristics of locust bean gum hydrolysate and its alleviating effect on dextran sulfate sodium-induced colitis. Front Microbiol 2022;13:985725. [DOI: 10.3389/fmicb.2022.985725] [Reference Citation Analysis]
44 Liu H, Wang Q, Huang Y, Deng J, Xie X, Zhu J, Yuan Y, He YM, Huang YY, Luo HB, He X. Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases. Eur J Med Chem 2022;242:114631. [PMID: 35985255 DOI: 10.1016/j.ejmech.2022.114631] [Reference Citation Analysis]
45 Lu C, Zhang X, Luo Y, Huang J, Yu M. Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer. Front Genet 2022;13:945414. [DOI: 10.3389/fgene.2022.945414] [Reference Citation Analysis]
46 Agrawal M, Christensen HS, Bøgsted M, Colombel JF, Jess T, Allin KH. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study. Gastroenterology 2022:S0016-5085(22)00881-2. [PMID: 35952799 DOI: 10.1053/j.gastro.2022.07.062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Moritmore AM, Bullen A, McMeniman EK. The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction. Australas J Dermatol 2022. [PMID: 35932467 DOI: 10.1111/ajd.13910] [Reference Citation Analysis]
48 Wang L, Ji T, Yuan Y, Fu H, Wang Y, Tian S, Hu J, Wang L, Wang Z. High-fructose corn syrup promotes proinflammatory Macrophage activation via ROS-mediated NF-κB signaling and exacerbates colitis in mice. International Immunopharmacology 2022;109:108814. [DOI: 10.1016/j.intimp.2022.108814] [Reference Citation Analysis]
49 Faye AS, Holmer AK, Axelrad JE. Cancer in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2022.05.003] [Reference Citation Analysis]
50 Caban M, Lewandowska U. Polyphenols and the potential mechanisms of their therapeutic benefits against inflammatory bowel diseases. Journal of Functional Foods 2022;95:105181. [DOI: 10.1016/j.jff.2022.105181] [Reference Citation Analysis]
51 Zhong Y, Xiao Q, Kang Z, Huang J, Ge W, Wan Q, Wang H, Zhou W, Zhao H, Liu D. Astragalus polysaccharide alleviates ulcerative colitis by regulating the balance of Tfh/Treg cells. Int Immunopharmacol 2022;111:109108. [PMID: 35926271 DOI: 10.1016/j.intimp.2022.109108] [Reference Citation Analysis]
52 Akbari H, Akbari A, Ghiasvand R, Tamizifar B, Saneei P, Feizi A, Pourmasoumi M. The association between dietary patterns and the risk of developing ulcerative colitis. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.08.009] [Reference Citation Analysis]
53 Dipasquale V, Romano C. Genes vs environment in inflammatory bowel disease: an update. Expert Rev Clin Immunol 2022. [PMID: 35912838 DOI: 10.1080/1744666X.2022.2108407] [Reference Citation Analysis]
54 Kii S, Kitamura H, Hashimoto S, Ikeo K, Ichikawa N, Yoshida T, Homma S, Tanino M, Taketomi A. STAT1-mediated induction of Ly6c-expressing macrophages are involved in the pathogenesis of an acute colitis model. Inflamm Res 2022. [PMID: 35913585 DOI: 10.1007/s00011-022-01620-z] [Reference Citation Analysis]
55 Greywoode R, Petralia F, Ullman TA, Frederic Colombel J, Ungaro RC. Racial Difference in Efficacy of Golimumab in Ulcerative Colitis. Inflamm Bowel Dis 2022:izac161. [PMID: 35913121 DOI: 10.1093/ibd/izac161] [Reference Citation Analysis]
56 Ugar M, Kamiş F, Beyazit Y. İnflamatuvar barsak hastalığı olan hastalarda klinik özellikler, tedavi seçenekleri ve komplikasyonların değerlendirilmesi. Fam Pract Palliat Care. [DOI: 10.22391/fppc.1088562] [Reference Citation Analysis]
57 Rosseto-welter EA, D’argenio-garcia L, Blasco Tavares Pereira Lopes F, Zulim Carvalho AE, Flaquer F, Severo-lemos V, Viero Nora CC, Steinwurz F, Pires Garcia Oliveria L, Aloia T, Rizzo LV, Pitangueira Mangueira CL, Carvalho KI, Gendron FP. Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-9. [DOI: 10.1155/2022/1307159] [Reference Citation Analysis]
58 Hahn GD, Golovics PA, Wetwittayakhlang P, Santa Maria DM, Britto U, Wild GE, Afif W, Bitton A, Bessissow T, Lakatos PL. Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. JCM 2022;11:4422. [DOI: 10.3390/jcm11154422] [Reference Citation Analysis]
59 Huang T, Xu J, Wang M, Pu K, Li L, Zhang H, Liang Y, Sun W, Wang Y. An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis. Medicine (Baltimore) 2022;101:e29790. [PMID: 35905229 DOI: 10.1097/MD.0000000000029790] [Reference Citation Analysis]
60 Adolph TE, Meyer M, Schwärzler J, Mayr L, Grabherr F, Tilg H. The metabolic nature of inflammatory bowel diseases. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35906289 DOI: 10.1038/s41575-022-00658-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Liu Z, Jiang Z, Zhang Z, Liu T, Fan Y, Liu T, Peng N. Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice. Microbiol Spectr 2022;:e0064122. [PMID: 35900082 DOI: 10.1128/spectrum.00641-22] [Reference Citation Analysis]
62 Núñez-sánchez MA, Melgar S, O’donoghue K, Martínez-sánchez MA, Fernández-ruiz VE, Ferrer-gómez M, Ruiz-alcaraz AJ, Ramos-molina B. Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. IJMS 2022;23:8361. [DOI: 10.3390/ijms23158361] [Reference Citation Analysis]
63 Wang N, Kong R, Han W, Bao W, Shi Y, Ye L, Lu J. Honokiol alleviates ulcerative colitis by targeting PPAR-γ-TLR4-NF-κB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro. Int Immunopharmacol 2022;111:109058. [PMID: 35901530 DOI: 10.1016/j.intimp.2022.109058] [Reference Citation Analysis]
64 Liu P, Lan X, Tao X, Tian J, Ying X, Stien D. A new alkaloid and two organic acids from Portulaca oleracea L. and their bioactivities. Natural Product Research. [DOI: 10.1080/14786419.2022.2103696] [Reference Citation Analysis]
65 Alrubia S, Al-Majdoub ZM, Achour B, Rostami-Hodjegan A, Barber J. Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters. J Pharm Sci 2022:S0022-3549(22)00303-3. [PMID: 35872023 DOI: 10.1016/j.xphs.2022.07.012] [Reference Citation Analysis]
66 Liu Y, Söderberg J, Chao J. Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn’s Disease. Pharmacy 2022;10:87. [DOI: 10.3390/pharmacy10040087] [Reference Citation Analysis]
67 Wang T, Wang S, Dong S, Zhang Y, Ismael M, Wang S, Shi C, Yang J, Wang X, Lü X. Interaction of Companilactobacillus crustorum MN047-derived bacteriocins with gut microbiota. Food Chem 2022;396:133730. [PMID: 35878442 DOI: 10.1016/j.foodchem.2022.133730] [Reference Citation Analysis]
68 Gama J, Neves B, Pereira A. Chronic Effects of Dietary Pesticides on the Gut Microbiome and Neurodevelopment. Front Microbiol 2022;13:931440. [PMID: 35847088 DOI: 10.3389/fmicb.2022.931440] [Reference Citation Analysis]
69 Goncin U, Curiel L, Geyer CR, Machtaler S. Aptamer-Functionalized Microbubbles Targeted to P-selectin for Ultrasound Molecular Imaging of Murine Bowel Inflammation. Mol Imaging Biol. [DOI: 10.1007/s11307-022-01755-9] [Reference Citation Analysis]
70 Alharbi O, Aljebreen AM, Azzam NA, Almadi MA, Saeed M, Hajkhdermullaissa B, Asiri H, Almutairi A, Alruthia Y. Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study. JCM 2022;11:4157. [DOI: 10.3390/jcm11144157] [Reference Citation Analysis]
71 Thomas SS, Cha Y, Kim K. Protective Effect of Diet-Supplemented and Endogenously Produced Omega-3 Fatty Acids against HFD-Induced Colon Inflammation in Mice. Foods 2022;11:2124. [DOI: 10.3390/foods11142124] [Reference Citation Analysis]
72 Li Z, Lin M, Li Y, Shao J, Huang R, Qiu Y, Liu Y, Chen L. Total flavonoids of Sophora flavescens and kurarinone ameliorated ulcerative colitis by regulating Th17/Treg cell homeostasis. J Ethnopharmacol 2022;:115500. [PMID: 35863614 DOI: 10.1016/j.jep.2022.115500] [Reference Citation Analysis]
73 Hwang SW. Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients? Gut Liver 2022;16:495-6. [PMID: 35843682 DOI: 10.5009/gnl220279] [Reference Citation Analysis]
74 Nag D, Farr D, Raychaudhuri S, Withey JH. An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from AIEC infection by probiotic E. coli Nissle. iScience 2022;25:104572. [PMID: 35769878 DOI: 10.1016/j.isci.2022.104572] [Reference Citation Analysis]
75 Zhu F, Qin Y, Wang Y, Zhang F, Xu Z, Dai F, Chu W, Wang Y, Zhou G. Critical roles of RGS16 in the mucosal inflammation of ulcerative colitis. Eur J Gastroenterol Hepatol 2022. [PMID: 35830366 DOI: 10.1097/MEG.0000000000002407] [Reference Citation Analysis]
76 Wu X, Liu K, Wu Q, Wang M, Chen X, Li Y, Qian L, Li C, Dai G, Zhang Q, Mu G, Wu J, Shan Z. Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study. Evid Based Complement Alternat Med 2022;2022:3319646. [PMID: 35815273 DOI: 10.1155/2022/3319646] [Reference Citation Analysis]
77 Liu JJ, Abraham BP, Adamson P, Barnes EL, Brister KA, Damas OM, Glover SC, Hooks K, Ingram A, Kaplan GG, Loftus EV, McGovern DPB, Narain-Blackwell M, Odufalu FD, Quezada S, Reeves V, Shen B, Stappenbeck TS, Ward L. The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2022:izac124. [PMID: 35816130 DOI: 10.1093/ibd/izac124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Iyer N, Williams MA, O'Callaghan AA, Dempsey E, Cabrera-Rubio R, Raverdeau M, Crispie F, Cotter PD, Corr SC. Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model. Microorganisms 2022;10:1383. [PMID: 35889102 DOI: 10.3390/microorganisms10071383] [Reference Citation Analysis]
79 Del Amor R, Meseguer P, Parigi TL, Villanacci V, Colomer A, Launet L, Bazarova A, Tontini GE, Bisschops R, de Hertogh G, Ferraz JG, Götz M, Gui X, Hayee B, Lazarev M, Panaccione R, Parra-Blanco A, Bhandari P, Pastorelli L, Rath T, Røyset ES, Vieth M, Zardo D, Grisan E, Ghosh S, Iacucci M, Naranjo V. Constrained multiple instance learning for ulcerative colitis prediction using histological images. Comput Methods Programs Biomed 2022;224:107012. [PMID: 35843078 DOI: 10.1016/j.cmpb.2022.107012] [Reference Citation Analysis]
80 Zhang Y, Si X, Yang L, Wang H, Sun Y, Liu N. Association between intestinal microbiota and inflammatory bowel disease. Animal Model Exp Med 2022. [PMID: 35808814 DOI: 10.1002/ame2.12255] [Reference Citation Analysis]
81 Hu X, Zhang H, Yu L, Ge W, Zhan-mu O, Li Y, Chen C, Hou T, Xiang H, Li Y, Su Y, Jing X, Cao J, Pan H, He W, Li M. Electroacupuncture Reduces Anxiety Associated With Inflammatory Bowel Disease By Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice. Front Pharmacol 2022;13:919553. [DOI: 10.3389/fphar.2022.919553] [Reference Citation Analysis]
82 Huang Y, Wu M, Xiao H, Liu H, Yang G. Mesalamine-Mediated Amelioration of Experimental Colitis in Piglets Involves Gut Microbiota Modulation and Intestinal Immune Cell Infiltration. Front Immunol 2022;13:883682. [DOI: 10.3389/fimmu.2022.883682] [Reference Citation Analysis]
83 Boks M, Lilja M, Widerström M, Karling P, Lindam A, Eriksson A, Sjöström M. Increased incidence of late-onset inflammatory bowel disease and microscopic colitis after a Cryptosporidium hominis outbreak. Scand J Gastroenterol 2022;:1-7. [PMID: 35802626 DOI: 10.1080/00365521.2022.2094722] [Reference Citation Analysis]
84 He J, Zhang Y, Ouyang K, Chen L, Meng W, Zhang Y, Wang W, Jakovljevic V. Extraction, Chemical Composition, and Protective Effect of Essential Oil from Chimonanthus nitens Oliv. Leaves on Dextran Sodium Sulfate-Induced Colitis in Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/9701938] [Reference Citation Analysis]
85 Otten AT, Bourgonje AR, Horinga PP, van der Meulen HH, Festen EAM, van Dullemen HM, Weersma RK, van Leer-buter CC, Dijkstra G, Visschedijk MC. Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease. Front Immunol 2022;13:920333. [DOI: 10.3389/fimmu.2022.920333] [Reference Citation Analysis]
86 Liang H, Zhang F, Wang W, Zhao W, Zhou J, Feng Y, Wu J, Li M, Bai X, Zeng Z, Niu J, Miao Y. Heat Shock Transcription Factor 2 Promotes Mitophagy of Intestinal Epithelial Cells Through PARL/PINK1/Parkin Pathway in Ulcerative Colitis. Front Pharmacol 2022;13:893426. [DOI: 10.3389/fphar.2022.893426] [Reference Citation Analysis]
87 Sand JR, Troelsen FS, Horváth-Puhó E, Henderson VW, Sørensen HT, Erichsen R. Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study. Aliment Pharmacol Ther 2022. [PMID: 35781292 DOI: 10.1111/apt.17119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Allin KH, Jensen CB, Jacobsen RK, Jess T. Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study. J Gastroenterol 2022. [PMID: 35780256 DOI: 10.1007/s00535-022-01896-2] [Reference Citation Analysis]
89 Lin S, Lau LH, Chanchlani N, Kennedy NA, Ng SC. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut 2022;71:1426-39. [PMID: 35477864 DOI: 10.1136/gutjnl-2021-326784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Feged-rivadeneira A, Andrade-rivas F, González-casabianca F, Escobedo FJ. Scaling patterns of human diseases and population size in Colombia. Global Environmental Change 2022;75:102546. [DOI: 10.1016/j.gloenvcha.2022.102546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Chen B, Zhou B, Song G, Li H, Li R, Liu Z, Wei C, Wang T, Wang S, Ma D, Liu J, Yuan X, Liu X. Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis. Transl Androl Urol 2022;11:959-73. [PMID: 35958893 DOI: 10.21037/tau-22-190] [Reference Citation Analysis]
92 Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Steinwurz F, Ahuja V, Ng SC, Rubin DT, Colombel J, Gearry R, Abreu M, Ahuja V, Allez M, Ananthakrishnan A, Bemelman W, Bernstein C, Braun J, Chowers Y, Colombel J, Danese S, D'haens G, D'hoore A, Dignass A, Dotan I, Dubinsky M, Ekbom A, Fleshner P, Gasche C, Gassull M, Gearry R, Ghosh S, Gibson P, Griffiths A, Halfvarson J, Hanauer S, Harpaz N, Hart A, Hibi T, Kamm M, Kaplan G, Kaser A, Korelitz B, Kotze P, Koutroubakis I, Kruis W, Lakatos P, Lewis J, Lindsay J, Loftus E, Louis E, Lukas M, Magro F, Mahadevan U, Mantzaris G, Mary J, Mcgovern D, Moum B, Munkholm P, Neurath M, Ng S, O'morain C, Oresland T, Panaccione R, Panes J, Panis Y, Pemberton J, Peyrin-biroulet L, Prantera C, Rachmilewitz D, Ran Z, Reinisch W, Remzi F, Rhodes J, Riddell R, Rogler G, Rubin D, Sachar D, Sandborn W, Sands B, Sartor B, Schoelmerich J, Schreiber S, Siegel C, Siegmund B, Silverberg M, Söderholm J, Sood A, Spinelli A, Stange E, Steinwurz F, Targan S, Travis S, Turner D, Tysk C, Vatn M, Vermeire S, Watanabe M, Yamamoto T, Yamamoto-furusho J. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. The Lancet Gastroenterology & Hepatology 2022;7:666-78. [DOI: 10.1016/s2468-1253(22)00021-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, Devel L, Dufour A. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacol Rev 2022;74:712-68. [PMID: 35738680 DOI: 10.1124/pharmrev.121.000349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
94 Hsieh C, Weng M, Tung C, Chen N, Chen H, Chien K, Wei S. Dietary beliefs and information resources of ulcerative colitis patients in clinical remission: A cross-sectional survey in Taiwan. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.07.005] [Reference Citation Analysis]
95 Du Y, Chen J, Shen L, Wang B. TRP channels in inflammatory bowel disease: potential therapeutic targets. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115195] [Reference Citation Analysis]
96 Huang F, Zhang S, Li X, Huang Y, He S, Luo L. STAT3-mediated ferroptosis is involved in ulcerative colitis. Free Radic Biol Med 2022;188:375-85. [PMID: 35779691 DOI: 10.1016/j.freeradbiomed.2022.06.242] [Reference Citation Analysis]
97 Prasad H, Mathew JKK, Visweswariah SS. Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities. Front Endocrinol 2022;13:911459. [DOI: 10.3389/fendo.2022.911459] [Reference Citation Analysis]
98 Gowd V, Kanika, Jori C, Chaudhary AA, Rudayni HA, Rashid S, Khan R. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease. J Nutr Biochem 2022;109:109101. [PMID: 35777588 DOI: 10.1016/j.jnutbio.2022.109101] [Reference Citation Analysis]
99 Shin YK, Kwon S, Hsieh YS, Han AY, Seol GH. Linalyl acetate restores colon contractility and blood pressure in repeatedly stressed-ulcerative colitis rats. Environ Health Prev Med 2022;27:27. [PMID: 35753805 DOI: 10.1265/ehpm.22-00041] [Reference Citation Analysis]
100 Korbecki J, Szatkowska I, Kupnicka P, Żwierełło W, Barczak K, Poziomkowska-gęsicka I, Wójcik J, Chlubek D, Baranowska-bosiacka I. The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs. IJMS 2022;23:7151. [DOI: 10.3390/ijms23137151] [Reference Citation Analysis]
101 Lee YH, Kim H, Nam S, Chu JR, Kim JH, Lim JS, Kim SE, Sung MK. Protective Effects of High-Fat Diet against Murine Colitis in Association with Leptin Signaling and Gut Microbiome. Life (Basel) 2022;12:972. [PMID: 35888062 DOI: 10.3390/life12070972] [Reference Citation Analysis]
102 Xu HM, Xu J, Yang MF, Liang YJ, Peng QZ, Zhang Y, Tian CM, Nie YQ, Wang LS, Yao J, Li DF. Epigenetic DNA methylation of Zbtb7b regulates the population of double-positive CD4+CD8+ T cells in ulcerative colitis. J Transl Med 2022;20:289. [PMID: 35761286 DOI: 10.1186/s12967-022-03477-6] [Reference Citation Analysis]
103 Suarez RG, Osornio-Vargas AR, Wine E. Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review. Dig Dis Sci 2022. [PMID: 35751831 DOI: 10.1007/s10620-022-07597-3] [Reference Citation Analysis]
104 Shi Z, Takeuchi T, Nakanishi Y, Kato T, Beck K, Nagata R, Kageyama T, Ito A, Ohno H, Satoh-Takayama N. A Japanese Herbal Formula, Daikenchuto, Alleviates Experimental Colitis by Reshaping Microbial Profiles and Enhancing Group 3 Innate Lymphoid Cells. Front Immunol 2022;13:903459. [PMID: 35720414 DOI: 10.3389/fimmu.2022.903459] [Reference Citation Analysis]
105 Bogale K, Maheshwari P, Kang M, Gorrepati VS, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K, Coates MD. Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease. Sci Rep 2022;12:10577. [PMID: 35732802 DOI: 10.1038/s41598-022-14838-y] [Reference Citation Analysis]
106 Xu L, Liu B, Huang L, Li Z, Cheng Y, Tian Y, Pan G, Li H, Xu Y, Wu W, Cui Z, Xie L. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Microbiol Spectr 2022;:e0065722. [PMID: 35730951 DOI: 10.1128/spectrum.00657-22] [Reference Citation Analysis]
107 Macleod A, Kavalukas SL, Scheurlen KM, Galandiuk S. State-of-the-art surgery for Crohn's disease: Part II-colonic Crohn's disease and associated neoplasms. Langenbecks Arch Surg 2022. [PMID: 35729401 DOI: 10.1007/s00423-022-02572-y] [Reference Citation Analysis]
108 Chen F, Liu Y, Shi Y, Zhang J, Liu X, Liu Z, Lv J, Leng Y. The emerging role of neutrophilic extracellular traps in intestinal disease. Gut Pathog 2022;14:27. [PMID: 35733158 DOI: 10.1186/s13099-022-00497-x] [Reference Citation Analysis]
109 He YM, Mao R, Yuan G, Liang RM, Long JY, Ye XQ, Iacucci M, Ghosh S, Ben-Horin S, Kaplan GG, He Y, Sung JJY, Peng S, Wang HB, Chen MH. The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018. Therap Adv Gastroenterol 2022;15:17562848221102307. [PMID: 35721841 DOI: 10.1177/17562848221102307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Watanabe K, Gardiner S, Arai S. Notable gaps between patients' and physicians' perspectives on communication and disease management in Japan: multifaceted ad hoc analyses of the global Ulcerative Colitis Narrative Survey for further optimal care. Therap Adv Gastroenterol 2022;15:17562848221095372. [PMID: 35721839 DOI: 10.1177/17562848221095372] [Reference Citation Analysis]
111 Zhu R, Tang J, Xing C, Nan Q, Liang G, Luo J, Zhou J, Miao Y, Cao Y, Dai S, Lan D. The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes. Front Microbiol 2022;13:883495. [DOI: 10.3389/fmicb.2022.883495] [Reference Citation Analysis]
112 Park SH, Park SH. Personalized medicine in inflammatory bowel disease: Perspectives on Asia. J Gastroenterol Hepatol 2022. [PMID: 35726657 DOI: 10.1111/jgh.15919] [Reference Citation Analysis]
113 Zhang J, Guo Y, Duan L. Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review. Front Med (Lausanne) 2022;9:773105. [PMID: 35721102 DOI: 10.3389/fmed.2022.773105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Zhong Y, Liu W, Xiong Y, Li Y, Wan Q, Zhou W, Zhao H, Xiao Q, Liu D. Astragaloside Ⅳ alleviates ulcerative colitis by regulating the balance of Th17/Treg cells. Phytomedicine 2022;104:154287. [PMID: 35752072 DOI: 10.1016/j.phymed.2022.154287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Wang W, Chen X, Pan J, Zhang X, Zhang L. Epstein-Barr Virus and Human Cytomegalovirus Infection in Intestinal Mucosa of Chinese Patients With Inflammatory Bowel Disease. Front Microbiol 2022;13:915453. [PMID: 35711779 DOI: 10.3389/fmicb.2022.915453] [Reference Citation Analysis]
116 Smith AP, Creagh EM. Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease. Front Pharmacol 2022;13:919567. [PMID: 35712726 DOI: 10.3389/fphar.2022.919567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Bauer N, Kairey L, Schlee C, Uecker C, Öznur Ö, Langhorst J. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002. Scand J Gastroenterol 2022;:1-7. [PMID: 35722930 DOI: 10.1080/00365521.2022.2078667] [Reference Citation Analysis]
118 Toskas A, Akbar A. IBD therapeutics: what is in the pipeline? Frontline Gastroenterol 2022;13:e35-43. [DOI: 10.1136/flgastro-2022-102130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Sokolova V, Ebel JF, Kollenda S, Klein K, Kruse B, Veltkamp C, Lange CM, Westendorf AM, Epple M. Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell Models. Small 2022;:e2201167. [PMID: 35712760 DOI: 10.1002/smll.202201167] [Reference Citation Analysis]
120 Liu N, Wang H, Yang Z, Zhao K, Li S, He N. The role of functional oligosaccharides as prebiotics in ulcerative colitis. Food Funct 2022. [PMID: 35703137 DOI: 10.1039/d2fo00546h] [Reference Citation Analysis]
121 Gonzalez-vivo M, Lund Tiirikainen MK, Andreu M, Fernandez-clotet A, López-garcía A, Murciano Gonzalo F, Abril Rodriguez L, de Jesús-gil C, Ruiz-romeu E, Sans-de San Nicolàs L, Santamaria-babí LF, Márquez-mosquera L. Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis. Front Med 2022;9:837294. [DOI: 10.3389/fmed.2022.837294] [Reference Citation Analysis]
122 Löwe B, Nestoriuc Y, Andresen V, Vettorazzi E, Zapf A, Hübener S, Maehder K, Peters L, Lohse AW. Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT). BMJ Open 2022;12:e059529. [PMID: 35701050 DOI: 10.1136/bmjopen-2021-059529] [Reference Citation Analysis]
123 Cho S, Stroup BM, Britto SL, Ruan W, Schady D, Hoffman KL, Kellermayer R. Increased number of children in households may protect against inflammatory bowel disease. Pediatr Res 2022. [PMID: 35701607 DOI: 10.1038/s41390-022-02149-x] [Reference Citation Analysis]
124 Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, Zhu W, Yang Y, Liu Z, Chen Q. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun 2022;13:3432. [PMID: 35701435 DOI: 10.1038/s41467-022-31171-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
125 Herrera-Gómez RG, Grecea M, Gallois C, Boige V, Pautier P, Pistilli B, Planchard D, Malka D, Ducreux M, Mir O. Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease. Cancers (Basel) 2022;14:2914. [PMID: 35740579 DOI: 10.3390/cancers14122914] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Liu L, Pu D, Wang D, Zhang M, Zhou C, Zhang Z, Feng B. Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis. Front Pharmacol 2022;13:905133. [DOI: 10.3389/fphar.2022.905133] [Reference Citation Analysis]
127 Uche-Anya E, Anyane-Yeboa A, Berzin TM, Ghassemi M, May FP. Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity. Gut 2022:gutjnl-2021-326271. [PMID: 35688612 DOI: 10.1136/gutjnl-2021-326271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Zhang S, Liang Y, Yao J, Li DF, Wang LS. Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs. Front Pharmacol 2022;13:833588. [PMID: 35677444 DOI: 10.3389/fphar.2022.833588] [Reference Citation Analysis]
129 Cui G, Florholmen J, Goll R. Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis? Front Immunol 2022;13:881112. [PMID: 35663996 DOI: 10.3389/fimmu.2022.881112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Wu Z, Yang J, Chen L, Du C, Zhang Q, Zhao S, Wang X, Yang J, Liu Y, Cai D, Du J, Liu H. Short-Term High-Fat Diet Fuels Colitis Progression in Mice Associated With Changes in Blood Metabolome and Intestinal Gene Expression. Front Nutr 2022;9:899829. [DOI: 10.3389/fnut.2022.899829] [Reference Citation Analysis]
131 . Stellungnahme der DGVS zur Nutzenbewertung des GBA zum Wirkstoff Filgotinib (Anwendungsgebiet: Colitis Ulcerosa, vorbehandelte Patient*innen). Z Gastroenterol 2022;60:1047-50. [DOI: 10.1055/a-1851-7777] [Reference Citation Analysis]
132 Zhao Z, Xu S, Zhang W, Wu D, Yang G. Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications. Food Funct 2022;13:5914-24. [PMID: 35583304 DOI: 10.1039/d2fo00226d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Mo X, Tang K, Deng L, Zhou X, Li X, Zhang Y, Wang J. Prevention of ulcerative colitis by Huangqin decoction: reducing the intestinal epithelial cell apoptosis rate through the IFN-γ/JAK/ETS signalling pathway. Pharm Biol 2022;60:1116-25. [PMID: 35654745 DOI: 10.1080/13880209.2022.2070220] [Reference Citation Analysis]
134 Qu P, Xie X, Chi J, Liu X, Liu P, Luo J, Li H, Cheng S, Xia X, Chen X, Xu C, Sun Y. Circulating Exosomal miR-144-3p from Crohn’s Disease Patients Inhibits Human Umbilical Vein Endothelial Cell Function by Targeting FN1. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/8219557] [Reference Citation Analysis]
135 Szigeti KA, Kalmár A, Galamb O, Valcz G, Barták BK, Nagy ZB, Zsigrai S, Felletár I, V. Patai Á, Micsik T, Papp M, Márkus E, Tulassay Z, Igaz P, Takács I, Molnár B. Global DNA hypomethylation of colorectal tumours detected in tissue and liquid biopsies may be related to decreased methyl-donor content. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09659-1] [Reference Citation Analysis]
136 Hu W, Fang T, Chen X. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis. Front Genet 2022;13:914384. [DOI: 10.3389/fgene.2022.914384] [Reference Citation Analysis]
137 Xu C, Chen S, Chen C, Ming Y, Du J, Mu J, Luo F, Huang D, Wang N, Lin Z, Weng Z. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy. Int J Pharm 2022;623:121884. [PMID: 35661797 DOI: 10.1016/j.ijpharm.2022.121884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Mak JWY, Yang S, Stanley A, Lin X, Morrison M, Ching JYL, Niu J, Wilson‐o'brien AL, Feng R, Tang W, Hamilton AL, Or L, Trakman GL, Lin WYY, Sung JJY, Chen MH, Mao Y, Kamm MA, Ng SC. Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study. JGH Open. [DOI: 10.1002/jgh3.12755] [Reference Citation Analysis]
139 Al Sharie AH, Al Zu'bi YO, Al-sweedan S, Khasawneh RA, Altamimi E. Successful management of dural venous sinus thrombosis secondary to ulcerative colitis in a pediatric patient: A case report. Radiology Case Reports 2022;17:2162-6. [DOI: 10.1016/j.radcr.2022.03.049] [Reference Citation Analysis]
140 Wu G, Zhang D, Yang L, Wu Q, Yuan L. MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice. Molecular Immunology 2022;146:57-68. [DOI: 10.1016/j.molimm.2022.03.121] [Reference Citation Analysis]
141 Zhang XX, Diao LZ, Chen LZ, Ma D, Wang YM, Jiang H, Ruan BF, Liu XH. Discovery of 4-((E)-3,5-dimethoxy-2-((E)-2-nitrovinyl)styryl)aniline derivatives as potent and orally active NLRP3 inflammasome inhibitors for colitis. European Journal of Medicinal Chemistry 2022;236:114357. [DOI: 10.1016/j.ejmech.2022.114357] [Reference Citation Analysis]
142 Nguepi Tsopmejio IS, Ding M, Wei J, Zhao C, Jiang Y, Li Y, Song H. Auricularia polytricha and Flammulina velutipes ameliorate inflammation and modulate the gut microbiota via regulation of NF-κB and Keap1/Nrf2 signaling pathways on DSS-induced inflammatory bowel disease. Food Bioscience 2022;47:101426. [DOI: 10.1016/j.fbio.2021.101426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Li Y, Nguepi Tsopmejio IS, Diao Z, Xiao H, Wang X, Jin Z, Song H. Aronia melanocarpa (Michx.) Elliott. attenuates dextran sulfate sodium-induced Inflammatory Bowel Disease via regulation of inflammation-related signaling pathways and modulation of the gut microbiota. Journal of Ethnopharmacology 2022;292:115190. [DOI: 10.1016/j.jep.2022.115190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Garza-hernandez D, Estrada K, Trevino V. Multivariate genome-wide association study models to improve prediction of Crohn’s disease risk and identification of potential novel variants. Computers in Biology and Medicine 2022;145:105398. [DOI: 10.1016/j.compbiomed.2022.105398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Feng Z, Zhou P, Wu X, Zhang J, Zhang M. Hydroxysafflor yellow A protects against ulcerative colitis via suppressing TLR4/NF-κB signaling pathway. Chem Biol Drug Des 2022;99:897-907. [PMID: 35319164 DOI: 10.1111/cbdd.14045] [Reference Citation Analysis]
146 Yu K, Faye AS, Wen T, Guglielminotti JR, Huang Y, Wright JD, D'Alton ME, Friedman AM. Outcomes during delivery hospitalisations with inflammatory bowel disease. BJOG 2022;129:1073-83. [PMID: 35152548 DOI: 10.1111/1471-0528.17039] [Reference Citation Analysis]
147 Watermeyer G, Awuku Y, Fredericks E, Epstein D, Setshedi M, Devani S, Mudombi W, Kassianides C, Katsidzira L. Challenges in the management of inflammatory bowel disease in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(22)00048-6] [Reference Citation Analysis]
148 Watermeyer G, Katsidzira L, Setshedi M, Devani S, Mudombi W, Kassianides C. Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(22)00047-4] [Reference Citation Analysis]
149 Jiang K, Chen B, Lou D, Zhang M, Shi Y, Dai W, Shen J, Zhou B, Hu J. Systematic review and meta-analysis: association between obesity/overweight and surgical complications in IBD. Int J Colorectal Dis 2022. [PMID: 35641579 DOI: 10.1007/s00384-022-04190-y] [Reference Citation Analysis]
150 Zhang S, Luo H, Tan D, Peng B, Zhong Z, Wang Y. Holism of Chinese herbal medicine prescriptions for inflammatory bowel disease: A review based on clinical evidence and experimental research. Phytomedicine 2022;102:154202. [PMID: 35665678 DOI: 10.1016/j.phymed.2022.154202] [Reference Citation Analysis]
151 Wu S, Xie S, Yuan C, Yang Z, Liu S, Zhang Q, Sun F, Wu J, Zhan S, Zhu S, Zhang S. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank. Inflamm Bowel Dis 2022:izac096. [PMID: 35639937 DOI: 10.1093/ibd/izac096] [Reference Citation Analysis]
152 He XQ, Liu D, Liu HY, Wu DT, Li HB, Zhang XS, Gan RY. Prevention of Ulcerative Colitis in Mice by Sweet Tea (Lithocarpus litseifolius) via the Regulation of Gut Microbiota and Butyric-Acid-Mediated Anti-Inflammatory Signaling. Nutrients 2022;14:2208. [PMID: 35684007 DOI: 10.3390/nu14112208] [Reference Citation Analysis]
153 Zhang Z, Yu X, Fang N, Long X, Ruan X, Qiu J, Tao S, Gong P, Nie K, Li A, Wang X, Tian L. Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn's disease in different treatments. BMC Gastroenterol 2022;22:250. [PMID: 35585617 DOI: 10.1186/s12876-022-02327-5] [Reference Citation Analysis]
154 Sweeney L, Windgassen S, Artom M, Norton C, Fawson S, Moss-Morris R. A Novel Digital Self-management Intervention for Symptoms of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Describing the Process of Development. JMIR Form Res 2022;6:e33001. [PMID: 35583924 DOI: 10.2196/33001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Tursi A, Mocci G, Allegretta L, Aragona G, Bianco MA, Colucci R, Cuomo A, Della Valle N, Ferronato A, Forti G, Gaiani F, Giorgetti G, Graziani MG, Lofano K, Lorenzetti R, Larussa T, Penna A, Pica R, Pranzo G, Rodino' S, Scarcelli A, Zampaletta C, Bassotti G, Cazzato AI, Chiri S, Clemente V, Cocco A, De' Angelis G, Donnarumma L, Faggiani R, Graziosi C, Le Grazie M, Luzza F, Meucci C, Monterubbianesi R, Pagnini C, Perazzo P, Picchio M, Sacco R, Sebkova L, Serio M, Napolitano D, Pugliese D, Scaldaferri F, Schiavoni E, Turchini L, Armuzzi A, Elisei W, Maconi G, Papa A. Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study. Inflamm Bowel Dis 2022:izac092. [PMID: 35579320 DOI: 10.1093/ibd/izac092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Sheehan GT, Twardus SW, Cagan A, Ananthakrishnan AN. E-cigarette Use and Disease Outcomes in Inflammatory Bowel Diseases: A Case-Control Study. Dig Dis Sci 2022. [PMID: 35579793 DOI: 10.1007/s10620-022-07539-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Chiarello MM, Pepe G, Fico V, Bianchi V, Tropeano G, Altieri G, Brisinda G. Therapeutic strategies in Crohn’s disease in an emergency surgical setting. World J Gastroenterol 2022; 28(18): 1902-1921 [DOI: 10.3748/wjg.v28.i18.1902] [Reference Citation Analysis]
158 Stamatiou D, Naumann DN, Foss H, Singhal R, Karandikar S. Effects of ethnicity and socioeconomic status on surgical outcomes from inflammatory bowel disease. Int J Colorectal Dis 2022. [PMID: 35554640 DOI: 10.1007/s00384-022-04180-0] [Reference Citation Analysis]
159 El-Nakeep S, Shawky A, Abbas SF, Abdel Latif O. Stem cell transplantation for induction of remission in medically refractory Crohn's disease. Cochrane Database Syst Rev 2022;5:CD013070. [PMID: 35556242 DOI: 10.1002/14651858.CD013070.pub2] [Reference Citation Analysis]
160 Li Y, Yang X, Yuan J, Lin R, Tian Y, Li Y, Zhang Y, Wang X, Xie Y, Wang S, Zheng X. Ilex rotunda Thunb Protects Against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Restoring the Intestinal Mucosal Barrier and Modulating the Oncostatin M/Oncostatin M Receptor Pathway. Front Pharmacol 2022;13:819826. [DOI: 10.3389/fphar.2022.819826] [Reference Citation Analysis]
161 Gong M, Zhang F, Miao Y, Niu J. Advances of Heat Shock Family in Ulcerative Colitis. Front Pharmacol 2022;13:869930. [DOI: 10.3389/fphar.2022.869930] [Reference Citation Analysis]
162 King D, Chandan JS, Thomas T, Denniston AK, Braithwaite T, Niranthrankumar K, Reulen R, Adderley N, Trudgill NJ. Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data. BMJ Open 2022;12:e052833. [PMID: 35545379 DOI: 10.1136/bmjopen-2021-052833] [Reference Citation Analysis]
163 Ouahhoud S, Khoulati A, Kadda S, Bencheikh N, Mamri S, Ziani A, Baddaoui S, Eddabbeh F, Lahmass I, Benabbes R, Addi M, Hano C, Asehraou A, Saalaoui E. Antioxidant Activity, Metal Chelating Ability and DNA Protective Effect of the Hydroethanolic Extracts of Crocus sativus Stigmas, Tepals and Leaves. Antioxidants 2022;11:932. [DOI: 10.3390/antiox11050932] [Reference Citation Analysis]
164 Rath E, Haller D. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol. [DOI: 10.1038/s41385-022-00514-x] [Reference Citation Analysis]
165 Ono K, Kishimoto M, Deshpande GA, Fukui S, Kawaai S, Sawada H, Matsuura M, Rodriguez VR, Proft F, Tada K, Tamura N, Taniguchi Y, Hirata A, Kameda H, Tsuji S, Kaneko Y, Dobashi H, Okano T, Haji Y, Morita A, Okada M, Komagata Y, Medina CL, Molto A, Dougados M, Hisamatsu T, Tomita T, Kaname S. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatol Int. [DOI: 10.1007/s00296-022-05117-0] [Reference Citation Analysis]
166 Huang JG, Wong YKY, Chew KS, Tanpowpong P, Calixto Mercado KS, Reodica A, Rajindrajith S, Chang KC, Ni YH, Treepongkaruna S, Lee WS, Aw MM. Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network. World J Gastroenterol 2022; 28(17): 1830-1844 [PMID: 35633913 DOI: 10.3748/wjg.v28.i17.1830] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Marquez-megias S, Nalda-molina R, Sanz-valero J, Más-serrano P, Diaz-gonzalez M, Candela-boix MR, Ramon-lopez A. Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review. Pharmaceutics 2022;14:1009. [DOI: 10.3390/pharmaceutics14051009] [Reference Citation Analysis]
168 Teng G, Liu Z, Liu Y, Wu T, Dai Y, Wang H, Wang W. Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota. Front Microbiol 2022;13:819336. [DOI: 10.3389/fmicb.2022.819336] [Reference Citation Analysis]
169 Weiß F, Czichos C, Knobe L, Voges L, Bojarski C, Michel G, Fromm M, Krug SM. MarvelD3 Is Upregulated in Ulcerative Colitis and Has Attenuating Effects during Colitis Indirectly Stabilizing the Intestinal Barrier. Cells 2022;11:1541. [DOI: 10.3390/cells11091541] [Reference Citation Analysis]
170 Rowan C, Ungaro R, Mehandru S, Colombel JF. An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitis. Expert Opin Pharmacother 2022. [PMID: 35503955 DOI: 10.1080/14656566.2022.2071605] [Reference Citation Analysis]
171 Kamath C, Brenner EJ. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic. Curr Res Pharmacol Drug Discov 2022;3:100101. [PMID: 35496814 DOI: 10.1016/j.crphar.2022.100101] [Reference Citation Analysis]
172 Xie W, Xiao S, Huang H, Zhang Z. Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis. Front Immunol 2022;13:847160. [PMID: 35300336 DOI: 10.3389/fimmu.2022.847160] [Reference Citation Analysis]
173 Vicentini FA, Szamosi JC, Rossi L, Griffin L, Nieves K, Bihan D, Lewis IA, Pittman QJ, Swain MG, Surette MG, Hirota SA, Sharkey KA. Colitis-associated microbiota drives changes in behaviour in male mice in the absence of inflammation. Brain Behav Immun 2022;102:266-78. [PMID: 35259427 DOI: 10.1016/j.bbi.2022.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
174 Wu Z, Liu D, Deng F. The Role of Vitamin D in Immune System and Inflammatory Bowel Disease. JIR 2022;Volume 15:3167-85. [DOI: 10.2147/jir.s363840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Kelsen J, Dawany N, Conrad M, Patel T, Devoto M, Maurer K, Sullivan KE. Clinical and laboratory predictors of monogenic very early onset inflammatory bowel disease. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109047] [Reference Citation Analysis]
176 Zhang Y, Lu F, Zhang H, Ye Y, Liu P, Lin D, Zhou H, Li M, Yang B. Polysaccharides from Agaricus blazei Murrill ameliorate dextran sulfate sodium-induced colitis via attenuating intestinal barrier dysfunction. Journal of Functional Foods 2022;92:105072. [DOI: 10.1016/j.jff.2022.105072] [Reference Citation Analysis]
177 Ozanne J, Shek B, Stephen LA, Novak A, Milne E, Mclachlan G, Midwood KS, Farquharson C. Tenascin-C is a driver of inflammation in the DSS model of colitis. Matrix Biology Plus 2022. [DOI: 10.1016/j.mbplus.2022.100112] [Reference Citation Analysis]
178 Si X, Jia H, Liu N, Li J, Pan L, Wang J, Wu Z. Alpha-Ketoglutarate Attenuates Colitis in Mice by Increasing Lactobacillus Abundance and Regulating Stem Cell Proliferation via Wnt-Hippo Signaling. Mol Nutr Food Res 2022;66:e2100955. [PMID: 35220672 DOI: 10.1002/mnfr.202100955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 Hernandez J, Rhimi S, Kriaa A, Mariaule V, Boudaya H, Drut A, Jablaoui A, Mkaouar H, Saidi A, Biourge V, Borgi MA, Rhimi M, Maguin E. Domestic Environment and Gut Microbiota: Lessons from Pet Dogs. Microorganisms 2022;10:949. [DOI: 10.3390/microorganisms10050949] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Abaach M, Morilla I. Learning models for colorectal cancer signature reconstruction and classification in patients with chronic inflammatory bowel disease. Artif Intell Cancer 2022; 3(2): 27-41 [DOI: 10.35713/aic.v3.i2.27] [Reference Citation Analysis]
181 Antonatos C, Panoutsopoulou M, Georgakilas GK, Evangelou E, Vasilopoulos Y. Gene Expression Meta-Analysis of Potential Shared and Unique Pathways between Autoimmune Diseases under Anti-TNFα Therapy. Genes 2022;13:776. [DOI: 10.3390/genes13050776] [Reference Citation Analysis]
182 Wu Q, Fan L, Tan H, Zhang Y, Fang Q, Yang J, Cui SW, Nie S. Impact of pectin with various esterification degrees on the profiles of gut microbiota and serum metabolites. Appl Microbiol Biotechnol 2022. [PMID: 35474485 DOI: 10.1007/s00253-022-11926-x] [Reference Citation Analysis]
183 Kiran S, Rakib A, Moore BM, Singh UP. Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis. Pharmaceutics 2022;14:936. [DOI: 10.3390/pharmaceutics14050936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Huang LJ, Wang YM, Gong LQ, Hu C, Gui Y, Zhang C, Tan X, Yu XK, Liao YL, Luo Y, Tang YQ, Dai YF, Deng Y, Wang D, Guo DL. N-Acetyldopamine Dimer Attenuates DSS-Induced Ulcerative Colitis by Suppressing NF-κB and MAPK Pathways. Front Pharmacol 2022;13:842730. [PMID: 35462925 DOI: 10.3389/fphar.2022.842730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
185 Liu J, Zhang L, Wang Z, Chen S, Feng S, He Y, Zhang S. Network Pharmacology-Based Strategy to Identify the Pharmacological Mechanisms of Pulsatilla Decoction against Crohn's Disease. Front Pharmacol 2022;13:844685. [PMID: 35450039 DOI: 10.3389/fphar.2022.844685] [Reference Citation Analysis]
186 Ye C, Zhu S, Yuan J. Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease. Front Immunol 2022;13:871312. [DOI: 10.3389/fimmu.2022.871312] [Reference Citation Analysis]
187 Zhang J, Nie J, Zou M, Zeng Q, Feng Y, Luo Z, Gan H. Prevalence and Associated Factors of Sexual Dysfunction in Patients With Inflammatory Bowel Disease. Front Endocrinol 2022;13:881485. [DOI: 10.3389/fendo.2022.881485] [Reference Citation Analysis]
188 Sun L, Han Y, Wang H, Liu H, Liu S, Yang H, Ren X, Fang Y. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis. J Int Med Res 2022;50:3000605221089503. [PMID: 35443818 DOI: 10.1177/03000605221089503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Tang ML, Li H, Ning JF, Shen X, Sun X. Discovery of First-in-Class TAK1-MKK3 Protein-Protein Interaction (PPI) Inhibitor (R)-STU104 for the Treatment of Ulcerative Colitis through Modulating TNF-α Production. J Med Chem 2022. [PMID: 35442672 DOI: 10.1021/acs.jmedchem.1c02198] [Reference Citation Analysis]
190 Gavrilescu O, Prelipcean CC, Dranga M, Popa IV, Mihai C. Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients. Medicina 2022;58:562. [DOI: 10.3390/medicina58050562] [Reference Citation Analysis]
191 Paller AS, Seyger MMB, Magariños GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, Somani N, Garrelts A, Papp KA; IXORA-PEDS Investigators. Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial. JAMA Dermatol 2022. [PMID: 35416908 DOI: 10.1001/jamadermatol.2022.0655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
192 Garza-Hernandez D, Sepulveda-Villegas M, Garcia-Pelaez J, Aguirre-Gamboa R, Lakatos PL, Estrada K, Martinez-Vazquez M, Trevino V. A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes. BMC Genomics 2022;23:302. [PMID: 35418025 DOI: 10.1186/s12864-022-08491-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Wang S, Bai M, Shu Q, Liu Z, Shao Y, Xu K, Xiong X, Liu H, Li Y. Modulating Effect of Paeonol on Piglets With Ulcerative Colitis. Front Nutr 2022;9:846684. [DOI: 10.3389/fnut.2022.846684] [Reference Citation Analysis]
194 Khan I, Wei J, Li A, Liu Z, Yang P, Jing Y, Chen X, Zhao T, Bai Y, Zha L, Li C, Ullah N, Che T, Zhang C. Lactobacillus plantarum strains attenuated DSS-induced colitis in mice by modulating the gut microbiota and immune response. Int Microbiol 2022. [PMID: 35414032 DOI: 10.1007/s10123-022-00243-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
195 Jess T, Vestergaard MV, Iversen AT, Allin KH. Undiagnosed inflammatory bowel disease among individuals undergoing colorectal cancer screening: a nationwide Danish cohort study 2014-2018. Gut 2022:gutjnl-2022-327296. [PMID: 35414571 DOI: 10.1136/gutjnl-2022-327296] [Reference Citation Analysis]
196 Ronchetti C, Cirillo F, Di Segni N, Cristodoro M, Busnelli A, Levi-setti PE. Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy—A Narrative Review. Nutrients 2022;14:1591. [DOI: 10.3390/nu14081591] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Xu M, Kong Y, Chen N, Peng W, Zi R, Jiang M, Zhu J, Wang Y, Yue J, Lv J, Zeng Y, Chin YE. Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis. Front Immunol 2022;13:855645. [PMID: 35392084 DOI: 10.3389/fimmu.2022.855645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Bai X, Liu W, Chen H, Zuo T, Wu X. Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease. Front Immunol 2022;13:861790. [PMID: 35371090 DOI: 10.3389/fimmu.2022.861790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Maeda K, Nakamura M, Yamamura T, Sawada T, Ishikawa E, Oishi A, Ikegami S, Kakushima N, Furukawa K, Iida T, Mizutani Y, Ishikawa T, Ohno E, Honda T, Ishigami M, Kawashima H. Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis. Biomedicines 2022;10:872. [DOI: 10.3390/biomedicines10040872] [Reference Citation Analysis]
200 Cortes GM, Marcialis MA, Bardanzellu F, Corrias A, Fanos V, Mussap M. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin. Front Microbiol 2022;13:856165. [PMID: 35391730 DOI: 10.3389/fmicb.2022.856165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
201 Wang L, Chen L, Wang X, Liu K, Li T, Yu Y, Han J, Xing S, Xu J, Tian D, Seidler U, Xiao F. Development of a Convolutional Neural Network-Based Colonoscopy Image Assessment Model for Differentiating Crohn’s Disease and Ulcerative Colitis. Front Med 2022;9:789862. [DOI: 10.3389/fmed.2022.789862] [Reference Citation Analysis]
202 Lyu D, Kou G, Li S, Li L, Li B, Zhou R, Yang X, Tian W, Li Y, Zuo X. Digital Spatial Profiling Reveals Functional Shift of Enterochromaffin Cell in Patients With Ulcerative Colitis. Front Cell Dev Biol 2022;10:841090. [DOI: 10.3389/fcell.2022.841090] [Reference Citation Analysis]
203 Gordon M, Sinopoulou V, Akobeng AK, Pana M, Gasiea R, Moran GW. Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis. Cochrane Database Syst Rev 2022;4:CD007216. [PMID: 35388476 DOI: 10.1002/14651858.CD007216.pub2] [Reference Citation Analysis]
204 Wang S, Zhen L, Li X, Fu X, Li P, Zhang D. Search for Key Genes and Functional Pathways of Ulcerative Colitis to Colon Cancer Based on Bioinformatics. Front Oncol 2022;12:857148. [PMID: 35372018 DOI: 10.3389/fonc.2022.857148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Chen R, Tie Y, Lu J, Li L, Zeng Z, Chen M, Zhang S. Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions. Cell Prolif 2022;:e13222. [PMID: 35373402 DOI: 10.1111/cpr.13222] [Reference Citation Analysis]
206 Erdmann A, Rehmann-sutter C, Bozzaro C. Clinicians’ and Researchers’ Views on Precision Medicine in Chronic Inflammation: Practices, Benefits and Challenges. JPM 2022;12:574. [DOI: 10.3390/jpm12040574] [Reference Citation Analysis]
207 Tian Z, Zhuang X, Zhuo S, Zhu Y, Hu S, Zhao M, Tang C, Zhang Z, Li X, Ma R, Zeng Z, Feng R, Chen M. Dietary inflammatory potential mediated gut microbiota and metabolite alterations in Crohn's disease: A fire-new perspective. Clinical Nutrition 2022. [DOI: 10.1016/j.clnu.2022.04.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Gu W, Zhang L, Han T, Huang H, Chen J. Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model. JIR 2022;Volume 15:2631-47. [DOI: 10.2147/jir.s358807] [Reference Citation Analysis]
209 Zamani M, Alizadeh-Tabari S, Singh S, Loomba R. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2022;55:894-907. [PMID: 35274325 DOI: 10.1111/apt.16879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Wang Z, Zhou H, Cheng F, Zhang Z, Long S. MiR-21 regulates epithelial–mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.04.007] [Reference Citation Analysis]
211 Papamichael K, Jairath V, Zou G, Cohen B, Ritter T, Sands B, Siegel C, Valentine J, Smith M, Vande Casteele N, Dubinsky M, Cheifetz A. Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial). BMJ Open 2022;12:e057656. [PMID: 35365535 DOI: 10.1136/bmjopen-2021-057656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Yang W, Dong HP, Wang P, Xu ZG, Xian J, Chen J, Wu H, Lou Y, Lin D, Zhong B. IL-36γ and IL-36Ra Reciprocally Regulate Colon Inflammation and Tumorigenesis by Modulating the Cell-Matrix Adhesion Network and Wnt Signaling. Adv Sci (Weinh) 2022;9:e2103035. [PMID: 35119210 DOI: 10.1002/advs.202103035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
213 Yi YS. Dual roles of the caspase-11 non-canonical inflammasome in inflammatory bowel disease. Int Immunopharmacol 2022;108:108739. [PMID: 35366642 DOI: 10.1016/j.intimp.2022.108739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Feng P, Li Q, Liu L, Wang S, Wu Z, Tao Y, Huang P, Wang P. Crocetin Prolongs Recovery Period of DSS-Induced Colitis via Altering Intestinal Microbiome and Increasing Intestinal Permeability. Int J Mol Sci 2022;23:3832. [PMID: 35409192 DOI: 10.3390/ijms23073832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
215 He P, Yu L, Tian F, Zhang H, Chen W, Zhai Q. Dietary Patterns and Gut Microbiota: the Crucial Actors in Inflammatory Bowel Disease. Adv Nutr 2022:nmac029. [PMID: 35348593 DOI: 10.1093/advances/nmac029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Kikut J, Mokrzycka M, Drozd A, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC). JCM 2022;11:1861. [DOI: 10.3390/jcm11071861] [Reference Citation Analysis]
217 Zheng L, Wen X, Duan S. Role of metabolites derived from gut microbiota in inflammatory bowel disease. WJCC 2022;10:2660-77. [DOI: 10.12998/wjcc.v10.i9.2660] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
218 Zeng J, Wang Z, Yang X. Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis. Eur J Clin Pharmacol. [DOI: 10.1007/s00228-022-03312-3] [Reference Citation Analysis]
219 Huang J, Zhang J, Ma J, Ma J, Liu J, Wang F, Tang X, Moreira H. Inhibiting Ferroptosis: A Novel Approach for Ulcerative Colitis Therapeutics. Oxidative Medicine and Cellular Longevity 2022;2022:1-9. [DOI: 10.1155/2022/9678625] [Reference Citation Analysis]
220 Zheng L, Wen XL, Duan SL. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World J Clin Cases 2022; 10(9): 2658-2675 [DOI: 10.12998/wjcc.v10.i9.2658] [Reference Citation Analysis]
221 Sinopoulou V, Gordon M, Limketkai BN, Mullin G, Aali G, Akobeng AK; Cochrane Gut Group. Prebiotics for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd015084] [Reference Citation Analysis]
222 Forbes L, Johnson SK. Online Mindfulness Intervention for Inflammatory Bowel Disease: Adherence and Efficacy. Front Psychol 2022;12:709899. [DOI: 10.3389/fpsyg.2021.709899] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Alkushi AG, Abdelfattah-Hassan A, Eldoumani H, Elazab ST, Mohamed SAM, Metwally AS, S El-Shetry E, Saleh AA, ElSawy NA, Ibrahim D. Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis. Sci Rep 2022;12:5116. [PMID: 35332200 DOI: 10.1038/s41598-022-08915-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
224 Che Y, Yu Z, Geng F, He M, Yang Z, Zheng Y, Zhang C, Zhao Y, Wu X, Liu H. Effects of the Traditional Chinese Medicine Formula Ento-PB in Experimental Models of Ulcerative Colitis. Natural Product Communications 2022;17:1934578X2210784. [DOI: 10.1177/1934578x221078453] [Reference Citation Analysis]
225 Bassi M, Singh S. Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases. BioDrugs 2022. [PMID: 35320515 DOI: 10.1007/s40259-022-00522-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Markovic M, Ben-shabat S, Nagendra Manda J, Abramov-harpaz K, Regev C, Miller Y, Aponick A, Zimmermann EM, Dahan A. PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics 2022;14:675. [DOI: 10.3390/pharmaceutics14030675] [Reference Citation Analysis]
227 Kopper JJ, Iennarella-Servantez C, Jergens AE, Sahoo DK, Guillot E, Bourgois-Mochel A, Martinez MN, Allenspach K, Mochel JP. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach. Front Toxicol 2021;3:773953. [PMID: 35295115 DOI: 10.3389/ftox.2021.773953] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Bosch S, Wintjens DSJ, Wicaksono A, Pierik M, Covington JA, de Meij TGJ, de Boer NKH. Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent. Sensors (Basel) 2022;22:2316. [PMID: 35336485 DOI: 10.3390/s22062316] [Reference Citation Analysis]
229 Yu B, Zhao L, Jin S, He H, Zhang J, Wang X. Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease. Front Immunol 2022;13:828219. [DOI: 10.3389/fimmu.2022.828219] [Reference Citation Analysis]
230 Adami G, Pontalti M, Cattani G, Rossini M, Viapiana O, Orsolini G, Benini C, Bertoldo E, Fracassi E, Gatti D, Fassio A. Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study. RMD Open 2022;8:e002055. [PMID: 35292563 DOI: 10.1136/rmdopen-2021-002055] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Zhang L, Liu F, Xue J, Lee SA, Liu L, Riordan SM. Bacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms. Front Microbiol 2022;13:801892. [PMID: 35283816 DOI: 10.3389/fmicb.2022.801892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Tian Y, Zhang D, Nakamura M. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/2939921] [Reference Citation Analysis]
233 Lin H, Bai Z, Wu Q, Chu G, Zhang Y, Guo X, Qi X. Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study. Front Public Health 2022;10:851295. [PMID: 35359771 DOI: 10.3389/fpubh.2022.851295] [Reference Citation Analysis]
234 Lim HJ, Kim HR, Jeong SJ, Yang HJ, Ryu MS, Jeong DY, Kim SY, Jung CH. Protective Effects of Fermented Soybeans (Cheonggukjang) on Dextran Sodium Sulfate (DSS)-Induced Colitis in a Mouse Model. Foods 2022;11:776. [PMID: 35327199 DOI: 10.3390/foods11060776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Schlee C, Uecker C, Bauer N, Koch AK, Langhorst J. Multimodal stress reduction and lifestyle modification program for patients with ulcerative colitis: a qualitative study. BMC Complement Med Ther 2022;22:60. [PMID: 35260152 DOI: 10.1186/s12906-021-03478-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
236 Zhang L, Lan Y, Wang Y, Yang Y, Han W, Li J, Wang Y, Liu X. Secoisolariciresinol diglucoside ameliorates high fat diet-induced colon inflammation and regulates gut microbiota in mice. Food Funct 2022;13:3009-22. [PMID: 35195134 DOI: 10.1039/d1fo04037e] [Reference Citation Analysis]
237 Liu H, Gu F, Zhu C, Yuan L, Zhu C, Zhu M, Yao J, Hu P, Zhang Y, Dicksved J, Bao W, Cai D. Epithelial Heat Shock Proteins Mediate the Protective Effects of Limosilactobacillus reuteri in Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2022;13:865982. [DOI: 10.3389/fimmu.2022.865982] [Reference Citation Analysis]
238 Li Y, Yao C, Xiong Q, Xie F, Luo L, Li T, Feng P. Network meta‐analysis on efficacy and safety of different Janus kinase inhibitors for ulcerative colitis. Clinical Pharmacy Therapeu. [DOI: 10.1111/jcpt.13622] [Reference Citation Analysis]
239 Özsoy M, Stummer N, Zimmermann FA, Feichtinger RG, Sperl W, Weghuber D, Schneider AM. Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac024. [PMID: 35247048 DOI: 10.1093/ibd/izac024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Kriaa A, Mariaule V, Jablaoui A, Rhimi S, Mkaouar H, Hernandez J, Korkmaz B, Lesner A, Maguin E, Aghdassi A, Rhimi M. Bile Acids: Key Players in Inflammatory Bowel Diseases? Cells 2022;11:901. [DOI: 10.3390/cells11050901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
241 Keung C, Heraud P, Kuk N, Lim R, Sievert W, Moore G, Wood B. Fourier-Transform Infra-Red Microspectroscopy Can Accurately Diagnose Colitis and Assess Severity of Inflammation. IJMS 2022;23:2849. [DOI: 10.3390/ijms23052849] [Reference Citation Analysis]
242 Yang Q, Ouyang J, Pi D, Feng L, Yang J. Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis. Front Immunol 2022;13:846469. [DOI: 10.3389/fimmu.2022.846469] [Reference Citation Analysis]
243 Li L, Ma J, Hua X, Zhou Y, Qiu Y, Zhu Z, Zheng Y, Xie Q, Liang Z, Xu J. Altered Intra- and Inter-Network Functional Connectivity in Patients With Crohn’s Disease: An Independent Component Analysis-Based Resting-State Functional Magnetic Resonance Imaging Study. Front Neurosci 2022;16:855470. [DOI: 10.3389/fnins.2022.855470] [Reference Citation Analysis]
244 Zhu L, Zong X, Xiao X, Cheng Y, Fu J, Lu Z, Jin M, Wang F, Wang Y. Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice. Front Immunol 2021;12:773070. [PMID: 35069545 DOI: 10.3389/fimmu.2021.773070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Wang Y, Li C, Wang W, Wang J, Li J, Qian S, Cai C, Liu Y. Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease. JIR 2022;Volume 15:1907-20. [DOI: 10.2147/jir.s347161] [Reference Citation Analysis]
246 Ukashi O, Barash Y, Klang E, Zilberman T, Ungar B, Kopylov U, Ben-Horin S, Veisman I. Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection. J Clin Med 2022;11:1359. [PMID: 35268450 DOI: 10.3390/jcm11051359] [Reference Citation Analysis]
247 Chen L, Jing T, Lin Z, Song W, Du W, Fan X, Li C, Li S, Xie F, Ou X, Huang L, Ma J. Metabolomic and transcriptomic responses of mouse testis to the dextran sulfate sodium induced colitis. Reproductive Toxicology 2022;108:35-42. [DOI: 10.1016/j.reprotox.2022.01.005] [Reference Citation Analysis]
248 Wang X, Li X, Guo X, Liu L, Jin Y, Lu Y, Cao Y, Long J, Wu H, Zhang D, Yang G, Hong J, Yang Y, Ma X. LncRNA-miRNA-mRNA Network Analysis Reveals the Potential Biomarkers in Crohn’s Disease Rats Treated with Herb-Partitioned Moxibustion. JIR 2022;Volume 15:1699-716. [DOI: 10.2147/jir.s351672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Fu Y, Yuan H, Xu Y, Liu R, Luo Y, Xiao J. Protective effects of Ligularia fischeri root extracts against ulcerative colitis in mice through activation of Bcl-2/Bax signalings. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
250 Tan C, Fan H, Ding J, Han C, Guan Y, Zhu F, Wu H, Liu Y, Zhang W, Hou X, Tan S, Tang Q. ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment. Materials Today Bio 2022;14:100246. [DOI: 10.1016/j.mtbio.2022.100246] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
251 Kawakami A, Tanaka M, Choong LM, Kunisaki R, Maeda S, Bjarnason I, Hayee B. Self-Reported Medication Adherence Among Patients with Ulcerative Colitis in Japan and the United Kingdom: A Secondary Analysis for Cross-Cultural Comparison. PPA 2022;Volume 16:671-8. [DOI: 10.2147/ppa.s346309] [Reference Citation Analysis]
252 Markovic M, Abramov-Harpaz K, Regev C, Ben-Shabat S, Aponick A, Zimmermann EM, Miller Y, Dahan A. Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation. Int J Mol Sci 2022;23:2673. [PMID: 35269813 DOI: 10.3390/ijms23052673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Mecocci S, Ottaviani A, Razzuoli E, Fiorani P, Pietrucci D, De Ciucis CG, Dei Giudici S, Franzoni G, Chillemi G, Cappelli K. Cow Milk Extracellular Vesicle Effects on an In Vitro Model of Intestinal Inflammation. Biomedicines 2022;10:570. [DOI: 10.3390/biomedicines10030570] [Reference Citation Analysis]
254 Louis-sidney F, Kahn V, Suzon B, De Bandt M, Deligny C, Arfi S, Jean-baptiste G. Epidemiology and Characteristics of Spondyloarthritis in the Predominantly Afro-Descendant Population of Martinique, a French Caribbean Island. JCM 2022;11:1299. [DOI: 10.3390/jcm11051299] [Reference Citation Analysis]
255 Wan J, Wu T, Liu Y, Yang M, Fichna J, Guo Y, Yin L, Chen C. Mast Cells Tryptase Promotes Intestinal Fibrosis in Natural Decellularized Intestinal Scaffolds. Tissue Eng Regen Med 2022. [PMID: 35218507 DOI: 10.1007/s13770-022-00433-9] [Reference Citation Analysis]
256 Huang B, Wang L, Liu M, Wu X, Lu Q, Liu R. The underlying mechanism of A-type procyanidins from peanut skin on DSS-induced ulcerative colitis mice by regulating gut microbiota and metabolism. J Food Biochem 2022;:e14103. [PMID: 35218055 DOI: 10.1111/jfbc.14103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Xiao Y, Xu B, Bordiga M, Li H, Travaglia F, Bai S, Chen J, Bai W. Cyanidin-3-O-Glucoside Supplement Improves Sperm Quality and Spermatogenesis in a Mice Model of Ulcerative Colitis. Nutrients 2022;14:984. [DOI: 10.3390/nu14050984] [Reference Citation Analysis]
258 Shi H, Wang D, Chen W, Li Y, Si G, Yang T, Alhumaydhi FA. Quality of Evidence Supporting the Role of Supplement Curcumin for the Treatment of Ulcerative Colitis: An Overview of Systematic Reviews. Gastroenterology Research and Practice 2022;2022:1-13. [DOI: 10.1155/2022/3967935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
259 Lamers CR, de Roos NM, Heerink HH, van de Worp-Kalter LA, Witteman BJM. Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention. Inflamm Bowel Dis 2022:izac027. [PMID: 35212382 DOI: 10.1093/ibd/izac027] [Reference Citation Analysis]
260 Shen Y, Cui Y, Shi Z, Wu H, Wang Z, Wu L, Lu Y, Huang Y, Liu Y, Long J, Lin Y, Ma Z. Investigating the influence of moxibustion on colonic mucosal barrier in rats with dextran sulfate sodium-induced ulcerative colitis. J Acupunct Tuina Sci 2022;20:1-11. [DOI: 10.1007/s11726-022-1286-8] [Reference Citation Analysis]
261 Bauset C, Lis-lopez L, Coll S, Gisbert-ferrándiz L, Macias-ceja DC, Seco-cervera M, Navarro F, Esplugues JV, Calatayud S, Ortiz-masia D, Barrachina MD, Cosín-roger J. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis. Biomedicines 2022;10:532. [DOI: 10.3390/biomedicines10030532] [Reference Citation Analysis]
262 Yang C, Kao Y, Lin P, Chien H, Lin S, Lee Y, Huang Y, Fang S. Case Report: Proteinase 3 Antineutrophil Cytoplasmic Antibody-Associated Ulcerative Colitis Presenting as Recurrent Intestinal Pseudo-Obstruction in a Teenage Patient With in situ Proteinase 3 Immunohistochemical Staining. Front Pediatr 2022;10:822491. [DOI: 10.3389/fped.2022.822491] [Reference Citation Analysis]
263 Philippou A, Birhanu B, Biello A, Keefer L, Gorbenko K. A Mixed-methods Assessment of the Impact of Insurance Issues on the Emotional and Physical Health of Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac022. [PMID: 35191977 DOI: 10.1093/ibd/izac022] [Reference Citation Analysis]
264 Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:733992. [DOI: 10.3389/fcimb.2022.733992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
265 Qian K, Chen S, Wang J, Sheng K, Wang Y, Zhang M. A β-N-acetylhexosaminidase Amuc_2109 from Akkermansia muciniphila protects against dextran sulfate sodium-induced colitis in mice by enhancing intestinal barrier and modulating gut microbiota. Food Funct 2022;13:2216-27. [PMID: 35133390 DOI: 10.1039/d1fo04094d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
266 Bian D, Liu X, Wang C, Jiang Y, Gu Y, Zhong J, Shi Y. Association between Dietary Inflammatory Index and Sarcopenia in Crohn's Disease Patients. Nutrients 2022;14:901. [PMID: 35215553 DOI: 10.3390/nu14040901] [Reference Citation Analysis]
267 Gutiérrez A, Zapater P, Ricart E, González-Vivó M, Gordillo J, Olivares D, Vera I, Mañosa M, Gisbert JP, Aguas M, Sánchez-Rodríguez E, Bosca-Watts M, Laredo V, Camps B, Marín-Jiménez I, Zabana Y, Martín-Arranz MD, Muñoz R, Navarro M, Sierra E, Madero L, Vela M, Pérez-Calle JL, Sainz E, Calvet X, Arias L, Morales V, Bermejo F, Fernández-Salazar L, Van Domselaar M, De Castro L, Rodríguez C, Muñoz-Villafranca C, Lorente R, Rivero M, Iglesias E, Herreros B, Busquets D, Riera J, Martínez-Montiel MP, Roldón M, Roncero O, Hinojosa E, Sierra M, Barrio J, De Francisco R, Huguet J, Merino O, Carpio D, Ginard D, Muñoz F, Piqueras M, Almela P, Argüelles-Arias F, Alcaín G, Bujanda L, Manceñido N, Lucendo AJ, Varela P, Rodríguez-Lago I, Ramos L, Sempere L, Sesé E, Barreiro-de Acosta M, Domènech E, Francés R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Front Med (Lausanne) 2022;9:823900. [PMID: 35178413 DOI: 10.3389/fmed.2022.823900] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
268 Palamenghi L, Figliuc P, Leone S, Graffigna G. Food and Inflammatory Bowel Diseases: A scoping review on the impact of food on patients' psychosocial quality of life. Health Soc Care Community 2022. [PMID: 35174921 DOI: 10.1111/hsc.13755] [Reference Citation Analysis]
269 Huo X, Li D, Wu F, Li S, Qiao Y, Wang C, Wang Y, Zhou C, Sun L, Luan Z, Yan Q, Wang J, Zhang Y, Zhao T, An Y, Zhang B, Tian X, Yu Z, Ma X. Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists. Gut 2022:gutjnl-2021-325413. [PMID: 35173042 DOI: 10.1136/gutjnl-2021-325413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
270 Müller EK, Białas N, Epple M, Hilger I. Nanoparticles Carrying NF-κB p65-Specific siRNA Alleviate Colitis in Mice by Attenuating NF-κB-Related Protein Expression and Pro-Inflammatory Cellular Mediator Secretion. Pharmaceutics 2022;14:419. [DOI: 10.3390/pharmaceutics14020419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
271 Lees CW, Deuring JJ, Chiorean M, Daperno M, Bonfanti G, Germino R, Brown PB, Modesto I, Edwards RA. Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies. Therap Adv Gastroenterol 2021;14:17562848211054710. [PMID: 35154388 DOI: 10.1177/17562848211054710] [Reference Citation Analysis]
272 Ruan J, Schlüter D, Naumann M, Waisman A, Wang X. Ubiquitin-modifying enzymes as regulators of colitis. Trends Mol Med 2022:S1471-4914(22)00025-9. [PMID: 35177326 DOI: 10.1016/j.molmed.2022.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Brown SC, Whelan K, Frampton C, Wall CL, Gearry RB, Day AS. Food-Related Quality of Life in Children and Adolescents With Crohn's Disease. Inflamm Bowel Dis 2022:izac010. [PMID: 35166341 DOI: 10.1093/ibd/izac010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
274 Li YF, Udayakumar V, Sathuvan M, Liu Y, Liu X, Zhang YQ, Ma WY, Zhang W, Tang S, Cheong KL. Effects of laminarin zwitterionic carboxylate and sulfonate on the intestinal barrier function and gut microbiota. Carbohydr Polym 2022;278:118898. [PMID: 34973726 DOI: 10.1016/j.carbpol.2021.118898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
275 Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, Zhang H, Zhang Z, He J, Cui B, Zhang X, Wu Z, Dong M, Cheng W, Tao S, Wei H. Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis. Front Immunol 2022;13:836542. [DOI: 10.3389/fimmu.2022.836542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
276 Qi Q, Liu Y, Lv S, Wu H, Zhang L, Cao Z, Liu H, Wang X, Wu L. Gut microbiome alterations in colitis rats after moxibustion at bilateral Tianshu acupoints. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02115-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Maia PDDS, Baião DDS, Nanini HF, da Silva VPF, Frambach LB, Cabral IM, Pêgo B, Ribeiro BE, Pavão MSG, Paschoalin VMF, de Souza HSP, Pierucci APTR. Bioactive Compounds from Pale Ale Beer Powder Attenuate Experimental Colitis in BALB/c Mice. Molecules 2022;27:1194. [PMID: 35208981 DOI: 10.3390/molecules27041194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Chen R, Pang X, Li L, Zeng Z, Chen M, Zhang S. Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation. Cell Death Dis 2022;13:139. [PMID: 35145062 DOI: 10.1038/s41419-022-04566-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
279 Olivier S, Diounou H, Pochard C, Frechin L, Durieu E, Foretz M, Neunlist M, Rolli-Derkinderen M, Viollet B. Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis. Cells 2022;11:590. [PMID: 35203241 DOI: 10.3390/cells11040590] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Chen X, Jiang L, Han W, Bai X, Ruan G, Guo M, Zhou R, Liang H, Yang H, Qian J. Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis. Front Immunol 2021;12:742080. [PMID: 34992592 DOI: 10.3389/fimmu.2021.742080] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
281 Deng L, Guo H, Wang S, Liu X, Lin Y, Zhang R, Tan W, Srejovic I. The Attenuation of Chronic Ulcerative Colitis by (R)-salbutamol in Repeated DSS-Induced Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/9318721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
282 Swanson GR, Kochman N, Amin J, Chouhan V, Yim W, Engen PA, Shaikh M, Naqib A, Tran L, Voigt RM, Forsyth CB, Green SJ, Keshavarzian A. Disrupted Circadian Rest-Activity Cycles in Inflammatory Bowel Disease Are Associated With Aggressive Disease Phenotype, Subclinical Inflammation, and Dysbiosis. Front Med 2022;8:770491. [DOI: 10.3389/fmed.2021.770491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Li J, Liu Z, Hu P, Wen Z, Cao Q, Zou X, Chen Y, Wang Y, Zhong J, Shen X, Demuth D, Fadeeva O, Xie L, Chen J, Qian J. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study. BMC Gastroenterol 2022;22:44. [PMID: 35120446 DOI: 10.1186/s12876-021-02074-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
284 Alvisi P, Labriola F, Scarallo L, Gandullia P, Knafelz D, Bramuzzo M, Zuin G, Pastore MR, Illiceto MT, Miele E, Graziano F, Romano C, Bartoletti D, Oliva S, Arrigo S, Bracci F, Renzo S, Agrusti A, Aloi M, Lionetti P; SIGENP IBD Working Group. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry. Dig Liver Dis 2022:S1590-8658(22)00001-9. [PMID: 35125313 DOI: 10.1016/j.dld.2021.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
285 Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal HC, Melum E, Løberg M, Blom J, Bretthauer M, Adami HO, Kalager M, Ye W. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. United European Gastroenterol J 2022. [PMID: 35107865 DOI: 10.1002/ueg2.12204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Huang M, Li X, Fan W, Li J, Zhu L, Lei P, Wu L, Sun Q, Zou Y, Han P. Alterations of Regional Homogeneity in Crohn's Disease With Psychological Disorders: A Resting-State fMRI Study. Front Neurol 2022;13:817556. [DOI: 10.3389/fneur.2022.817556] [Reference Citation Analysis]
287 Tan H, Nie S. From universal recipes to customerised choices: Innovations, challenges and prospects of the polysaccharides-based food. Food Bioscience 2022. [DOI: 10.1016/j.fbio.2022.101613] [Reference Citation Analysis]
288 Wang CJ, Byun MJ, Kim S, Park W, Park HH, Kim T, Lee JS, Park CG. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
289 Alexander JL, Kennedy NA, Ibraheim H, Anandabaskaran S, Saifuddin A, Castro Seoane R, Liu Z, Nice R, Bewshea C, D'mello A, Constable L, Jones GR, Balarajah S, Fiorentino F, Sebastian S, Irving PM, Hicks LC, Williams HRT, Kent AJ, Linger R, Parkes M, Kok K, Patel KV, Teare JP, Altmann DM, Boyton RJ, Goodhand JR, Hart AL, Lees CW, Ahmad T, Powell N, Chukwurah I, Haq S, Shah P, Wilken-smith S, Ramanathan A, Patel M, Romanczuk L, King R, Domingo J, Shamtally D, Mendoza V, Sanchez J, Stark H, Knight B, Bee L, Estember C, Barnes A, Watkins D, Stone S, Kirkwood J, Parkinson M, Gardner-thorpe H, Covil K, Derikx L, Gros Alcalde B, Lee I, Cipriano B, Ruocco G, Baden M, Cooke G, Pollock K. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(22)00005-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 32.0] [Reference Citation Analysis]
290 Walakira A, Ocira J, Duroux D, Fouladi R, Moškon M, Rozman D, Van Steen K. Detecting gene-gene interactions from GWAS using diffusion kernel principal components. BMC Bioinformatics 2022;23:57. [PMID: 35105309 DOI: 10.1186/s12859-022-04580-7] [Reference Citation Analysis]
291 Yang W, Zhao P, Li X, Guo L, Gao W. The potential roles of natural plant polysaccharides in inflammatory bowel disease: A review. Carbohydr Polym 2022;277:118821. [PMID: 34893238 DOI: 10.1016/j.carbpol.2021.118821] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
292 Chen G, Xie J, Liang T, Wang Y, Liao W, Song L, Zhang X. Inflammatory Bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization. Acta Otolaryngol 2022;142:191-6. [PMID: 35195051 DOI: 10.1080/00016489.2022.2035431] [Reference Citation Analysis]
293 Luo H, Cao G, Luo C, Tan D, Vong CT, Xu Y, Wang S, Lu H, Wang Y, Jing W. Emerging Pharmacotherapy for Inflammatory Bowel Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
294 Morsink M, Severino P, Luna-Ceron E, Hussain MA, Sobahi N, Shin SR. Effects of electrically conductive nano-biomaterials on regulating cardiomyocyte behavior for cardiac repair and regeneration. Acta Biomater 2022;139:141-56. [PMID: 34818579 DOI: 10.1016/j.actbio.2021.11.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
295 Ver Berne J, Li J, Shaheen E, Politis C, Peeters H, Jacobs R. Prevalence and characteristics of systemic conditions in patients undergoing orthognathic surgery: a retrospective study. International Journal of Oral and Maxillofacial Surgery 2022. [DOI: 10.1016/j.ijom.2022.02.004] [Reference Citation Analysis]
296 Khan R, Roy N, Ali H, Naeem M, Sakai E. Fecal Microbiota Transplants for Inflammatory Bowel Disease Treatment: Synthetic- and Engineered Communities-Based Microbiota Transplants Are the Future. Gastroenterology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/9999925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Liu C, Zeng Y, Wen Y, Huang X, Liu Y. Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis. Front Pharmacol 2022;13:806148. [DOI: 10.3389/fphar.2022.806148] [Reference Citation Analysis]
298 Kim S, Park Y, Kim SP, Lee SH, Oh SH, Yang S, Yoon H, Kim KM. Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data. Dig Dis Sci. [DOI: 10.1007/s10620-021-07328-0] [Reference Citation Analysis]
299 Furukawa S, Yagi S, Shiraishi K, Miyake T, Tange K, Hashimoto Y, Kitahata S, Kawamura T, Ninomiya T, Mori K, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Ikeda Y, Hiasa Y. Effect of disease duration on the association between C-reactive protein-albumin ratio and endoscopic activity in ulcerative colitis. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02113-3] [Reference Citation Analysis]
300 Limketkai BN, Hamideh M, Shah R, Sauk JS, Jaffe N. Dietary Patterns and Their Association With Symptoms Activity in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab335] [Reference Citation Analysis]
301 Guzzo GL, Andrews JM, Weyrich LS. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Plevris N, Lees CW. Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities. Gastroenterology 2022:S0016-5085(22)00078-6. [PMID: 35101422 DOI: 10.1053/j.gastro.2022.01.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
303 Bargo D, Tritton T, Cappelleri JC, DiBonaventura M, Smith TW, Tsuchiya T, Gardiner S, Modesto I, Holbrook T, Bluff D, Kobayashi T. Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use. Inflamm Intest Dis 2021;6:186-98. [PMID: 35083284 DOI: 10.1159/000519123] [Reference Citation Analysis]
304 Iglay K, Bennett D, Kappelman MD, Thai S, Aldridge M, Karki C, Cook SF. A systematic review of the patient burden of Crohn’s disease-related rectovaginal and anovaginal fistulas. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-021-02079-8] [Reference Citation Analysis]
305 da Luz Moreira A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, Elia C, Fiocchi C, de Souza HSP. Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study. Inflamm Bowel Dis 2022:izab346. [PMID: 35089325 DOI: 10.1093/ibd/izab346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
306 Tamburini B, La Manna MP, La Barbera L, Mohammadnezhad L, Badami GD, Shekarkar Azgomi M, Dieli F, Caccamo N. Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease. Cells 2022;11:455. [DOI: 10.3390/cells11030455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
307 Liu Z, Jiao Y, Yu T, Wang H, Zhang Y, Liu D, Xu Y, Guan Q, Lu M. A Review on the Immunomodulatory Mechanism of Acupuncture in the Treatment of Inflammatory Bowel Disease. Evid Based Complement Alternat Med 2022;2022:8528938. [PMID: 35075366 DOI: 10.1155/2022/8528938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Cui J, Wang F, Zhao C, Zhou S, Zheng J. Orange Pectin with Compact Conformation Effectively Alleviates Acute Colitis in Mice. J Agric Food Chem 2022. [PMID: 35080177 DOI: 10.1021/acs.jafc.1c07951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Coscueta ER, Sousa AS, Reis CA, Pintado MM. Phenylethyl Isothiocyanate: A Bioactive Agent for Gastrointestinal Health. Molecules 2022;27:794. [PMID: 35164058 DOI: 10.3390/molecules27030794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Choe JY, Choi S, Song KH, Jang HJ, Choi KH, Yi DY, Hong SJ, Hwang JH, Cho SM, Kim YJ, Choe BH, Kang B. Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the Daegu-Kyungpook Province From 2017 to 2020. Front Pediatr 2021;9:810173. [PMID: 35059365 DOI: 10.3389/fped.2021.810173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Yamamoto-Furusho JK, Parra-Holguín NN, Juliao-Baños F, Puentes F, López R, Bosques-Padilla F, Torres EA, Nieves-Jimenéz H, Veitia-Velásquez GR, Jara-Alba ML, Bautista S, Piñol-Jimenez FN, Salgado-Rosado P, Villa-Ovalles KC, Abreu-Martinez YA, Borges Z, Davila-Bedoya S, Otoya-Moreno G, Iadé-Vergara B; EPILATAM study group. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean. Medicine (Baltimore) 2022;101:e28624. [PMID: 35060539 DOI: 10.1097/MD.0000000000028624] [Reference Citation Analysis]
312 Gabbiadini R, D'Amico F, De Marco A, Terrin M, Zilli A, Furfaro F, Allocca M, Fiorino G, Danese S. Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question. J Clin Med 2022;11:509. [PMID: 35159961 DOI: 10.3390/jcm11030509] [Reference Citation Analysis]
313 Zhou F, Jiang H, Kong N, Lin J, Zhang F, Mai T, Cao Z, Xu M, Wang K. Electroacupuncture Attenuated Anxiety and Depression-Like Behavior via Inhibition of Hippocampal Inflammatory Response and Metabolic Disorders in TNBS-Induced IBD Rats. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/8295580] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Lin H, Bai Z, Meng F, Wu Y, Luo L, Shukla A, Yoshida EM, Guo X, Qi X. Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:744505. [PMID: 35111772 DOI: 10.3389/fmed.2021.744505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Wang H, Vilches-moure JG, Bettinger T, Cherkaoui S, Lutz A, Paulmurugan R. Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α−/− Transgenic Mouse Model Using Targeted Microbubbles. Nanomaterials 2022;12:280. [DOI: 10.3390/nano12020280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Jeong YJ, Kim DH, Lee KW. Homeostasis effects of fermented Maillard reaction products by Lactobacillus gasseri 4M13 in dextran sulfate sodium-induced colitis mice. J Sci Food Agric 2022;102:434-44. [PMID: 34143895 DOI: 10.1002/jsfa.11374] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
317 Shah A, Holtmann G. Small intestinal bacterial overgrowth in inflammatory bowel disease. Indian J Gastroenterol 2022. [PMID: 35031976 DOI: 10.1007/s12664-021-01235-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Kaplan GG, Underwood FE, Coward S, Agrawal M, Ungaro RC, Brenner EJ, Gearry RB, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Zhang X, Kappelman MD, Colombel JF. The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis. Inflamm Bowel Dis 2022:izab339. [PMID: 35032167 DOI: 10.1093/ibd/izab339] [Reference Citation Analysis]
319 Shen JL, Zhou Z, Cao JS, Zhang B, Hu JH, Li JY, Liu XM, Juengpanich S, Li MS, Feng X. Biologic therapy for Crohn’s disease over the last 3 decades. World J Clin Cases 2022; 10(2): 594-606 [DOI: 10.12998/wjcc.v10.i2.594] [Reference Citation Analysis]
320 Raoul P, Cintoni M, Palombaro M, Basso L, Rinninella E, Gasbarrini A, Mele MC. Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis. Microorganisms 2022;10:167. [PMID: 35056616 DOI: 10.3390/microorganisms10010167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
321 Lu JJ, Maimaiti M, Liu H, Liu WD, Hui WJ, Huang XL, Gao F. Potential Biomarkers Associated with Differential Manifestations of Ulcerative Colitis (UC) in Uyghur and Han Population in China. J Inflamm Res 2021;14:7431-41. [PMID: 35002277 DOI: 10.2147/JIR.S335293] [Reference Citation Analysis]
322 Yamamoto Y, Carreras J, Shimizu T, Kakizaki M, Kikuti YY, Roncador G, Nakamura N, Kotani A. Anti-HBV drug entecavir ameliorates DSS-induced colitis through PD-L1 induction. Pharmacol Res 2022;:105918. [PMID: 35031477 DOI: 10.1016/j.phrs.2021.105918] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Lamb CA, Saifuddin A, Powell N, Rieder F. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. Gastroenterology 2022;162:1525-42. [PMID: 34995532 DOI: 10.1053/j.gastro.2021.09.077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
324 Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado D F, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI; InsightScope Pediatric IBD Epidemiology Group. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology 2022;162:1147-1159.e4. [PMID: 34995526 DOI: 10.1053/j.gastro.2021.12.282] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
325 Wu Z, Bi Y. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients. J Clin Lab Anal 2022;:e24130. [PMID: 34997981 DOI: 10.1002/jcla.24130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
326 Liso M, Sila A, Verna G, Scarano A, Donghia R, Castellana F, Cavalcanti E, Pesole PL, Sommella EM, Lippolis A, Armentano R, Giudetti AM, Vergara D, Campiglia P, Sardone R, Curlo M, Mastronardi M, Petroni K, Tonelli C, Santino A, Chieppa M. Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study. Antioxidants 2022;11:138. [DOI: 10.3390/antiox11010138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
327 Turanlı Y, Acartürk F. Preparation and characterization of colon-targeted pH/Time-dependent nanoparticles using anionic and cationic polymethacrylate polymers. Eur J Pharm Sci 2022;171:106122. [PMID: 35007712 DOI: 10.1016/j.ejps.2022.106122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
328 Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne) 2021;8:765474. [PMID: 34988090 DOI: 10.3389/fmed.2021.765474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
329 Ge C, Lu Y, Shen H, Zhu L. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scand J Gastroenterol 2022;:1-12. [PMID: 34994661 DOI: 10.1080/00365521.2021.2022193] [Reference Citation Analysis]
330 Annese V, Nathwani R, Alkhatry M, Al-Rifai A, Al Awadhi S, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Taha MS, Limdi JK. Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates. Therap Adv Gastroenterol 2021;14:17562848211065329. [PMID: 34987611 DOI: 10.1177/17562848211065329] [Reference Citation Analysis]
331 Chen R, Zheng J, Li L, Li C, Chao K, Zeng Z, Chen M, Zhang S. Metabolomics facilitate the personalized management in inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211064489. [PMID: 34987610 DOI: 10.1177/17562848211064489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
332 Long J, Liu XK, Kang ZP, Wang MX, Zhao HM, Huang JQ, Xiao QP, Liu DY, Zhong YB. Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora. Eur J Pharmacol 2022;917:174742. [PMID: 34999087 DOI: 10.1016/j.ejphar.2022.174742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
333 Huang X, Ai F, Ji C, Tu P, Gao Y, Wu Y, Yan F, Yu T. A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1. Front Microbiol 2021;12:760385. [PMID: 34975786 DOI: 10.3389/fmicb.2021.760385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
334 Huang Y, Yao D, Guo F, Zhou Z, Li Y. Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn's Disease. J Invest Surg 2022;:1-9. [PMID: 34983280 DOI: 10.1080/08941939.2021.2023713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
335 Kővári B, Báthori Á, Friedman MS, Lauwers GY. Histologic Diagnosis of Inflammatory Bowel Diseases. Adv Anat Pathol 2022;29:48-61. [PMID: 34879038 DOI: 10.1097/PAP.0000000000000325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
336 Li M, Li P, Tang R, Lu H. Resveratrol and its derivates improve inflammatory bowel disease by targeting gut microbiota and inflammatory signaling pathways. Food Science and Human Wellness 2022;11:22-31. [DOI: 10.1016/j.fshw.2021.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
337 Gong C, Xu R, Zou P, Zhang Y, Wang X. Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies. Eur J Cancer Prev 2022;31:54-63. [PMID: 34871199 DOI: 10.1097/CEJ.0000000000000667] [Reference Citation Analysis]
338 Li F, Liu H, Fu J, Fan L, Lu S, Zhang H, Liu Z. Knockdown of long non-coding RNA NEAT1 relieves inflammation of ulcerative colitis by regulating the miR-603/FGF9 pathway. Exp Ther Med 2022;23:131. [PMID: 34970354 DOI: 10.3892/etm.2021.11054] [Reference Citation Analysis]
339 Xing C, Zhang T, Liu X, Li C, Yang G, Zhang H, Wang R, Wang K, Miao Y, Lan D. Guanylin ligand protects the intestinal immune barrier by activating the guanylate cyclase-C signaling pathway. Acta Histochem 2022;124:151811. [PMID: 34920371 DOI: 10.1016/j.acthis.2021.151811] [Reference Citation Analysis]
340 陈 雅. Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation. HJFNS 2022;11:44-55. [DOI: 10.12677/hjfns.2022.111006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Xie H, Jiao Y, Zhou X, Liao X, Chen J, Chen H, Chen L, Yu S, Deng Q, Sun L, Xu X, Wang J. Integrin αvβ6 contributes to the development of intestinal fibrosis via the FAK/AKT signaling pathway. Exp Cell Res 2021;411:113003. [PMID: 34979108 DOI: 10.1016/j.yexcr.2021.113003] [Reference Citation Analysis]
342 Zhang X, Ma L, Shen Y, Zhang C, Hou B, Zhou Y. Transcription factor paired related homeobox 1 (PRRX1) activates matrix metalloproteinases (MMP)13, which promotes the dextran sulfate sodium-induced inflammation and barrier dysfunction of NCM460 cells. Bioengineered 2022;13:645-54. [PMID: 34967278 DOI: 10.1080/21655979.2021.2012549] [Reference Citation Analysis]
343 Bosi A, Banfi D, Bistoletti M, Moretto P, Moro E, Crema F, Maggi F, Karousou E, Viola M, Passi A, Vigetti D, Giaroni C, Baj A. Hyaluronan: A Neuroimmune Modulator in the Microbiota-Gut Axis. Cells 2021;11:126. [PMID: 35011688 DOI: 10.3390/cells11010126] [Reference Citation Analysis]
344 Nascimento RPD, Machado APDF, Lima VS, Moya AMTM, Reguengo LM, Bogusz Junior S, Leal RF, Cao-Ngoc P, Rossi JC, Leclercq L, Cottet H, Cazarin CBB, Marostica Junior MR. Chemoprevention with a tea from hawthorn (Crataegus oxyacantha) leaves and flowers attenuates colitis in rats by reducing inflammation and oxidative stress. Food Chem X 2021;12:100139. [PMID: 34712949 DOI: 10.1016/j.fochx.2021.100139] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
345 Zou M, Zeng QS, Nie J, Yang JH, Luo ZY, Gan HT. The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe? Front Immunol 2021;12:769167. [PMID: 34956195 DOI: 10.3389/fimmu.2021.769167] [Reference Citation Analysis]
346 Cheng WX, Ren Y, Lu MM, Xu LL, Gao JG, Chen D, Kalyani FS, Lv ZY, Chen CX, Ji F, Lin HN, Jin X. Palmitoylation in Crohn’s disease: Current status and future directions. World J Gastroenterol 2021; 27(48): 8201-8215 [DOI: 10.3748/wjg.v27.i48.8201] [Reference Citation Analysis]
347 Chen JA, Ma H, Liu Z, Tian J, Lu S, Fang W, Ze S, Lu W, Xie Q, Huang J, Wang Y. Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease. J Med Chem 2021. [PMID: 34957834 DOI: 10.1021/acs.jmedchem.1c01746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
348 Kumric M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, Vilovic M, Martinovic D, Bratanic A, Lizatovic IK, Bozic J. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics 2022;12:45. [DOI: 10.3390/diagnostics12010045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Ibaraki H, Hatakeyama N, Arima N, Takeda A, Seta Y, Kanazawa T. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis. Eur J Pharm Biopharm 2021:S0939-6411(21)00358-1. [PMID: 34963657 DOI: 10.1016/j.ejpb.2021.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
350 Wu KC, Lee DY, Hsu JT, Cheng CF, Lan JL, Chiu SC, Cho DY, Hsu JL. Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2021;12:696158. [PMID: 34938175 DOI: 10.3389/fphar.2021.696158] [Reference Citation Analysis]
351 Shah R, Elangovan A, Jordan DW, Katz J, Cooper GS. 10-Year Trend of Abdominal Magnetic Resonance Imaging Compared With Abdominal Computed Tomography Scans in Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab284. [PMID: 34935946 DOI: 10.1093/ibd/izab284] [Reference Citation Analysis]
352 Wei LY, Zhang JK, Zheng L, Chen Y. The functional role of sulforaphane in intestinal inflammation: a review. Food Funct 2021. [PMID: 34935814 DOI: 10.1039/d1fo03398k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
353 Zeng Z, Xie Z, Chen G, Sun Y, Zeng X, Liu Z. Anti-inflammatory and gut microbiota modulatory effects of polysaccharides from Fuzhuan brick tea on colitis in mice induced by dextran sulfate sodium. Food Funct 2021. [PMID: 34932051 DOI: 10.1039/d1fo02702f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
354 Yu X, Liu Y. Diosmetin attenuate experimental ulcerative colitis in rats via suppression of NF-κB, TNF-α and IL-6 signalling pathways correlated with down-regulation of apoptotic events. Eur J Inflamm 2021;19:205873922110672. [DOI: 10.1177/20587392211067292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
355 Poláková L, Raus V, Cuchalová L, Poręba R, Hrubý M, Kučka J, Větvička D, Trhlíková O, Sedláková Z. SHARP hydrogel for the treatment of inflammatory bowel disease. Int J Pharm 2021;613:121392. [PMID: 34933083 DOI: 10.1016/j.ijpharm.2021.121392] [Reference Citation Analysis]
356 Chen M, Peng WY, Tang TC, Zheng H. Differential Sleep Traits Have No Causal Effect on Inflammatory Bowel Diseases: A Mendelian Randomization Study. Front Pharmacol 2021;12:763649. [PMID: 34916940 DOI: 10.3389/fphar.2021.763649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
357 Wynne J, Kozuch P. Medical marijuana for inflammatory bowel disease: the highs and lows. Scand J Gastroenterol 2021;:1-9. [PMID: 34919496 DOI: 10.1080/00365521.2021.1998604] [Reference Citation Analysis]
358 Kuo CJ, Le PH, Tai WC, Wu KL, Yen HH, Yen CW, Tung SY, Chung CS, Su MY, Chiu CT. The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study. J Formos Med Assoc 2021:S0929-6646(21)00532-5. [PMID: 34924273 DOI: 10.1016/j.jfma.2021.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Zhang J, Wang W, Zhu S, Chen Y. Increased SERPINA3 Level Is Associated with Ulcerative Colitis. Diagnostics (Basel) 2021;11:2371. [PMID: 34943607 DOI: 10.3390/diagnostics11122371] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
360 Magalhães HIR, Castelucci P. Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor. World J Gastroenterol 2021; 27(46): 7909-7924 [DOI: 10.3748/wjg.v27.i46.7909] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Liu N, Feng G, Zhang X, Hu Q, Sun S, Sun J, Sun Y, Wang R, Zhang Y, Wang P, Li Y. The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease. Front Nutr 2021;8:759507. [PMID: 34901112 DOI: 10.3389/fnut.2021.759507] [Reference Citation Analysis]
362 Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 2021;21:103016. [PMID: 34915182 DOI: 10.1016/j.autrev.2021.103016] [Reference Citation Analysis]
363 Ağagündüz D, Yılmaz B, Şahin TÖ, Güneşliol BE, Ayten Ş, Russo P, Spano G, Rocha JM, Bartkiene E, Özogul F. Dairy Lactic Acid Bacteria and Their Potential Function in Dietetics: The Food-Gut-Health Axis. Foods 2021;10:3099. [PMID: 34945650 DOI: 10.3390/foods10123099] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
364 Zhang LC, Wu XY, Yang RB, Chen F, Liu JH, Hu YY, Wu ZD, Wang LF, Sun X. Recombinant protein Schistosoma japonicum-derived molecule attenuates dextran sulfate sodium-induced colitis by inhibiting miRNA-217-5p to alleviate apoptosis. World J Gastroenterol 2021; 27(46): 7982-7994 [DOI: 10.3748/wjg.v27.i46.7982] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Wang Z, Du A, Liu H, Wang Z, Hu J. Systematic Analysis of the Global, Regional and National Burden of Cardiovascular Diseases from 1990 to 2017. J Epidemiol Glob Health 2021. [PMID: 34902116 DOI: 10.1007/s44197-021-00024-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Zhu C, Yu Y, Wang S, Wang X, Gao Y, Li C, Li J, Ge Y, Wu X. A Novel Clinical Radiomics Nomogram to Identify Crohn's Disease from Intestinal Tuberculosis. J Inflamm Res 2021;14:6511-21. [PMID: 34887674 DOI: 10.2147/JIR.S344563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
367 Wagatsuma K, Yokoyama Y, Nakase H. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life (Basel) 2021;11:1375. [PMID: 34947906 DOI: 10.3390/life11121375] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
368 Arnone D, Chabot C, Heba AC, Kökten T, Caron B, Hansmannel F, Dreumont N, Ananthakrishnan AN, Quilliot D, Peyrin-Biroulet L. Sugars and Gastrointestinal Health. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01305-7. [PMID: 34902573 DOI: 10.1016/j.cgh.2021.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
369 Ye C, Zhu S, Yuan J. Construction of ceRNA Network to Reveal Potential Biomarkers in Crohn's Disease and Validation in a TNBS Induced Mice Model. J Inflamm Res 2021;14:6447-59. [PMID: 34880646 DOI: 10.2147/JIR.S338053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
370 Hijos-Mallada G, Velamazán R, Marti R, Chueca E, Arechavaleta S, Lué A, Gomollón F, Lanas A, Sostres C. A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients. Diagnostics (Basel) 2021;11:2323. [PMID: 34943560 DOI: 10.3390/diagnostics11122323] [Reference Citation Analysis]
371 Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, Zhang H, Chiu PWY, Bian L. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat Commun 2021;12:7162. [PMID: 34887414 DOI: 10.1038/s41467-021-27463-6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
372 Dhaliwal J, Tuna M, Shah BR, Murthy S, Herrett E, Griffiths AM, Benchimol EI. Incidence of Inflammatory Bowel Disease in South Asian and Chinese People: A Population-Based Cohort Study from Ontario, Canada. Clin Epidemiol 2021;13:1109-18. [PMID: 34876857 DOI: 10.2147/CLEP.S336517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
373 Shariff S, Moran G, Grimes C, Cooney RM. Current Use of EEN in Pre-Operative Optimisation in Crohn's Disease. Nutrients 2021;13:4389. [PMID: 34959941 DOI: 10.3390/nu13124389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
374 Chiba M, Tsuji T, Ohno H, Komatsu M. Stepwise Treatment With Plant-Based Diet and Medication for Patient With Mild Ulcerative Colitis. Perm J 2021;25. [PMID: 35348099 DOI: 10.7812/TPP/21.052] [Reference Citation Analysis]
375 Kociszewska D, Chan J, Thorne PR, Vlajkovic SM. The Link between Gut Dysbiosis Caused by a High-Fat Diet and Hearing Loss. Int J Mol Sci 2021;22:13177. [PMID: 34947974 DOI: 10.3390/ijms222413177] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
376 Ren R, Gao X, Shi Y, Li J, Peng L, Sun G, Wang Z, Yan B, Zhi J, Yang Y. Long-Term Efficacy of Low-Intensity Single Donor Fecal Microbiota Transplantation in Ulcerative Colitis and Outcome-Specific Gut Bacteria. Front Microbiol 2021;12:742255. [PMID: 34867859 DOI: 10.3389/fmicb.2021.742255] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
377 Sun D, Ge X, Tang S, Liu Y, Sun J, Zhou Y, Luo L, Xu Z, Zhou W, Sheng J. Bacterial Characteristics of Intestinal Tissues From Patients With Crohn's Disease. Front Cell Infect Microbiol 2021;11:711680. [PMID: 34869050 DOI: 10.3389/fcimb.2021.711680] [Reference Citation Analysis]
378 Chen Z, Yi L, Pan Y, Long X, Mu J, Yi R, Zhao X. Lactobacillus fermentum ZS40 Ameliorates Inflammation in Mice With Ulcerative Colitis Induced by Dextran Sulfate Sodium. Front Pharmacol 2021;12:700217. [PMID: 34867317 DOI: 10.3389/fphar.2021.700217] [Reference Citation Analysis]
379 Arnone D, Vallier M, Hergalant S, Chabot C, Ndiaye NC, Moulin D, Aignatoaei AM, Alberto JM, Louis H, Boulard O, Mayeur C, Dreumont N, Peuker K, Strigli A, Zeissig S, Hansmannel F, Chamaillard M, Kökten T, Peyrin-Biroulet L. Long-Term Overconsumption of Fat and Sugar Causes a Partially Reversible Pre-inflammatory Bowel Disease State. Front Nutr 2021;8:758518. [PMID: 34869528 DOI: 10.3389/fnut.2021.758518] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
380 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
381 Delaroque C, Chervy M, Gewirtz AT, Chassaing B. Social overcrowding impacts gut microbiota, promoting stress, inflammation, and dysglycemia. Gut Microbes 2021;13:2000275. [PMID: 34856844 DOI: 10.1080/19490976.2021.2000275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
382 Chen J, Zhou J, Yang J, Cong R, Sun J, Xiao J, Shi J, He B. Efficiency of dual-energy computed tomography enterography in the diagnosis of Crohn's disease. BMC Med Imaging 2021;21:185. [PMID: 34861843 DOI: 10.1186/s12880-021-00716-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
383 Gkikas K, Logan M, Nichols B, Ijaz UZ, Clark CM, Svolos V, Gervais L, Duncan H, Garrick V, Curtis L, Buchanan E, Cardigan T, Armstrong L, Delahunty C, Flynn DM, Barclay AR, Tayler R, Milling S, Hansen R, Russell RK, Gerasimidis K. Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn's disease: a pilot study. BMC Gastroenterol 2021;21:454. [PMID: 34861829 DOI: 10.1186/s12876-021-02029-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
384 Nascimento RDPD, Polezi G, Rizzato JS, Batista PB, Santos NMD, Loubet Filho PS, Reguengo LM, Morari J, Bogusz Junior S, Paiotti APR, Pereira JA, Martinez CAR, Velloso LA, Cazarin CBB, Marostica Junior MR. Brazilian berries prevent colitis induced in obese mice by reducing the clinical signs and intestinal damage. Food Bioscience 2021;44:101447. [DOI: 10.1016/j.fbio.2021.101447] [Reference Citation Analysis]
385 Snyder EF, Davis S, Aldrich K, Veerabagu M, Larussa T, Abenavoli L, Boccuto L. Crohn disease: Identification, diagnosis, and clinical management. Nurse Pract 2021;46:22-30. [PMID: 34808643 DOI: 10.1097/01.NPR.0000798212.61425.4f] [Reference Citation Analysis]
386 He Y, Ma J, Fan X, Ding L, Ding X, Zhang QY, Lin G. The key role of gut-liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity. Acta Pharm Sin B 2021;11:3820-35. [PMID: 35024309 DOI: 10.1016/j.apsb.2021.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
387 Goodday SM, Travis S, Walsh A, Friend SH. Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's disease. Eur J Gastroenterol Hepatol 2021;33:1511-6. [PMID: 33512845 DOI: 10.1097/MEG.0000000000002081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Gan J, Liu Y, Sun L, Ma W, Chen G, Zhao C, Wen L, Zhao Y, Sun L. Orally administrated nucleotide-delivery particles from microfluidics for inflammatory bowel disease treatment. Applied Materials Today 2021;25:101231. [DOI: 10.1016/j.apmt.2021.101231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
389 Leite-Gomes E, Dias AM, Azevedo CM, Santos-Pereira B, Magalhães M, Garrido M, Amorim R, Lago P, Marcos-Pinto R, Pinho SS. Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player. Inflamm Bowel Dis 2021:izab291. [PMID: 34849933 DOI: 10.1093/ibd/izab291] [Reference Citation Analysis]
390 Kurnik-Łucka M, Pasieka P, Łączak P, Wojnarski M, Jurczyk M, Gil K. Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review. Int J Mol Sci 2021;22:12932. [PMID: 34884737 DOI: 10.3390/ijms222312932] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
391 Boccarelli A, Del Buono N, Esposito F. Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF. Pathol Res Pract 2021;229:153728. [PMID: 34953405 DOI: 10.1016/j.prp.2021.153728] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 Jiang Q, Xu Q, Wang Y, Li P, Zhang Y, Wang Y, Sun J, Zhang T, He Z. Modulation of Naturally Occurring Linear Dipeptide Chirality to Reduce the Affinity for Oligopeptide Transporter 1 and Increase Intestinal Stability for an Enhanced Colon-Targeting Effect in the Treatment of Inflammatory Bowel Disease: An Application of trans-4-l-Hydroxyprolyl-l-serine. J Med Chem 2021. [PMID: 34842428 DOI: 10.1021/acs.jmedchem.1c01276] [Reference Citation Analysis]
393 Sun Y, Geng J, Chen X, Chen H, Wang X, Chen J, Li X, Hesketh T. Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study. Inflamm Bowel Dis 2021:izab300. [PMID: 34849925 DOI: 10.1093/ibd/izab300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
394 Malibary NH, Ezzat MA, Mogharbel AM, Kouzaba KA, Alkadi AA, Malki UH, Gharib SM, Altowairqi FM, Saadah OI, Mosli MH. Factors Affecting Ulcerative Colitis Flare-Ups: Associations With Smoking Habits and Other Patient Characteristics. Cureus 2021;13:e19834. [PMID: 34824952 DOI: 10.7759/cureus.19834] [Reference Citation Analysis]
395 Lee JG, Lee J, Lee AR, Jo SV, Park CH, Han DS, Eun CS. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model. J Nutr Biochem 2021;101:108926. [PMID: 34848335 DOI: 10.1016/j.jnutbio.2021.108926] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
396 Yewale RV, Natarajan K, Ubal Dhus J, Parameswaran SA, Ramaswamy Palaniswamy K, Babu Vinish D, Somasundaram A, Ramakrishnan A, Karmegam S, Arun RS, Manmohan US, Mahadevan B, Harri Prasad B, Chandrasekar TS, Gokul BJ, Dutta A, Joseph AJ, Venkatraman J, Ganesh P, Shanmuganathan S, Alagammai PL, Ramasubramanian R, Venkatakrishnan L, Ganesan R, Chandrasekaran Arun A, Srinivas S, Kannan M, Revathy MS, Sathiyasekaran M, Sarangapani A, Rajesh N, Arulselvan V, Aravind A, Premkumar K, Kavitha S, Varadarajulu HV, Manimaran M, Basumani P, Murali A, Ramakrishna BS. Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices. JGH Open 2021;5:1306-13. [PMID: 34816017 DOI: 10.1002/jgh3.12673] [Reference Citation Analysis]
397 Török S, Almási N, Valkusz Z, Pósa A, Varga C, Kupai K. Investigation of H2S Donor Treatment on Neutrophil Extracellular Traps in Experimental Colitis. Int J Mol Sci 2021;22:12729. [PMID: 34884536 DOI: 10.3390/ijms222312729] [Reference Citation Analysis]
398 Zhilu X, Xiangqian D, Keli Y, Caroline C, Jingwan Z, Yu L, Tao Z, Cheung CL, Yang S, Fengrui Z, Kl CF, Jy SJ, Jun Y, Anthony B, Nicolas B, Jean-Frédéric C, Sunny Hei W, Yinglei M, Siew C N. Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn's disease. Gut Microbes 2021;13:1994833. [PMID: 34812117 DOI: 10.1080/19490976.2021.1994833] [Reference Citation Analysis]
399 Wang Y, Zhang J, Xu L, Ma J, Lu M, Ma J, Liu Z, Wang F, Tang X. Modified Gegen Qinlian Decoction Regulates Treg/Th17 Balance to Ameliorate DSS-Induced Acute Experimental Colitis in Mice by Altering the Gut Microbiota. Front Pharmacol 2021;12:756978. [PMID: 34803700 DOI: 10.3389/fphar.2021.756978] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
400 He Z, Wu J, Gong J, Ke J, Ding T, Zhao W, Cheng WM, Luo Z, He Q, Zeng W, Yu J, Jiao N, Liu Y, Zheng B, Dai L, Zhi M, Wu X, Jobin C, Lan P. Microbiota in mesenteric adipose tissue from Crohn's disease promote colitis in mice. Microbiome 2021;9:228. [PMID: 34814945 DOI: 10.1186/s40168-021-01178-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
401 Yuan X, Chen B, Duan Z, Xia Z, Ding Y, Chen T, Liu H, Wang B, Yang B, Wang X, Liu S, Zhou JY, Liu Y, Wang Q, Shen Z, Xiao J, Shang H, Liu W, Shi G, Zhu L, Chen Y. Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes 2021;13:1987779. [PMID: 34806521 DOI: 10.1080/19490976.2021.1987779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
402 [DOI: 10.1109/piers53385.2021.9694766] [Reference Citation Analysis]
403 Juul N, Dahl SS, Chiranth DJ, Penninga L. Extensive extraintestinal manifestations of ulcerative colitis in a patient initially suspected to have disseminated malignancy. BMJ Case Rep 2021;14:e241163. [PMID: 34799384 DOI: 10.1136/bcr-2020-241163] [Reference Citation Analysis]
404 Hadid B, Buehring W, Mannino A, Weisberg MD, Golub IJ, Ng MK, Razi AE. Crohn's Disease Increases In-Hospital Lengths of Stay, Medical Complications, and Costs of Care following Primary Total Knee Arthroplasty. J Knee Surg 2021. [PMID: 34794196 DOI: 10.1055/s-0041-1739199] [Reference Citation Analysis]
405 Furukawa S, Ikeda Y, Yagi S, Miyake T, Shiraishi K, Tange K, Hashimoto Y, Mori K, Ninomiya T, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Hiasa Y. Association Between Peripheral Blood Monocyte Count and Mucosal Healing in Japanese Patients With Ulcerative Colitis. Clin Transl Gastroenterol 2021;12:e00429. [PMID: 34797817 DOI: 10.14309/ctg.0000000000000429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 Huang S, Hu S, Liu S, Tang B, Liu Y, Tang L, Lei Y, Zhong L, Yang S, He S. Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner. Pharmacol Res 2021;175:105992. [PMID: 34801681 DOI: 10.1016/j.phrs.2021.105992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
407 Li B, Wu Y, Wang Z, Xing M, Xu W, Zhu Y, Du P, Wang X, Yang H. Non-invasive diagnosis of Crohn's disease based on SERS combined with PCA-SVM. Anal Methods 2021;13:5264-73. [PMID: 34665186 DOI: 10.1039/d1ay01377g] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
408 Čužić S, Antolić M, Ognjenović A, Stupin-polančec D, Petrinić Grba A, Hrvačić B, Dominis Kramarić M, Musladin S, Požgaj L, Zlatar I, Polančec D, Aralica G, Banić M, Urek M, Mijandrušić Sinčić B, Čubranić A, Glojnarić I, Bosnar M, Eraković Haber V. Claudins: Beyond Tight Junctions in Human IBD and Murine Models. Front Pharmacol 2021;12:682614. [DOI: 10.3389/fphar.2021.682614] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
409 Keefer L, Gorbenko K, Siganporia T, Manning L, Tse S, Biello A, Ungaro R, Cohen LJ, Cohen BL, Dubinsky MC. Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and Opioids. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01225-8. [PMID: 34798332 DOI: 10.1016/j.cgh.2021.11.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Radulović NS, Nikolić MG, Mladenović MZ, Ranđelović P, Stojanović NM, Stojanović‐radić Z, Jovanović L. Antispasmodic and antimicrobial activities of pyrazole‐containing ferrocenyl alkanols versus their phenyl analogs, and the entry point to potential multitarget treatment for inflammatory bowel diseases. Applied Organom Chemis 2022;36. [DOI: 10.1002/aoc.6514] [Reference Citation Analysis]
411 Mu J, Xu J, Wang L, Chen C, Chen P. Anti-inflammatory effects of purple sweet potato anthocyanin extract in DSS-induced colitis: modulation of commensal bacteria and attenuated bacterial intestinal infection. Food Funct 2021;12:11503-14. [PMID: 34700334 DOI: 10.1039/d1fo02454j] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
412 Cui M, Zhang M, Liu K. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review. Carbohydr Polym 2021;272:118530. [PMID: 34420762 DOI: 10.1016/j.carbpol.2021.118530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
413 Li Y, Chen J, Bolinger AA, Chen H, Liu Z, Cong Y, Brasier AR, Pinchuk IV, Tian B, Zhou J. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:S38-62. [PMID: 34791293 DOI: 10.1093/ibd/izab190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
414 Kaplan GG, Windsor JW, Crain J, Barrett L, Bernstein CN, Bitton A, Chauhan U, Coward S, Fowler S, Ghia JE, Gibson DL, Griffiths AM, Jones JL, Khanna R, Kuenzig ME, Lakatos PL, Lee K, Mack DR, Marshall JK, Mawani M, Murthy SK, Panaccione R, Seow CH, Targownik LE, Zelinsky S, Benchimol EI. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy. J Can Assoc Gastroenterol 2021;4:S10-9. [PMID: 34755034 DOI: 10.1093/jcag/gwab028] [Reference Citation Analysis]
415 Ellen Kuenzig M, Windsor JW, Barrett L, Bernstein CN, Bitton A, Carroll MW, Chauhan U, Coward S, Fowler S, Ghia JE, Geist R, Gibson DL, Graff LA, Griffiths AM, Guoxian Huang J, Jones JL, Khanna R, Lakatos PL, Lee K, Mack DR, Marshall JK, Mukhtar MS, Murthy SK, Nguyen GC, Panaccione R, Seow CH, Singh H, Tandon P, Targownik LE, Zelinsky S, Benchimol EI, Kaplan GG. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary. J Can Assoc Gastroenterol 2021;4:S1-9. [PMID: 34755033 DOI: 10.1093/jcag/gwab027] [Reference Citation Analysis]
416 Lee WS, Song ZL, Wong SY, Gan CW, Koay ZL, Em JM, Chong SY, Lim CB, Wong SY, Chew KS, Kam CC. Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health 2021. [PMID: 34761458 DOI: 10.1111/jpc.15830] [Reference Citation Analysis]
417 Furuya Y, Fukai K, Nakazawa S, Kojimahara N, Hoshi K, Toyota A, Tatemichi M. Occupational physical activity differentially affects the risk for developing later-onset Crohn's disease and ulcerative colitis among middle-aged and older populations. Scand J Gastroenterol 2021;:1-8. [PMID: 34762552 DOI: 10.1080/00365521.2021.1999495] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
418 Mahadea D, Adamczewska E, Ratajczak AE, Rychter AM, Zawada A, Eder P, Dobrowolska A, Krela-Kaźmierczak I. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review. Nutrients 2021;13:4008. [PMID: 34836263 DOI: 10.3390/nu13114008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
419 Fujita Y, Tominaga K, Tanaka T, Sugaya T, Yoshihara S. Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer. BMC Gastroenterol 2021;21:424. [PMID: 34758726 DOI: 10.1186/s12876-021-02010-1] [Reference Citation Analysis]
420 Rong Y, Hong G, Zhu N, Liu Y, Jiang Y, Liu T. Photodynamic Therapy of Novel Photosensitizer Ameliorates TNBS-Induced Ulcerative Colitis via Inhibition of AOC1. Front Pharmacol 2021;12:746725. [PMID: 34744725 DOI: 10.3389/fphar.2021.746725] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
421 Kröner PT, Merchea A, Colibaseanu D, Picco MF, Farraye FA, Stocchi L. The use of ileal pouch-anal anastomosis in patients with ulcerative colitis from 2009 to 2018. Colorectal Dis 2021. [PMID: 34743378 DOI: 10.1111/codi.15985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
422 Arkko A, Kaseva T, Salli E, Mäkelä T, Savolainen S, Kangasniemi M. Automatic detection of Crohn's disease using quantified motility in magnetic resonance enterography: initial experiences. Clin Radiol 2021:S0009-9260(21)00483-9. [PMID: 34753588 DOI: 10.1016/j.crad.2021.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Bachmann J, Le Thi G, Brückner A, Kalteis AL, Schwerd T, Koletzko S, Lurz E. Epstein-Barr Virus Prevalence at Diagnosis and Seroconversion during Follow-Up in Pediatric Inflammatory Bowel Disease. J Clin Med 2021;10:5187. [PMID: 34768707 DOI: 10.3390/jcm10215187] [Reference Citation Analysis]
424 Vutcovici M, Sewitch M, Kachan N, Stone M, Morin I, Bouchard S, Heatherington J, Devitt KS, Nguyen GC, Bitton A. Patient Perspectives of IBD Care and Services: An Integral Part of a Pan-Canadian Quality Improvement Initiative. J Can Assoc Gastroenterol 2021;4:229-33. [PMID: 34738068 DOI: 10.1093/jcag/gwaa044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
425 Sasson AN. A whole-food exclusion diet as monotherapy for Crohn's disease. Lancet Gastroenterol Hepatol 2022;7:6-7. [PMID: 34739864 DOI: 10.1016/S2468-1253(21)00335-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Liu F, Wang X, Cui Y, Yin Y, Qiu D, Li S, Li X. Apple Polyphenols Extract (APE) Alleviated Dextran Sulfate Sodium Induced Acute Ulcerative Colitis and Accompanying Neuroinflammation via Inhibition of Apoptosis and Pyroptosis. Foods 2021;10:2711. [PMID: 34828992 DOI: 10.3390/foods10112711] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
427 Gao W, Zhang T, Wu H. Emerging Pathological Engagement of Ferroptosis in Gut Diseases. Oxid Med Cell Longev 2021;2021:4246255. [PMID: 34733403 DOI: 10.1155/2021/4246255] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
428 Alenazi N, Alsaeed H, Alsulami A, Alanzi T. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease. Int J Gen Med 2021;14:7099-105. [PMID: 34729019 DOI: 10.2147/IJGM.S336678] [Reference Citation Analysis]
429 Kavalukas SL, Scheurlen KM, Galandiuk S. State-of-the-art surgery for Crohn's disease: Part I-small intestine/ileal disease. Langenbecks Arch Surg 2021. [PMID: 34738167 DOI: 10.1007/s00423-021-02324-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
430 Najafimehr H, Aghdaei HA, Pourhoseingholi MA, Shalmani HM, Vahedian-Azimi A, Kroh M, Zali MR, Sahebkar A. A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal Cancer. Gastroenterol Res Pract 2021;2021:4874459. [PMID: 34725546 DOI: 10.1155/2021/4874459] [Reference Citation Analysis]
431 Shao J, Li Z, Gao Y, Zhao K, Lin M, Li Y, Wang S, Liu Y, Chen L. Construction of a "Bacteria-Metabolites" Co-Expression Network to Clarify the Anti-Ulcerative Colitis Effect of Flavonoids of Sophora flavescens Aiton by Regulating the "Host-Microbe" Interaction. Front Pharmacol 2021;12:710052. [PMID: 34721011 DOI: 10.3389/fphar.2021.710052] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
432 Manthey CF, Reher D, Huber S. [What is confirmed in the treatment of chronic inflammatory bowel diseases]. Internist (Berl) 2021. [PMID: 34727190 DOI: 10.1007/s00108-021-01207-6] [Reference Citation Analysis]
433 Xiang BJ, Jiang M, Sun MJ, Dai C. Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Visc Med 2021;37:338-48. [PMID: 34722717 DOI: 10.1159/000514196] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
434 Fairbrass KM, Lovatt J, Barberio B, Yuan Y, Gracie DJ, Ford AC. Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut 2021:gutjnl-2021-325985. [PMID: 34725197 DOI: 10.1136/gutjnl-2021-325985] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
435 Deng M, Wu X, Duan X, Xu J, Yang X, Sheng X, Lou P, Shao C, Lv C, Yu Z. Lactobacillus paracasei L9 improves colitis by expanding butyrate-producing bacteria that inhibit the IL-6/STAT3 signaling pathway. Food Funct 2021;12:10700-13. [PMID: 34605504 DOI: 10.1039/d1fo02077c] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
436 Ou AT, Zhang JX, Fang YF, Wang R, Tang XP, Zhao PF, Zhao YG, Zhang M, Huang YZ. Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases. Acta Pharmacol Sin 2021;42:1913-20. [PMID: 34561552 DOI: 10.1038/s41401-021-00770-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
437 Lee EG, Yoon YC, Yoon J, Lee SJ, Oh YK, Kwon SW. Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease. Biomol Ther (Seoul) 2021;29:582-95. [PMID: 34565718 DOI: 10.4062/biomolther.2021.125] [Reference Citation Analysis]
438 Si X, Liu N, Jia H, Wang J, Pan L, Dong L, Rong Z, Yang Y, Wu Z. Gut relief formula attenuates dextran sulfate sodium-induced colitis by regulating NF-κB signaling and the intestinal microbiota in mice. Food Funct 2021;12:10983-93. [PMID: 34652352 DOI: 10.1039/d1fo01477c] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
439 Wallace JW, Constant DA, Nice TJ. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases. Front Immunol 2021;12:767505. [PMID: 34712246 DOI: 10.3389/fimmu.2021.767505] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
440 Han Y, Liu X, Dong H, Wen D. Screening of characteristic genes in ulcerative colitis by integrating gene expression profiles. BMC Gastroenterol 2021;21:415. [PMID: 34717557 DOI: 10.1186/s12876-021-01940-0] [Reference Citation Analysis]
441 Huangfu LX, Cai XT, Yang JN, Wang HC, Li YX, Dai ZF, Yang RL, Lin XH. Irisin attenuates inflammation in a mouse model of ulcerative colitis by altering the intestinal microbiota. Exp Ther Med 2021;22:1433. [PMID: 34707714 DOI: 10.3892/etm.2021.10868] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
442 Gu G, Lv X, Liu G, Zeng R, Li S, Chen L, Liang Z, Wang H, Lu F, Zhan L, Lv X. Tnfaip6 Secreted by Bone Marrow-Derived Mesenchymal Stem Cells Attenuates TNBS-Induced Colitis by Modulating Follicular Helper T Cells and Follicular Regulatory T Cells Balance in Mice. Front Pharmacol 2021;12:734040. [PMID: 34707499 DOI: 10.3389/fphar.2021.734040] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
443 Kłos P, Dabravolski SA. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer. Int J Mol Sci 2021;22:11673. [PMID: 34769108 DOI: 10.3390/ijms222111673] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
444 Noda M, Danshiitsoodol N, Kanno K, Uchida T, Sugiyama M. The Exopolysaccharide Produced by Lactobacillus paracasei IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS-Induced Ulcerative Colitis. Microorganisms 2021;9:2243. [PMID: 34835369 DOI: 10.3390/microorganisms9112243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
445 Xie Z, Zhang M, Zhou G, Lin L, Han J, Wang Y, Li L, He Y, Zeng Z, Chen M, Zhang S. Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease. Cell Death Discov 2021;7:314. [PMID: 34702800 DOI: 10.1038/s41420-021-00679-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
446 Geng Y, Yue Y, Guan Q, Ren Y, Guo L, Fan Y, Lu ZM, Shi JS, Xu ZH. Cereal Vinegar Sediment Alleviates Spontaneous Ulcerative Colitis in Il-10 Deficient Mice. Mol Nutr Food Res 2021;:e2001227. [PMID: 34699119 DOI: 10.1002/mnfr.202001227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
447 Shi J, Ma W, Tang H. Research progress of phosphodiesterase inhibitors in inflammatory bowel disease treatment. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021;50:659-65. [PMID: 34986542 DOI: 10.3724/zdxbyxb-2021-0170] [Reference Citation Analysis]
448 Wang J, Chen C, Ren Y, Zhou X, Yu S. Metformin alleviates intestinal epithelial barrier damage by inhibiting endoplasmic reticulum stress-induced cell apoptosis in colitis cell model. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021;50:627-32. [PMID: 34986539 DOI: 10.3724/zdxbyxb-2021-0242] [Reference Citation Analysis]
449 Ding P, Liu J, Li Q, Lu Q, Li J, Shi R, Shi L, Mao T, Ge D, Niu H, Peng G, Wang Z. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification. Drug Des Devel Ther 2021;15:4259-73. [PMID: 34675488 DOI: 10.2147/DDDT.S326029] [Reference Citation Analysis]
450 Choi YY, Lee JK, Kim HS, Kim DW, Kim HM, Kang DR. Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method. Yonsei Med J 2021;62:997-1004. [PMID: 34672133 DOI: 10.3349/ymj.2021.62.11.997] [Reference Citation Analysis]
451 Qin Y, Wang G, Kong D, Li G, Wang H, Qin H, Wang H. Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis. Diagnostics (Basel) 2021;11:1952. [PMID: 34829298 DOI: 10.3390/diagnostics11111952] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
452 Bu F, Ding Y, Chen T, Wang Q, Wang R, Zhou JY, Jiang F, Zhang D, Xu M, Shi G, Chen Y. Total flavone of Abelmoschus Manihot improves colitis by promoting the growth of Akkermansia in mice. Sci Rep 2021;11:20787. [PMID: 34675239 DOI: 10.1038/s41598-021-00070-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
453 Khan N, Patel D, Trivedi C, Pernes T, Kavani H, Xie D, Yang YX. The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients. Aliment Pharmacol Ther 2022;55:64-72. [PMID: 34664313 DOI: 10.1111/apt.16610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
454 Liao M, Zhang Y, Qiu Y, Wu Z, Zhong Z, Zeng X, Zeng Y, Xiong L, Wen Y, Liu R. Fructooligosaccharide supplementation alleviated the pathological immune response and prevented the impairment of intestinal barrier in DSS-induced acute colitis mice. Food Funct 2021;12:9844-54. [PMID: 34664584 DOI: 10.1039/d1fo01147b] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
455 Wang Z, Huang Y, Wang D, Wang R, Li K, Qi Q, Ma Z, Gu M, Zheng H, Lu Y, Wu L. Genome-Wide Regulation of Acupuncture and Moxibustion on Ulcerative Colitis Rats. Evid Based Complement Alternat Med 2021;2021:9945121. [PMID: 34659440 DOI: 10.1155/2021/9945121] [Reference Citation Analysis]
456 Zhou X, Ren M, Yang J, Pan H, Yu M, Ji F. Curcumin Improves Epithelial Barrier Integrity of Caco-2 Monolayers by Inhibiting Endoplasmic Reticulum Stress and Subsequent Apoptosis. Gastroenterol Res Pract 2021;2021:5570796. [PMID: 34659400 DOI: 10.1155/2021/5570796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Yang C, Du Y, Ren D, Yang X, Zhao Y. Gut microbiota-dependent catabolites of tryptophan play a predominant role in the protective effects of turmeric polysaccharides against DSS-induced ulcerative colitis. Food Funct 2021;12:9793-807. [PMID: 34664583 DOI: 10.1039/d1fo01468d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
458 Alshammari MT, Stevenson R, Abdul-Aema B, Zou G, Jairath V, Radford S, Marciani L, Moran GW. Diagnostic Accuracy of Non-Invasive Imaging for Detection of Colonic Inflammation in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Diagnostics (Basel) 2021;11:1926. [PMID: 34679624 DOI: 10.3390/diagnostics11101926] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
459 Jones E, Stentz R, Telatin A, Savva GM, Booth C, Baker D, Rudder S, Knight SC, Noble A, Carding SR. The Origin of Plasma-Derived Bacterial Extracellular Vesicles in Healthy Individuals and Patients with Inflammatory Bowel Disease: A Pilot Study. Genes (Basel) 2021;12:1636. [PMID: 34681030 DOI: 10.3390/genes12101636] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
460 Lin TY, Lai YF, Chen PH, Chung CH, Chen CL, Chen YH, Chen JT, Kuo PC, Chien WC, Hsieh YH. Association Between Ischemic Optic Neuropathy and Inflammatory Bowel Disease: A Population-Based Cohort Study in Taiwan. Front Med (Lausanne) 2021;8:753367. [PMID: 34651004 DOI: 10.3389/fmed.2021.753367] [Reference Citation Analysis]
461 Ferreiro B, Llopis-Salinero S, Lardies B, Granados-Colomina C, Milà-Villarroel R. Clinical and Nutritional Impact of a Semi-Elemental Hydrolyzed Whey Protein Diet in Patients with Active Crohn's Disease: A Prospective Observational Study. Nutrients 2021;13:3623. [PMID: 34684624 DOI: 10.3390/nu13103623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
462 Chiba M, Morita N, Nakamura A, Tsuji K, Harashima E. Increased Incidence of Inflammatory Bowel Disease in Association with Dietary Transition (Westernization) in Japan. JMA J 2021;4:347-57. [PMID: 34796289 DOI: 10.31662/jmaj.2021-0038] [Reference Citation Analysis]
463 Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases. Front Immunol 2021;12:749192. [PMID: 34646275 DOI: 10.3389/fimmu.2021.749192] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
464 Morikubo H, Kobayashi T, Fukuda T, Nagahama T, Hisamatsu T, Hibi T. Development of algorithms for identifying patients with Crohn's disease in the Japanese health insurance claims database. PLoS One 2021;16:e0258537. [PMID: 34644342 DOI: 10.1371/journal.pone.0258537] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
465 van Rijn KL, Meima-van Praag EM, Bossuyt PM, D'Haens GR, Gecse KB, Horsthuis K, Snijder HJ, Tielbeek JAW, Buskens CJ, Stoker J. Fibrosis and MAGNIFI-CD activity index at MRI to predict treatment outcome in perianal fistulising Crohn's disease patients. J Crohns Colitis 2021:jjab168. [PMID: 34644395 DOI: 10.1093/ecco-jcc/jjab168] [Reference Citation Analysis]
466 Deissler H, Krammer H, Gillessen A. pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review). Biomed Rep 2021;15:96. [PMID: 34631051 DOI: 10.3892/br.2021.1472] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Abd Al-Aliem AEE, Badr EAE, El-Shayeb EI, Taman AMA, Gadallah AEAE. Association of the myosin heavy chain 9 gene single nucleotide polymorphism with inflammatory bowel disease. Biochem Biophys Rep 2021;28:101113. [PMID: 34604548 DOI: 10.1016/j.bbrep.2021.101113] [Reference Citation Analysis]
468 Vuyyuru SK, Kedia S, Kalaivani M, Sahu P, Kante B, Kumar P, Ranjan MK, Makharia G, Ananthakrishnan A, Ahuja V. Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. Future Microbiol 2021;16:1215-27. [PMID: 34590904 DOI: 10.2217/fmb-2020-0242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
469 Wang L, Liao Y, Yang R, Zhu Z, Zhang L, Wu Z, Sun X. An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis. Bioeng Transl Med 2021;6:e10219. [PMID: 34589596 DOI: 10.1002/btm2.10219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
470 Qiao D, Zhang Z, Zhang Y, Chen Q, Chen Y, Tang Y, Sun X, Tang Z, Dai Y. Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis. Front Pharmacol 2021;12:697360. [PMID: 34588980 DOI: 10.3389/fphar.2021.697360] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
471 Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 2021;70:1989-2003. [PMID: 34266966 DOI: 10.1136/gutjnl-2020-322362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
472 Lundgren D, Widbom L, Hultdin J, Karling P. Preclinical Markers in Inflammatory Bowel Disease. A Nested Case–Control Study. Crohn's & Colitis 360 2021;3:otab072. [DOI: 10.1093/crocol/otab072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Faye AS, Oh A, Kumble LD, Kiran RP, Wen T, Lawlor G, Lichtiger S, Abreu MT, Hur C. Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients. Inflamm Bowel Dis 2020;26:1368-76. [PMID: 31880776 DOI: 10.1093/ibd/izz307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
474 Connor SJ, Sechi A, Andrade M, Deuring JJ, Witcombe D. Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views. JGH Open 2021;5:1033-40. [PMID: 34584972 DOI: 10.1002/jgh3.12627] [Reference Citation Analysis]
475 Iannuzzi JP, King JA, Leong JH, Quan J, Windsor JW, Tanyingoh D, Coward S, Forbes N, Heitman SJ, Shaheen AA, Swain M, Buie M, Underwood FE, Kaplan GG. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis. Gastroenterology 2022;162:122-34. [PMID: 34571026 DOI: 10.1053/j.gastro.2021.09.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
476 Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679. [PMID: 34567271 DOI: 10.1177/17562848211042679] [Reference Citation Analysis]
477 Liu TW, Wang CM, Ci YH, Liu J, Qi XS. Effect of psychological problems and interventions on gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1043-1048 [DOI: 10.11569/wcjd.v29.i18.1043] [Reference Citation Analysis]
478 Ricciuto A, Lamb CA, Benchimol EI, Walker GJ, Kennedy NA, Kuenzig ME, Kaplan GG, Kappelman MD, Ungaro RC, Colombel JF, Brenner EJ, Agrawal M, Reinisch W, Griffiths AM, Sebastian S. Inflammatory Bowel Disease Clinical Activity Is Associated with COVID-19 Severity Especially in Younger Patients. J Crohns Colitis 2021:jjab172. [PMID: 34570886 DOI: 10.1093/ecco-jcc/jjab172] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
479 Xu H, Luo R, Dong L, Pu X, Chen Q, Ye N, Qi S, Han X, Nie W, Fu C, Hu Y, Zhang J, Gao F. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis. Nanomedicine 2022;39:102461. [PMID: 34562656 DOI: 10.1016/j.nano.2021.102461] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
480 Kelm M, Germer CT, Schlegel N, Flemming S. The Revival of Surgery in Crohn's Disease-Early Intestinal Resection as a Reasonable Alternative in Localized Ileitis. Biomedicines 2021;9:1317. [PMID: 34680434 DOI: 10.3390/biomedicines9101317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
481 Yu Y, Zheng C, Lu X, Deng C, Xu Q, Guo W, Wu Q, Wang Q, Liu C, Huang X, Song J. GB1a Ameliorates Ulcerative Colitis via Regulation of the NF-κB and Nrf2 Signaling Pathways in an Experimental Model. Front Med (Lausanne) 2021;8:654867. [PMID: 34557497 DOI: 10.3389/fmed.2021.654867] [Reference Citation Analysis]
482 Sun Z, Li J, Wang W, Liu Y, Liu J, Jiang H, Lu Q, Ding P, Shi R, Zhao X, Yuan W, Tan X, Shi X, Xing Y, Mao T. Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice. Front Pharmacol 2021;12:738152. [PMID: 34557102 DOI: 10.3389/fphar.2021.738152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
483 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
484 Shang X, Gu F, Bian Q, Wang M, Lin Z. Effects of a Written Expression-Based Positive Psychological Intervention on the Psychological Status of Patients With Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterol Nurs 2021;44:437-48. [PMID: 34560705 DOI: 10.1097/SGA.0000000000000594] [Reference Citation Analysis]
485 Yang L, Luo H, Tan D, Zhang S, Zhong Z, Wang S, Vong CT, Wang Y. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 2021;92:153709. [PMID: 34560518 DOI: 10.1016/j.phymed.2021.153709] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
486 Miao X, Mao R, You Y, Zhou H, Qiu C, Li X, Chen Z, Ren J, Chen M, Wang P, Zheng R, Yin T. Intracolic ultrasound molecular imaging: a novel method for assessing colonic tumor necrosis factor-α expression in inflammatory bowel disease. Mol Med 2021;27:119. [PMID: 34556023 DOI: 10.1186/s10020-021-00379-z] [Reference Citation Analysis]
487 Fernández-Tomé S, Ortega Moreno L, Chaparro M, Gisbert JP. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:10224. [PMID: 34638564 DOI: 10.3390/ijms221910224] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
488 Majidova K, Handfield J, Kafi K, Martin RD, Kubinski R. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes (Basel) 2021;12:1465. [PMID: 34680860 DOI: 10.3390/genes12101465] [Reference Citation Analysis]
489 Zhang C, Chen Z, He Y, Xian J, Luo R, Zheng C, Zhang J. Oral colon-targeting core-shell microparticles loading curcumin for enhanced ulcerative colitis alleviating efficacy. Chin Med 2021;16:92. [PMID: 34551815 DOI: 10.1186/s13020-021-00449-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
490 Sienkiewicz M, Szymańska P, Maciejewska O, Niewiadomska J, Wiśniewska‐jarosińska M, Fichna J. Assessment of dietary habits in inflammatory bowel disease patients: A cross‐sectional study from Poland. Nutr Bull 2021;46:432-42. [DOI: 10.1111/nbu.12525] [Reference Citation Analysis]
491 Xie XT, Zheng LX, Duan HM, Liu Y, Chen XQ, Cheong KL. Structural characteristics of Gracilaria lemaneiformis oligosaccharides and their alleviation of dextran sulphate sodium-induced colitis by modulating the gut microbiota and intestinal metabolites in mice. Food Funct 2021;12:8635-46. [PMID: 34346464 DOI: 10.1039/d1fo01201k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
492 Lask A, Biebl M, Dittrich L, Fischer A, Adler A, Tacke F, Aigner F, Schmuck R, Chopra S, Knoop M, Pratschke J, Gül-Klein S. Safety of transanal ileal pouch-anal anastomosis for ulcerative colitis: a retrospective observational cohort study. Patient Saf Surg 2021;15:31. [PMID: 34537080 DOI: 10.1186/s13037-021-00306-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
493 Zhang D, Verstrepen L, De Medts J, Duysburgh C, Van den Abbeele P, Marzorati M, Khoo C. A Cranberry Concentrate Decreases Adhesion and Invasion of Escherichia coli (AIEC) LF82 In Vitro. Pathogens 2021;10:1217. [PMID: 34578249 DOI: 10.3390/pathogens10091217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
494 Kim ES, Kim MJ. Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents. Clin Exp Pediatr 2022;65:21-8. [PMID: 34530520 DOI: 10.3345/cep.2021.00661] [Reference Citation Analysis]
495 Petryszyn P, Dudkowiak R, Gruca A, Jaźwińska-Tarnawska E, Ekk-Cierniakowski P, Poniewierka E, Wiela-Hojeńska A, Głowacka K. C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case-Control and Meta-Analysis Study. Genes (Basel) 2021;12:1419. [PMID: 34573401 DOI: 10.3390/genes12091419] [Reference Citation Analysis]
496 Shute A, Callejas BE, Li S, Wang A, Jayme TS, Ohland C, Lewis IA, Layden BT, Buret AG, McKay DM. Cooperation between host immunity and the gut bacteria is essential for helminth-evoked suppression of colitis. Microbiome 2021;9:186. [PMID: 34517928 DOI: 10.1186/s40168-021-01146-2] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
497 Marion-Letellier R, Leboutte M, Amamou A, Raman M, Savoye G, Ghosh S. Diet in Intestinal Fibrosis: A Double-Edged Sword. Nutrients 2021;13:3148. [PMID: 34579023 DOI: 10.3390/nu13093148] [Reference Citation Analysis]
498 Nijakowski K, Rutkowski R, Eder P, Simon M, Korybalska K, Witowski J, Surdacka A. Potential Salivary Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis. Life (Basel) 2021;11:943. [PMID: 34575091 DOI: 10.3390/life11090943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
499 Jabandziev P, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:985-93. [PMID: 32009179 DOI: 10.1093/ibd/izaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
500 Ostrowski J, Kulecka M, Zawada I, Żeber-Lubecka N, Paziewska A, Graca-Pakulska K, Dąbkowski K, Skubisz K, Cybula P, Ambrożkiewicz F, Urasińska E, Mikula M, Starzyńska T. The gastric microbiota in patients with Crohn's disease; a preliminary study. Sci Rep 2021;11:17866. [PMID: 34504159 DOI: 10.1038/s41598-021-97261-z] [Reference Citation Analysis]
501 Yang M, Gu Y, Li L, Liu T, Song X, Sun Y, Cao X, Wang B, Jiang K, Cao H. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients 2021;13:3143. [PMID: 34579027 DOI: 10.3390/nu13093143] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
502 Zhai Z, Niu KM, Liu Y, Lin C, Wu X. The Gut Microbiota-Bile Acids-TGR5 Axis Mediates Eucommia ulmoides Leaf Extract Alleviation of Injury to Colonic Epithelium Integrity. Front Microbiol 2021;12:727681. [PMID: 34489916 DOI: 10.3389/fmicb.2021.727681] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
503 Mikocka-Walus A, Skvarc D, de Acosta MB, Evertsz FB, Bernstein CN, Burisch J, Ferreira N, Gearry RB, Graff LA, Jedel S, Mokrowiecka A, Stengel A, Trindade IA, van Tilburg MAL, Knowles SR. Exploring the Relationship Between Self-Isolation and Distress Among People with Gastrointestinal Disorders During the COVID-19 Pandemic. J Clin Psychol Med Settings 2021. [PMID: 34494184 DOI: 10.1007/s10880-021-09818-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
504 Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, Zhang G, Zhao J, Wang J. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 2021;9:184. [PMID: 34493333 DOI: 10.1186/s40168-021-01115-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 47] [Article Influence: 2.0] [Reference Citation Analysis]
505 Ślósarz D, Poniewierka E, Neubauer K, Kempiński R. Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease-Systematic Review. J Clin Med 2021;10:4044. [PMID: 34575156 DOI: 10.3390/jcm10184044] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
506 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
507 Wei Y, Chen T, Yang W, Li H, Fang C, Liu Q, Chen Y, Mei Q. Detection of a novel antigen for Crohn's disease. Scand J Gastroenterol 2021;56:1427-33. [PMID: 34487462 DOI: 10.1080/00365521.2021.1973088] [Reference Citation Analysis]
508 Molinas A, Heil S, Koch S. The Candidate IBD Risk Gene CCNY Is Dispensable for Intestinal Epithelial Homeostasis. Cells 2021;10:2330. [PMID: 34571979 DOI: 10.3390/cells10092330] [Reference Citation Analysis]
509 Chamorro N, Montero DA, Gallardo P, Farfán M, Contreras M, De la Fuente M, Dubois K, Hermoso MA, Quera R, Pizarro-Guajardo M, Paredes-Sabja D, Ginard D, Rosselló-Móra R, Vidal R. Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease. Microb Cell 2021;8:223-38. [PMID: 34527721 DOI: 10.15698/mic2021.09.760] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
510 Shivaji UN, Segal JP, Plumb AA, Quraishi MN, Ghosh S, Iacucci M. Intestinal ultrasonography: a useful skill for efficient, non-invasive monitoring of patients with IBD using a clinic-based point-of-care approach. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2021-101852] [Reference Citation Analysis]
511 Rocha R, de J Santos G, Santana G. Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2021; 12(5): 90-99 [PMID: 34616585 DOI: 10.4292/wjgpt.v12.i5.90] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 Skamnelos A, Lazaridis N, Vlachou E, Koukias N, Apostolopoulos P, Murino A, Christodoulou D, Despott EJ. The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021. Ann Gastroenterol 2021;34:599-611. [PMID: 34475730 DOI: 10.20524/aog.2021.0652] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Frandsen LT, Westmark S, Melgaard D, Krarup AL. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate. United European Gastroenterol J 2021;9:910-8. [PMID: 34477326 DOI: 10.1002/ueg2.12146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
514 Hosomi S, Nishida Y, Fujiwara Y. The Impact of Human Herpesviruses in Clinical Practice of Inflammatory Bowel Disease in the Era of COVID-19. Microorganisms 2021;9:1870. [PMID: 34576764 DOI: 10.3390/microorganisms9091870] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
515 Adepoju AA, Akere A, Ogun GO, Ogunbosi BO, Asinobi AO, Bello O, Orimadegun AE, Allen S, Akinyinka OO. Co-existing sickle cell anaemia and inflammatory bowel disease: case report and review of the literature. Paediatr Int Child Health 2021;:1-7. [PMID: 34474658 DOI: 10.1080/20469047.2021.1936393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
516 Niccum B, Casey K, Burke K, Lopes EW, Lochhead P, Ananthakrishnan A, Richter JM, Ludvigsson JF, Chan AT, Khalili H. Alcohol Consumption is Associated With An Increased Risk of Microscopic Colitis: Results From 2 Prospective US Cohort Studies. Inflamm Bowel Dis 2021:izab220. [PMID: 34473269 DOI: 10.1093/ibd/izab220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
517 Gubatan J, Keyashian K, Rubin SJS, Wang J, Buckman CA, Sinha S. Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives. Clin Exp Gastroenterol 2021;14:333-42. [PMID: 34466013 DOI: 10.2147/CEG.S293272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
518 Zu M, Ma Y, Cannup B, Xie D, Jung Y, Zhang J, Yang C, Gao F, Merlin D, Xiao B. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv Drug Deliv Rev 2021;176:113887. [PMID: 34314785 DOI: 10.1016/j.addr.2021.113887] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
519 Liu H, Cai Z, Wang F, Hong L, Deng L, Zhong J, Wang Z, Cui W. Colon-Targeted Adhesive Hydrogel Microsphere for Regulation of Gut Immunity and Flora. Adv Sci (Weinh) 2021;8:e2101619. [PMID: 34292669 DOI: 10.1002/advs.202101619] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
520 Liu P, Gao C, Chen H, Vong CT, Wu X, Tang X, Wang S, Wang Y. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies. Acta Pharm Sin B 2021;11:2798-818. [PMID: 34589398 DOI: 10.1016/j.apsb.2020.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
521 Stascheit F, Hotter B, Hoffmann S, Kohler S, Lehnerer S, Sputtek A, Meisel A. Calprotectin as potential novel biomarker in myasthenia gravis. J Transl Autoimmun 2021;4:100111. [PMID: 34458711 DOI: 10.1016/j.jtauto.2021.100111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
522 Liu S, Eisenstein S. State-of-the-art surgery for ulcerative colitis. Langenbecks Arch Surg 2021;406:1751-61. [PMID: 34453611 DOI: 10.1007/s00423-021-02295-6] [Reference Citation Analysis]
523 Imrei M, Németh D, Szakács Z, Hegyi P, Kiss S, Alizadeh H, Dembrovszky F, Pázmány P, Bajor J, Párniczky A. Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis. J Pers Med 2021;11:859. [PMID: 34575636 DOI: 10.3390/jpm11090859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
524 Yoo BS, D'Souza SM, Houston K, Patel A, Lau J, Elmahdi A, Parekh PJ, Johnson D. Artificial intelligence and colonoscopy − enhancements and improvements. Artif Intell Gastrointest Endosc 2021; 2(4): 157-167 [DOI: 10.37126/aige.v2.i4.157] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
525 Lo CH, Khandpur N, Rossato SL, Lochhead P, Lopes EW, Burke KE, Richter JM, Song M, Ardisson Korat AV, Sun Q, Fung TT, Khalili H, Chan AT, Ananthakrishnan AN. Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00911-3. [PMID: 34461300 DOI: 10.1016/j.cgh.2021.08.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
526 He L, Zhou X, Liu Y, Zhou L, Li F. Fecal miR-142a-3p from dextran sulfate sodium-challenge recovered mice prevents colitis by promoting the growth of Lactobacillus reuteri. Mol Ther 2021:S1525-0016(21)00419-6. [PMID: 34450255 DOI: 10.1016/j.ymthe.2021.08.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
527 de Mello-Neto JM, Nunes JGR, Tadakamadla SK, da Silva Figueredo CM. Immunological Traits of Patients with Coexistent Inflammatory Bowel Disease and Periodontal Disease: A Systematic Review. Int J Environ Res Public Health 2021;18:8958. [PMID: 34501547 DOI: 10.3390/ijerph18178958] [Reference Citation Analysis]
528 Guo F, Cai D, Li Y, Gu H, Qu H, Zong Q, Bao W, Chen A, Liu HY. How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease? Front Nutr 2021;8:690073. [PMID: 34422881 DOI: 10.3389/fnut.2021.690073] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
529 Kaczmarek-Ryś M, Hryhorowicz ST, Lis E, Banasiewicz T, Paszkowski J, Borejsza-Wysocki M, Walkowiak J, Cichy W, Krokowicz P, Czkwianianc E, Hnatyszyn A, Krela-Kaźmierczak I, Dobrowolska A, Słomski R, Pławski A. Crohn's Disease Susceptibility and Onset Are Strongly Related to Three NOD2 Gene Haplotypes. J Clin Med 2021;10:3777. [PMID: 34501225 DOI: 10.3390/jcm10173777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Chen S, Wu X, Yu Z. Juglone Suppresses Inflammation and Oxidative Stress in Colitis Mice. Front Immunol 2021;12:674341. [PMID: 34421890 DOI: 10.3389/fimmu.2021.674341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
531 Agraib LM, Yamani MI, Rayyan YM, Abu-Sneineh AT, Tamimi TA, Tayyem RF. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metab Pers Ther 2021;37:7-19. [PMID: 35385892 DOI: 10.1515/dmpt-2021-0150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
532 Wibowo S, Subandiyah K, Handono K, Poeranto S. Role of vitamin D in Wnt pathway activation for colonic epithelial cell differentiation. J Taibah Univ Med Sci 2021;16:575-81. [PMID: 34408615 DOI: 10.1016/j.jtumed.2021.01.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Stürzl M, Kunz M, Krug SM, Naschberger E. Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:643607. [PMID: 34409045 DOI: 10.3389/fmed.2021.643607] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
534 Dasharathy SS, Limketkai BN, Sauk JS. What's New in the Postoperative Management of Crohn's Disease? Dig Dis Sci 2021. [PMID: 34406585 DOI: 10.1007/s10620-021-07205-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
535 Wu F, Shao Q, Cheng Z, Xiong X, Fang K, Zhao Y, Dong R, Xu L, Lu F, Chen G. Traditional herbal formula Wu-Mei-Wan alleviates TNBS-induced colitis in mice by inhibiting necroptosis through increasing RIPK3 O-GlcNAcylation. Chin Med 2021;16:78. [PMID: 34399822 DOI: 10.1186/s13020-021-00493-4] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
536 Zou J, Liu C, Jiang S, Qian D, Duan J. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infect Immun 2021;89:e0001421. [PMID: 33526559 DOI: 10.1128/IAI.00014-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
537 Weingarden AR, Rubin SJS, Gubatan J. Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(8): 772-798 [PMID: 34457186 DOI: 10.4251/wjgo.v13.i8.772] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
538 Ghoshal UC, Yadav A, Fatima B, Agrahari AP, Misra A. Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study. Indian J Gastroenterol 2021. [PMID: 34390471 DOI: 10.1007/s12664-021-01211-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
539 Xu B, Huang S, Chen Y, Wang Q, Luo S, Li Y, Wang X, Chen J, Luo X, Zhou L. Synergistic effect of combined treatment with baicalin and emodin on DSS-induced colitis in mouse. Phytother Res 2021;35:5708-19. [PMID: 34379340 DOI: 10.1002/ptr.7230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
540 Xu J, Chen X, Ma K, Nie K, Luo W, Wu X, Pan S, Wang X. Correlation Between Sleep, Life, Mood, and Diet and Severity of Inflammatory Bowel Disease in China: A Retrospective Study. Med Sci Monit 2021;27:e930511. [PMID: 34370718 DOI: 10.12659/MSM.930511] [Reference Citation Analysis]
541 Li S, Rajeev S, Wang A, McKay DM. Infection with Hymenolepis diminuta Blocks Colitis and Hastens Recovery While Colitis Has Minimal Impact on Expulsion of the Cestode from the Mouse Host. Pathogens 2021;10:994. [PMID: 34451458 DOI: 10.3390/pathogens10080994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
542 Li DF, Chang X, Zhao JL, Chen XM, Xu ZL, Zhang DG, Wu BH, Wang LS, Bai Y, Yao J. Colonic Epithelial PHLPP2 Deficiency Promotes Colonic Epithelial Pyroptosis by Activating the NF-κB Signaling Pathway. Oxid Med Cell Longev 2021;2021:5570731. [PMID: 34394827 DOI: 10.1155/2021/5570731] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
543 Madarame A, Fukuzawa M, Yamauchi Y, Kono S, Sugimoto A, Yamaguchi H, Morise T, Koyama Y, Uchida K, Suguro M, Matsumoto T, Yasuyuki K, Kawai T, Itoi T. Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase. PLoS One 2021;16:e0255620. [PMID: 34347848 DOI: 10.1371/journal.pone.0255620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
544 Chen Q, Huang S, Wu Y, Zhang S, Liu Q, Chen M. Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract 2021;2021:4963641. [PMID: 34394344 DOI: 10.1155/2021/4963641] [Reference Citation Analysis]
545 Linson EA, Hanauer SB. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape. Curr Gastroenterol Rep 2021;23:16. [PMID: 34338892 DOI: 10.1007/s11894-021-00816-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
546 He N, Yang Y, Wang H, Liu N, Yang Z, Li S. Unsaturated alginate oligosaccharides (UAOS) protects against dextran sulfate sodium-induced colitis associated with regulation of gut microbiota. Journal of Functional Foods 2021;83:104536. [DOI: 10.1016/j.jff.2021.104536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
547 Qin Y, Zhao R, Qin H, Chen L, Chen H, Zhao Y, Nie G. Colonic mucus-accumulating tungsten oxide nanoparticles improve the colitis therapy by targeting Enterobacteriaceae. Nano Today 2021;39:101234. [DOI: 10.1016/j.nantod.2021.101234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
548 Nowak JK, Dworacka M, Gubaj N, Dossimov A, Dossimov Z, Walkowiak J. Expression profiling of ileal mucosa in asthma reveals upregulation of innate immunity and genes characteristic of Paneth and goblet cells. Allergy Asthma Clin Immunol 2021;17:82. [PMID: 34332619 DOI: 10.1186/s13223-021-00584-9] [Reference Citation Analysis]
549 Barreau F, Tisseyre C, Ménard S, Ferrand A, Carriere M. Titanium dioxide particles from the diet: involvement in the genesis of inflammatory bowel diseases and colorectal cancer. Part Fibre Toxicol 2021;18:26. [PMID: 34330311 DOI: 10.1186/s12989-021-00421-2] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
550 Muse K, Johnson E, David AL. A Feeling of Otherness: A Qualitative Research Synthesis Exploring the Lived Experiences of Stigma in Individuals with Inflammatory Bowel Disease. Int J Environ Res Public Health 2021;18:8038. [PMID: 34360327 DOI: 10.3390/ijerph18158038] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
551 Zhang Y, Liu W, Zhang D, Yang Y, Wang X, Li L. Fermented and Germinated Processing Improved the Protective Effects of Foxtail Millet Whole Grain Against Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis and Gut Microbiota Dysbiosis in C57BL/6 Mice. Front Nutr 2021;8:694936. [PMID: 34395495 DOI: 10.3389/fnut.2021.694936] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
552 Day AS. Aspects of the Pathogenesis and Management of Inflammatory Bowel Diseases. GastrointestDisord 2021;3:96-9. [DOI: 10.3390/gidisord3030010] [Reference Citation Analysis]
553 Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Drug Des Devel Ther 2021;15:3255-76. [PMID: 34349502 DOI: 10.2147/DDDT.S319786] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
554 Mosli M, Alzahrani AM, Bahafzalla RA, Gazzaz TA, Slaghour RM, Altabsh GZ, Aljadani SB, Alturkestani RN, Hussein SS, Kashgary A, Saadah OI. Prevalence of Renal Stones Among Patients With Inflammatory Bowel Disease in Saudi Arabia. Cureus 2021;13:e15787. [PMID: 34295595 DOI: 10.7759/cureus.15787] [Reference Citation Analysis]
555 Yao S, Zhao Z, Wang W, Liu X. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. J Immunol Res 2021;2021:8030297. [PMID: 34337079 DOI: 10.1155/2021/8030297] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
556 Berger K, Somineni H, Prince J, Kugathasan S, Gibson G. Altered splicing associated with the pathology of inflammatory bowel disease. Hum Genomics 2021;15:47. [PMID: 34301333 DOI: 10.1186/s40246-021-00347-y] [Reference Citation Analysis]
557 Amamou A, Rouland M, Yaker L, Goichon A, Guérin C, Aziz M, Savoye G, Marion-Letellier R. Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation. Sci Rep 2021;11:15055. [PMID: 34301970 DOI: 10.1038/s41598-021-94280-8] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
558 Kowalska-Duplaga K, Gawlik-Scislo A, Krzesiek E, Jarocka-Cyrta E, Łazowska-Przeorek I, Duplaga M, Banaszkiewicz A. Determinants of disease-specific knowledge among children with inflammatory bowel disease and their parents: A multicentre study. World J Gastroenterol 2021; 27(27): 4468-4480 [PMID: 34366617 DOI: 10.3748/wjg.v27.i27.4468] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
559 Chen P, Li Y, Zhang X, Zhang Y. Systematic review with meta-analysis: effectiveness of hyperbaric oxygenation therapy for ulcerative colitis. Therap Adv Gastroenterol 2021;14:17562848211023394. [PMID: 34349835 DOI: 10.1177/17562848211023394] [Reference Citation Analysis]
560 Bilotta S, Paruchuru LB, Feilhauer K, Köninger J, Lorentz A. Resveratrol Is a Natural Inhibitor of Human Intestinal Mast Cell Activation and Phosphorylation of Mitochondrial ERK1/2 and STAT3. Int J Mol Sci 2021;22:7640. [PMID: 34299258 DOI: 10.3390/ijms22147640] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
561 Gargallo-Puyuelo CJ, Laredo V, Gomollón F. Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era? Front Med (Lausanne) 2021;8:681907. [PMID: 34336887 DOI: 10.3389/fmed.2021.681907] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
562 Kim J, Ahn M, Choi Y, Kang T, Kim J, Lee NH, Kim GO, Shin T. Alpha-Linolenic Acid Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Inflammation 2020;43:1876-83. [PMID: 32468499 DOI: 10.1007/s10753-020-01260-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
563 Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Front Pharmacol 2021;12:684486. [PMID: 34335253 DOI: 10.3389/fphar.2021.684486] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
564 Deng F, Xia P, Wu Z, Zhou H, Wang X. Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn's Disease. Int J Gen Med 2021;14:3387-96. [PMID: 34285563 DOI: 10.2147/IJGM.S315505] [Reference Citation Analysis]
565 Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis 2020;26:820-42. [PMID: 31833544 DOI: 10.1093/ibd/izz259] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 44.0] [Reference Citation Analysis]
566 Zhou J, Liu J, Gao Y, Shen L, Li S, Chen S. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Front Pharmacol 2021;12:707776. [PMID: 34305614 DOI: 10.3389/fphar.2021.707776] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
567 Chen ZA, Sun YF, Wang QX, Ma HH, Ma ZZ, Yang CJ. Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis. Front Genet 2021;12:697514. [PMID: 34306038 DOI: 10.3389/fgene.2021.697514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
568 Axiaris G, Zampeli E, Michopoulos S, Bamias G. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment. World J Gastroenterol 2021; 27(25): 3762-3779 [PMID: 34321842 DOI: 10.3748/wjg.v27.i25.3762] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
569 Torrell H, Cereto-Massagué A, Kazakova P, García L, Palacios H, Canela N. Multiomic Approach to Analyze Infant Gut Microbiota: Experimental and Analytical Method Optimization. Biomolecules 2021;11:999. [PMID: 34356622 DOI: 10.3390/biom11070999] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
570 Yu L, Zhao D, Nian Y, Li C. Casein-fed mice showed faster recovery from DSS-induced colitis than chicken-protein-fed mice. Food Funct 2021;12:5806-20. [PMID: 34047734 DOI: 10.1039/d1fo00659b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
571 Nishihara Y, Ogino H, Tanaka M, Ihara E, Fukaura K, Nishioka K, Chinen T, Tanaka Y, Nakayama J, Kang D, Ogawa Y. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis. Sci Rep 2021;11:13743. [PMID: 34215773 DOI: 10.1038/s41598-021-92870-0] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
572 Walshe M, Borowski K, Battat R, Hudesman D, Wolf DC, Okada L, Jain A, Silverberg MS. Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index. Crohn's & Colitis 360 2021;3:otab032. [DOI: 10.1093/crocol/otab032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
573 Escaffi MJ, Navia C, Quera R, Simian D. Nutrición y enfermedad inflamatoria intestinal: posibles mecanismos en la incidencia y manejo. Revista Médica Clínica Las Condes 2021;32:491-501. [DOI: 10.1016/j.rmclc.2021.01.013] [Reference Citation Analysis]
574 Ben Ghezala I, Charkaoui M, Michiels C, Bardou M, Luu M. Small Molecule Drugs in Inflammatory Bowel Diseases. Pharmaceuticals (Basel) 2021;14:637. [PMID: 34209234 DOI: 10.3390/ph14070637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
575 Yamashita S, Kinoshita M, Miyazawa T. Dietary Sphingolipids Contribute to Health via Intestinal Maintenance. Int J Mol Sci 2021;22:7052. [PMID: 34208952 DOI: 10.3390/ijms22137052] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
576 Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Botella B, Sapiña A, Cruz N, Forcelledo JLF, Bouhmidi A, Castaño-Milla C, Opio V, Nicolás I, Kutz M, Abraldes Bechiarelli A, Gordillo J, Ber Y, Torres Domínguez Y, Novella Durán MT, Rodríguez Mondéjar S, Martínez-Cerezo FJ, Kolle L, Sabat M, Ledezma C, Iyo E, Roncero Ó, Irisarri R, Lluis L, Blázquez Gómez I, Zapata EM, José Alcalá M, Martínez Pascual C, Montealegre M, Mata L, Monrobel A, Hernández Camba A, Hernández L, Tejada M, Mir A, Galve ML, Soler M, Hervías D, Gómez-Valero JA, Barreiro-de Acosta M, Rodríguez-Artalejo F, García-Esquinas E, Gisbert JP, On Behalf Of The EpidemIBD Study Group Of Geteccu. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J Clin Med 2021;10:2885. [PMID: 34209680 DOI: 10.3390/jcm10132885] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
577 Toyonaga T, Araba KC, Kennedy MM, Keith BP, Wolber EA, Beasley C, Steinbach EC, Schaner MR, Jain A, Long MD, Barnes EL, Herfarth HH, Isaacs KL, Hansen JJ, Kapadia MR, Guillem JG, Gulati AS, Sethupathy P, Furey TS, Ehre C, Sheikh SZ. Increased colonic expression of ACE2 associates with poor prognosis in Crohn's disease. Sci Rep 2021;11:13533. [PMID: 34188154 DOI: 10.1038/s41598-021-92979-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
578 Luo L, Qing L, Yao C, Liu D, Li Y, Li T, Feng P. Efficacy and safety of hyperbaric oxygen therapy for moderate-to-severe ulcerative colitis: a protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e047543. [PMID: 34183344 DOI: 10.1136/bmjopen-2020-047543] [Reference Citation Analysis]
579 Shah N, Jyala A, Patel H, Makker J. Utility of artificial intelligence in colonoscopy. Artif Intell Gastrointest Endosc 2021; 2(3): 79-88 [DOI: 10.37126/aige.v2.i3.79] [Reference Citation Analysis]
580 Zhang H, Wang X. Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:693927. [PMID: 34262920 DOI: 10.3389/fmed.2021.693927] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
581 Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol 2021; 27(24): 3609-3629 [PMID: 34239273 DOI: 10.3748/wjg.v27.i24.3609] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 18.0] [Reference Citation Analysis]
582 Shah N, Jyala A, Patel H, Makker J. Utility of artificial intelligence in colonoscopy. AIGE 2021;2:78-87. [DOI: 10.37126/aige.v2.i3.78] [Reference Citation Analysis]
583 Zhao YY, Zhang L, Yang YX, Hao N, Wang BB, Liu YF. Psychological problems and intervention studies of patients with inflammatory bowel disease in the "Internet +" era: A review. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 628-632 [DOI: 10.11569/wcjd.v29.i12.628] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
584 Lucchini V, Sivignon A, Pieren M, Gitzinger M, Lociuro S, Barnich N, Kemmer C, Trebosc V. The Role of OmpR in Bile Tolerance and Pathogenesis of Adherent-Invasive Escherichia coli. Front Microbiol 2021;12:684473. [PMID: 34262546 DOI: 10.3389/fmicb.2021.684473] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
585 Johnson AM, Loftus EV. Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD. Saudi J Gastroenterol 2021;27:183-90. [PMID: 34169900 DOI: 10.4103/sjg.sjg_30_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
586 Guevara M, Salamanca-Fernández E, Miqueleiz E, Gavrila D, Amiano P, Bonet C, Rodríguez-Barranco M, Huerta JM, Bujanda L, Sánchez MJ, Chirlaque MD, Agudo A, Ardanaz E, Castilla J. Inflammatory Potential of the Diet and Incidence of Crohn's Disease and Ulcerative Colitis in the EPIC-Spain Cohort. Nutrients 2021;13:2201. [PMID: 34206846 DOI: 10.3390/nu13072201] [Reference Citation Analysis]
587 Gu L, Ren F, Fang X, Yuan L, Liu G, Wang S. Exosomal MicroRNA-181a Derived From Mesenchymal Stem Cells Improves Gut Microbiota Composition, Barrier Function, and Inflammatory Status in an Experimental Colitis Model. Front Med (Lausanne) 2021;8:660614. [PMID: 34249964 DOI: 10.3389/fmed.2021.660614] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
588 Hashimoto-Hill S, Alenghat T. Inflammation-Associated Microbiota Composition Across Domestic Animals. Front Genet 2021;12:649599. [PMID: 34239536 DOI: 10.3389/fgene.2021.649599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
589 Sassaki LY, Miszputen SJ, Kaiser Junior RL, Catapani WR, Bafutto M, Scotton AS, Zaltman C, Baima JP, Ramos HS, Faria MAG, Gonçalves CD, Guimaraes IM, Flores C, Amarante HMBS, Nones RB, Parente JML, Lima MM, Chebli JM, Ferrari MLA, Campos JF, Sanna MGP, Ramos O, Parra RS, da Rocha JJR, Feres O, Feitosa MR, Caratin RF, Senra JT, Santana GO. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil. World J Gastroenterol 2021; 27(23): 3396-3412 [PMID: 34163120 DOI: 10.3748/wjg.v27.i23.3396] [Reference Citation Analysis]
590 Morosi LG, Cutine AM, Cagnoni AJ, Manselle-Cocco MN, Croci DO, Merlo JP, Morales RM, May M, Pérez-Sáez JM, Girotti MR, Méndez-Huergo SP, Pucci B, Gil AH, Huernos SP, Docena GH, Sambuelli AM, Toscano MA, Rabinovich GA, Mariño KV. Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits. Sci Adv 2021;7:eabf8630. [PMID: 34144987 DOI: 10.1126/sciadv.abf8630] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
591 Wu Q, Xie S, Zhu Y, Chen J, Tian J, Xiong S, Wu C, Ye Y, Peng Y. Wogonin Strengthens the Therapeutic Effects of Mesenchymal Stem Cells in DSS-Induced Colitis via Promoting IL-10 Production. Oxid Med Cell Longev 2021;2021:5527935. [PMID: 34239686 DOI: 10.1155/2021/5527935] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
592 Euers L, Abughazaleh S, Glassner K, Gajula P, Jones-Pauley M, Ezeana C, Puppala M, Wang L, Wong S, Oglat A, Nickerson S, Abraham BP. Risk Factors for and Frequency of CT Scans, Steroid Use, and Repeat Visits in Inflammatory Bowel Disease Patients Seen at a Single-Center Emergency Department: A Retrospective Cohort Study. J Clin Med 2021;10:2679. [PMID: 34204580 DOI: 10.3390/jcm10122679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
593 Liang L, Lin R, Xie Y, Lin H, Shao F, Rui W, Chen H. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer. Int J Biol Sci 2021;17:2548-60. [PMID: 34326693 DOI: 10.7150/ijbs.58671] [Reference Citation Analysis]
594 Barnhoorn MC, Hakuno SK, Bruckner RS, Rogler G, Hawinkels LJAC, Scharl M. Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:995-1009. [PMID: 32160284 DOI: 10.1093/ecco-jcc/jjaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
595 Li L, Ma J, Xu JG, Zheng YL, Xie Q, Rong L, Liang ZH. Brain functional changes in patients with Crohn's disease: A resting-state fMRI study. Brain Behav 2021;11:e2243. [PMID: 34124857 DOI: 10.1002/brb3.2243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
596 van Linschoten RCA, Visser E, Niehot CD, van der Woude CJ, Hazelzet JA, van Noord D, West RL. Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Aliment Pharmacol Ther 2021;54:234-48. [PMID: 34114667 DOI: 10.1111/apt.16445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
597 Rao J, Shao L, Lin M, Huang J, Fan L. LncRNA UCA1 Accelerates the Progression of Ulcerative Colitis via Mediating the miR-331-3p/BRD4 Axis. Int J Gen Med 2021;14:2427-35. [PMID: 34140798 DOI: 10.2147/IJGM.S304837] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
598 Nguyen VQ, Eden K, Morrison HA, Sammons MB, Knight KK, Sorrentino S, Brock RM, Grider DJ, Allen IC, Sorrentino D. Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents. Front Pharmacol 2021;12:655887. [PMID: 34177575 DOI: 10.3389/fphar.2021.655887] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
599 Wu Z, Zeng H, Zhang L, Pu Y, Li S, Yuan Y, Zhang T, Wang B. Patchouli Alcohol: a Natural Sesquiterpene Against Both Inflammation and Intestinal Barrier Damage of Ulcerative Colitis. Inflammation 2020;43:1423-35. [PMID: 32388657 DOI: 10.1007/s10753-020-01219-8] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
600 Yalchin M, Baker AM, Graham TA, Hart A. Predicting Colorectal Cancer Occurrence in IBD. Cancers (Basel) 2021;13:2908. [PMID: 34200768 DOI: 10.3390/cancers13122908] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
601 Jiang Y, Zhao L, Chen Q, Zhou L. Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology. Evid Based Complement Alternat Med 2021;2021:9970240. [PMID: 34211579 DOI: 10.1155/2021/9970240] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
602 Chen K, Lou Y, Zhu Y. Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2021;2021:5548764. [PMID: 34211567 DOI: 10.1155/2021/5548764] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
603 Ayyar KK, Moss AC. Exosomes in Intestinal Inflammation. Front Pharmacol 2021;12:658505. [PMID: 34177577 DOI: 10.3389/fphar.2021.658505] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
604 Weissman S, Sharma, S, Fung BM, Aziz M, Sciarra M, Swaminath A, Feuerstein JD. Increased Mortality and Healthcare Costs Upon Hospital Readmissions of Ulcerative Colitis Flares: A Large Population-Based Cohort Study. Crohn's & Colitis 360 2021;3:otab029. [DOI: 10.1093/crocol/otab029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
605 Dore MP, Rocchi C, Longo NP, Scanu AM, Vidili G, Padedda F, Pes GM. Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a Retrospective Cohort Study. Probiotics Antimicrob Proteins 2020;12:152-9. [PMID: 30685823 DOI: 10.1007/s12602-019-9517-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
606 Yagi S, Furukawa S, Shiraishi K, Hashimoto Y, Tange K, Mori K, Ninomiya T, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Ikeda Y, Hiasa Y. Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis. BMJ Open Gastroenterol 2021;8:e000662. [PMID: 34099464 DOI: 10.1136/bmjgast-2021-000662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
607 Wang Y, Zhu H, Wang X, Yu Y, Xie J. Natural Food Polysaccharides Ameliorate Inflammatory Bowel Disease and Its Mechanisms. Foods 2021;10:1288. [PMID: 34199820 DOI: 10.3390/foods10061288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
608 Mkaouar H, Mariaule V, Rhimi S, Hernandez J, Kriaa A, Jablaoui A, Akermi N, Maguin E, Lesner A, Korkmaz B, Rhimi M. Gut Serpinome: Emerging Evidence in IBD. Int J Mol Sci 2021;22:6088. [PMID: 34200095 DOI: 10.3390/ijms22116088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
609 Liebert A, Wileńska A, Czuber-Dochan W, Kłopocka M. Translation and validation of the inflammatory bowel disease fatigue (IBD-F) patient self-assessment questionnaire. Prz Gastroenterol 2021;6:136-43. [PMID: 34276841 DOI: 10.5114/pg.2021.106665] [Reference Citation Analysis]
610 Niu K, Li Q, Liu Y, Qiao Y, Li B, Wei C, Wang K, Cui L, Zheng C, Wang R, Zhang L, Zhang H, Sun B, Yu B. Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med 2021;2021:9929093. [PMID: 34149863 DOI: 10.1155/2021/9929093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
611 Ónody A, Veres-Székely A, Pap D, Rokonay R, Szebeni B, Sziksz E, Oswald F, Veres G, Cseh Á, Szabó AJ, Vannay Á. Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases. J Transl Med 2021;19:237. [PMID: 34078403 DOI: 10.1186/s12967-021-02890-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
612 Chung WS, Chung S, Hsu CY, Lin CL. Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood. Front Med (Lausanne) 2021;8:661752. [PMID: 34150801 DOI: 10.3389/fmed.2021.661752] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
613 Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci 2021;21:270-83. [PMID: 33052081 DOI: 10.17305/bjbms.2020.5016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
614 Barani M, Rahdar A, Sargazi S, Amiri MS, Sharma PK, Bhalla N. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and Bio-Sensing Research 2021;32:100417. [DOI: 10.1016/j.sbsr.2021.100417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
615 Guan Y, Hao Y, Guan Y, Bu H, Wang H. Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis. Eur J Nutr 2021. [PMID: 34075433 DOI: 10.1007/s00394-021-02603-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
616 Agrawal M, Corn G, Shrestha S, Nielsen NM, Frisch M, Colombel JF, Jess T. Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: a population-based cohort study. Gut 2021;70:1037-43. [PMID: 32895335 DOI: 10.1136/gutjnl-2020-321798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
617 Yu Y, Chen J, Zhang X, Wang Y, Wang S, Zhao L, Wang Y. Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases. Chin Med 2021;16:42. [PMID: 34059101 DOI: 10.1186/s13020-021-00452-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
618 Agista AZ, Rusbana TB, Islam J, Ohsaki Y, Sultana H, Hirakawa R, Watanabe K, Nochi T, Ardiansyah, Budijanto S, Yang SC, Koseki T, Aso H, Komai M, Shirakawa H. Fermented Rice Bran Supplementation Prevents the Development of Intestinal Fibrosis Due to DSS-Induced Inflammation in Mice. Nutrients 2021;13:1869. [PMID: 34070845 DOI: 10.3390/nu13061869] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
619 Yang S, Liang X, Song J, Li C, Liu A, Luo Y, Ma H, Tan Y, Zhang X. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther 2021;12:315. [PMID: 34051868 DOI: 10.1186/s13287-021-02404-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
620 Tulumović E, Salkić N, Tulumović D. Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up. World J Gastroenterol 2021; 27(20): 2630-2642 [PMID: 34092980 DOI: 10.3748/wjg.v27.i20.2630] [Reference Citation Analysis]
621 Shang L, Liu H, Yu H, Chen M, Yang T, Zeng X, Qiao S. Core Altered Microorganisms in Colitis Mouse Model: A Comprehensive Time-Point and Fecal Microbiota Transplantation Analysis. Antibiotics (Basel) 2021;10:643. [PMID: 34071229 DOI: 10.3390/antibiotics10060643] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
622 Louis E, Ramos-Goñi JM, Cuervo J, Kopylov U, Barreiro-de Acosta M, McCartney S, Rosenfeld G, Bettenworth D, Hart A, Novak K, Donnet X, Easton D, Saldaña R, Protze K, Tzur E, Alperovich G, Casellas F. A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective. Patient 2020;13:317-25. [PMID: 31997116 DOI: 10.1007/s40271-019-00407-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
623 Bunt DV, Minnaard AJ, El Aidy S. Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases. Pharmaceuticals (Basel) 2021;14:506. [PMID: 34073220 DOI: 10.3390/ph14060506] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
624 Geng Z, Geng Q. Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis. Front Surg 2021;8:636791. [PMID: 34124132 DOI: 10.3389/fsurg.2021.636791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
625 Chen G, Yang Z, Wen D, Guo J, Xiong Q, Li P, Zhao L, Wang J, Wu C, Dong L. Polydatin has anti-inflammatory and antioxidant effects in LPS-induced macrophages and improves DSS-induced mice colitis. Immun Inflamm Dis 2021;9:959-70. [PMID: 34010516 DOI: 10.1002/iid3.455] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
626 Liu TC, Kern JT, Jain U, Sonnek NM, Xiong S, Simpson KF, VanDussen KL, Winkler ES, Haritunians T, Malique A, Lu Q, Sasaki Y, Storer C, Diamond MS, Head RD, McGovern DPB, Stappenbeck TS. Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation. Cell Host Microbe 2021;29:988-1001.e6. [PMID: 34010595 DOI: 10.1016/j.chom.2021.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
627 Su S, Wang X, Xi X, Zhu L, Chen Q, Zhang H, Qin Y, Yang B, Che N, Cao H, Zhong W, Wang B. Phellodendrine promotes autophagy by regulating the AMPK/mTOR pathway and treats ulcerative colitis. J Cell Mol Med 2021;25:5707-20. [PMID: 34002930 DOI: 10.1111/jcmm.16587] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
628 Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, Hong SH, Yon DK, Lee SW, Kim MS, Wasuwanich P, Karnsakul W, Shin JI, Kronbichler A. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci 2021;17:2112-23. [PMID: 34131410 DOI: 10.7150/ijbs.59904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
629 Bernstein CN, Ng SC, Banerjee R, Steinwurz F, Shen B, Carbonnel F, Hamid S, Sood A, Yamamoto-Furusho JK, Griffiths A, Benchimol EI, Travis S, Lopes S, Rubin DT, Kaplan GG, Armstrong D, Gearry R; IBD-Emerging Nations Consortium and the WGO IBD Task Force on COVID-19. Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflamm Bowel Dis 2021;27:836-47. [PMID: 32793973 DOI: 10.1093/ibd/izaa202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
630 Xiao Y, Hinrichs R, Johnson N, McKinley A, Carlson J, Agley J, Yip PSF. Suicide Prevention Among College Students Before and During the COVID-19 Pandemic: Protocol for a Systematic Review and Meta-analysis. JMIR Res Protoc 2021;10:e26948. [PMID: 33878016 DOI: 10.2196/26948] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
631 Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 2021;302:211-27. [PMID: 33993489 DOI: 10.1111/imr.12974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
632 Benchimol EI, Afif W, Plamondon S, Newhook D, Nicholls SG, Lévesque D. Medical Summary Template for the Transfer of Patients with Inflammatory Bowel Disease from Pediatric to Adult Care. Journal of the Canadian Association of Gastroenterology 2022;5:3-11. [DOI: 10.1093/jcag/gwab009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
633 Agrawal M, Sabino J, Frias-Gomes C, Hillenbrand CM, Soudant C, Axelrad JE, Shah SC, Ribeiro-Mourão F, Lambin T, Peter I, Colombel JF, Narula N, Torres J. Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses. EClinicalMedicine 2021;36:100884. [PMID: 34308303 DOI: 10.1016/j.eclinm.2021.100884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
634 He Z, Chen L, Catalan-Dibene J, Bongers G, Faith JJ, Suebsuwong C, DeVita RJ, Shen Z, Fox JG, Lafaille JJ, Furtado GC, Lira SA. Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23. Cell Metab 2021;33:1358-1371.e5. [PMID: 33989521 DOI: 10.1016/j.cmet.2021.04.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
635 Hornschuh M, Wirthgen E, Wolfien M, Singh KP, Wolkenhauer O, Däbritz J. The role of epigenetic modifications for the pathogenesis of Crohn's disease. Clin Epigenetics 2021;13:108. [PMID: 33980294 DOI: 10.1186/s13148-021-01089-3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
636 Wang K, Ding Y, Xu C, Hao M, Li H, Ding L. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity. Oncoimmunology 2021;10:1923910. [PMID: 34026335 DOI: 10.1080/2162402X.2021.1923910] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
637 De Simone B, Davies J, Chouillard E, Di Saverio S, Hoentjen F, Tarasconi A, Sartelli M, Biffl WL, Ansaloni L, Coccolini F, Chiarugi M, De'Angelis N, Moore EE, Kluger Y, Abu-Zidan F, Sakakushev B, Coimbra R, Celentano V, Wani I, Pintar T, Sganga G, Di Carlo I, Tartaglia D, Pikoulis M, Cardi M, De Moya MA, Leppaniemi A, Kirkpatrick A, Agnoletti V, Poggioli G, Carcoforo P, Baiocchi GL, Catena F. WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting. World J Emerg Surg 2021;16:23. [PMID: 33971899 DOI: 10.1186/s13017-021-00362-3] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
638 Chiu E, Oleynick C, Raman M, Bielawska B. Optimizing Inpatient Nutrition Care of Adult Patients with Inflammatory Bowel Disease in the 21st Century. Nutrients 2021;13:1581. [PMID: 34065070 DOI: 10.3390/nu13051581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
639 Gubatan J, Levitte S, Patel A, Balabanis T, Wei MT, Sinha SR. Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions. World J Gastroenterol 2021; 27(17): 1920-1935 [PMID: 34007130 DOI: 10.3748/wjg.v27.i17.1920] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 16] [Article Influence: 27.0] [Reference Citation Analysis]
640 Olfatifar M, Zali MR, Pourhoseingholi MA, Balaii H, Ghavami SB, Ivanchuk M, Ivanchuk P, Nazari SH, Shahrokh S, Sabour S, Khodakarim S, Aghdaei HA, Rohani P, Mehralian G. The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study. BMC Gastroenterol 2021;21:204. [PMID: 33957874 DOI: 10.1186/s12876-021-01745-1] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
641 Hu YA, Zhu Y, Liu G, Yao X, Yan X, Yang Y, Wang W, Zou X, Li X. Expression profiles of circular RNAs in colon biopsies from Crohn's disease patients by microarray analysis. J Clin Lab Anal 2021;35:e23788. [PMID: 33955043 DOI: 10.1002/jcla.23788] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
642 Cai C, Zhu S, Tong J, Wang T, Feng Q, Qiao Y, Shen J. Relating the transcriptome and microbiome by paired terminal ileal Crohn disease. iScience 2021;24:102516. [PMID: 34113837 DOI: 10.1016/j.isci.2021.102516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
643 Ye B, Lai L. Yu Shi An Chang Fang Ameliorates TNBS-Induced Colitis in Mice by Reducing Inflammatory Response and Protecting the Intestinal Mucosal Barrier. Evid Based Complement Alternat Med 2021;2021:8870901. [PMID: 34055024 DOI: 10.1155/2021/8870901] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
644 Jiang P, Wu S, Luo Q, Zhao XM, Chen WH. Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models. mSystems 2021;6:e00112-21. [PMID: 33947803 DOI: 10.1128/mSystems.00112-21] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
645 Lochhead P, Khalili H, Sachs MC, Chan AT, Olén O, Ludvigsson JF. Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study. J Crohns Colitis 2021;15:757-65. [PMID: 33216873 DOI: 10.1093/ecco-jcc/jjaa235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
646 Ferreira-Duarte M, Rodrigues-Pinto T, Sousa T, Faria MA, Rocha MS, Menezes-Pinto D, Esteves-Monteiro M, Magro F, Dias-Pereira P, Duarte-Araújo M, Morato M. Interaction between the Renin-Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis. Int J Mol Sci 2021;22:4836. [PMID: 34063607 DOI: 10.3390/ijms22094836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
647 Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T, Shiotani A, Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study. J Gastroenterol 2021;56:560-9. [PMID: 33942166 DOI: 10.1007/s00535-021-01793-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
648 Peyrin-Biroulet L, Louis E, Loftus EV Jr, Lacerda A, Zhou Q, Sanchez Gonzalez Y, Ghosh S. Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's Disease. Adv Ther 2021;38:2339-52. [PMID: 33755884 DOI: 10.1007/s12325-021-01660-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
649 Cocetta V, Governa P, Borgonetti V, Tinazzi M, Peron G, Catanzaro D, Berretta M, Biagi M, Manetti F, Dall'Acqua S, Montopoli M. Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress. Front Pharmacol 2021;12:641210. [PMID: 33995048 DOI: 10.3389/fphar.2021.641210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
650 Palacio FGM, de Souza LMP, Moreira JPL, Luiz RR, de Souza HSP, Zaltman C. Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis. BMC Gastroenterol 2021;21:192. [PMID: 33906627 DOI: 10.1186/s12876-021-01781-x] [Reference Citation Analysis]
651 Li C, Wu G, Zhao H, Dong N, Wu B, Chen Y, Lu Q. Natural-Derived Polysaccharides From Plants, Mushrooms, and Seaweeds for the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2021;12:651813. [PMID: 33981232 DOI: 10.3389/fphar.2021.651813] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
652 Lirhus SS, Høivik ML, Moum B, Anisdahl K, Melberg HO. Incidence and Prevalence of Inflammatory Bowel Disease in Norway and the Impact of Different Case Definitions: A Nationwide Registry Study. Clin Epidemiol 2021;13:287-94. [PMID: 33935519 DOI: 10.2147/CLEP.S303797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
653 Wang Y, Zou J, Jia Y, Zhang X, Wang C, Shi Y, Guo D, Wu Z, Wang F. The Mechanism of Lavender Essential Oil in the Treatment of Acute Colitis Based on "Quantity-Effect" Weight Coefficient Network Pharmacology. Front Pharmacol 2021;12:644140. [PMID: 33981227 DOI: 10.3389/fphar.2021.644140] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
654 Tavassolifar MJ, Changaei M, Salehi Z, Ghasemi F, Javidan M, Nicknam MH, Pourmand MR. Redox imbalance in Crohn's disease patients is modulated by Azathioprine. Redox Rep 2021;26:80-4. [PMID: 33882797 DOI: 10.1080/13510002.2021.1915665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
655 Tao Z, Zhou X, Zhang Y, Pu W, Yang Y, Wei F, Zhou Q, Zhang L, Du Z, Wu J. Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-α-Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy. Mediators Inflamm 2021;2021:1610251. [PMID: 33967625 DOI: 10.1155/2021/1610251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
656 Plevy S. A molecular connection hints at how a genetic risk factor drives Crohn's disease. Nature 2021;593:201-3. [PMID: 33875878 DOI: 10.1038/d41586-021-00979-z] [Reference Citation Analysis]
657 Marescotti D, Lo Sasso G, Guerrera D, Renggli K, Ruiz Castro PA, Piault R, Jaquet V, Moine F, Luettich K, Frentzel S, Peitsch MC, Hoeng J. Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds. Front Pharmacol 2021;12:639716. [PMID: 33935729 DOI: 10.3389/fphar.2021.639716] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
658 Derkacz A, Olczyk P, Jura-Półtorak A, Olczyk K, Komosinska-Vassev K. The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn's Disease and Ulcerative Colitis. J Clin Med 2021;10:1722. [PMID: 33923501 DOI: 10.3390/jcm10081722] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
659 Wilkens R, Novak KL, Maaser C, Panaccione R, Kucharzik T. Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives. Therap Adv Gastroenterol 2021;14:17562848211006672. [PMID: 33948115 DOI: 10.1177/17562848211006672] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
660 Wang Y, Wen R, Liu D, Zhang C, Wang ZA, Du Y. Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo. Molecules 2021;26:2199. [PMID: 33920375 DOI: 10.3390/molecules26082199] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
661 Ratajczak AE, Szymczak-Tomczak A, Rychter AM, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases. J Clin Med 2021;10:1515. [PMID: 33916465 DOI: 10.3390/jcm10071515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
662 Wdowiak A, Gujski M, Bojar I, Raczkiewicz D, Bartosińska J, Wdowiak-Filip A, Filip R. Chronic Inflammation Impairs Male Fertility-A Case-Control Study in Ulcerative Colitis Patients. J Clin Med 2021;10:1460. [PMID: 33918143 DOI: 10.3390/jcm10071460] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
663 Copeland JK, Chao G, Vanderhout S, Acton E, Wang PW, Benchimol EI, El Sohami A, Croitoru K, Gommerman JL, Guttman DS; GEMINI Research Team. The Impact of Migration on the Gut Metagenome of South Asian Canadians. Gut Microbes 2021;13:1-29. [PMID: 33794735 DOI: 10.1080/19490976.2021.1902705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
664 Ungaro RC, Brenner EJ, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut 2021;70:725-32. [PMID: 33082265 DOI: 10.1136/gutjnl-2020-322539] [Cited by in Crossref: 148] [Cited by in F6Publishing: 137] [Article Influence: 148.0] [Reference Citation Analysis]
665 Li H, Mo Y, Huang C, Ren Q, Xia X, Nan X, Shuai X, Meng X. An MSCT-based radiomics nomogram combined with clinical factors can identify Crohn's disease and ulcerative colitis. Ann Transl Med 2021;9:572. [PMID: 33987270 DOI: 10.21037/atm-21-1023] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
666 Rasmussen NF, Bech BH, Rubin KH, Andersen V. Associations between participation in, intensity of, and time spent on leisure time physical activity and risk of inflammatory bowel disease among older adults (PA-IBD): a prospective cohort study. BMC Public Health 2021;21:634. [PMID: 33794834 DOI: 10.1186/s12889-021-10492-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
667 Juliao-baños F, Puentes F, López R, Saffon M, Reyes G, Parra V, Galiano M, Barraza M, Molano J, Álvarez E, Corrales R, Vargas L, Gil F, Álvarez P, Limas L, Prieto R, Yance P, Díaz F, Bareño J, Juliao-baños F, Arrubla M, Camargo J, Puentes F, Arango L, López R, García R, Mendoza B, Saffon MA, Roldan LF, Zuleta J, Reyes G, Parra V, Flórez C, Nuñez E, Galiano MT, Barraza M, Sanchez IC, Molano JL, Lizarazo JI, Cuellar I, Álvarez E, Corrales R, Gil F, Vargas LE, Álvarez P, Limas LM, Prieto R, Ballén H, Delgado L, Yance P, Díaz F. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Revista de Gastroenterología de México (English Edition) 2021;86:153-62. [DOI: 10.1016/j.rgmxen.2020.05.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
668 Hu JE, Weiß F, Bojarski C, Branchi F, Schulzke JD, Fromm M, Krug SM. Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis. BMC Gastroenterol 2021;21:141. [PMID: 33789594 DOI: 10.1186/s12876-021-01723-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
669 Schmitt H, Neurath MF, Atreya R. Role of the IL23/IL17 Pathway in Crohn's Disease. Front Immunol 2021;12:622934. [PMID: 33859636 DOI: 10.3389/fimmu.2021.622934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
670 Wei Z, Yuan J, Wang G, Ocansey DKW, Xu Z, Mao F. Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases. Stem Cells Int 2021;2021:5583994. [PMID: 33859701 DOI: 10.1155/2021/5583994] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
671 Kotze PG, Holubar SD, Lipman JM, Spinelli A. Training for Minimally Invasive Surgery for IBD: A Current Need. Clin Colon Rectal Surg 2021;34:172-80. [PMID: 33814999 DOI: 10.1055/s-0040-1718685] [Reference Citation Analysis]
672 Loftus EV. The increasing burden of inflammatory bowel disease. Med J Aust 2021;214:361-2. [PMID: 33774833 DOI: 10.5694/mja2.51001] [Reference Citation Analysis]
673 Freeman K, Ryan R, Parsons N, Taylor-Phillips S, Willis BH, Clarke A. The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database. BMC Gastroenterol 2021;21:139. [PMID: 33771127 DOI: 10.1186/s12876-021-01716-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
674 Stidham RW, Liu Y, Enchakalody B, Van T, Krishnamurthy V, Su GL, Zhu J, Waljee AK. The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease. Inflamm Bowel Dis 2021;27:1328-34. [PMID: 33769477 DOI: 10.1093/ibd/izab035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
675 Zhou W, Zhang H, Pan Y, Xu Y, Cao Y. circRNA expression profiling of colon tissue from mesalazine-treated mouse of inflammatory bowel disease reveals an important circRNA-miRNA-mRNA pathway. Aging (Albany NY) 2021;13:10187-207. [PMID: 33819198 DOI: 10.18632/aging.202780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
676 Daniel N, Lécuyer E, Chassaing B. Host/microbiota interactions in health and diseases-Time for mucosal microbiology! Mucosal Immunol 2021;14:1006-16. [PMID: 33772148 DOI: 10.1038/s41385-021-00383-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
677 Kuiper SZ, Dirksen CD, Breukink SO. Proctological oblivion. Colorectal Dis 2021;23:573. [PMID: 33760344 DOI: 10.1111/codi.15595] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
678 Kim KU, Kim J, Kim WH, Min H, Choi CH. Treatments of inflammatory bowel disease toward personalized medicine. Arch Pharm Res 2021;44:293-309. [PMID: 33763844 DOI: 10.1007/s12272-021-01318-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
679 Ma S, Qian C, Li N, Fang Z, Zhao J, Zhang H, Chen W, Liu Z, Lu W. Protein diets with the role of immune and gut microbial regulation alleviate DSS-induced chronic ulcerative colitis. Food Sci Nutr 2021;9:1259-70. [PMID: 33747442 DOI: 10.1002/fsn3.1914] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
680 Chebli JMF, Queiroz NSF, Damião AOMC, Chebli LA, Costa MHM, Parra RS. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. World J Gastroenterol 2021; 27(11): 1022-1042 [PMID: 33776370 DOI: 10.3748/wjg.v27.i11.1022] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
681 Lu K, Zhou J, Deng J, Li Y, Wu C, Bao J. Periplaneta americana Oligosaccharides Exert Anti-Inflammatory Activity through Immunoregulation and Modulation of Gut Microbiota in Acute Colitis Mice Model. Molecules 2021;26:1718. [PMID: 33808686 DOI: 10.3390/molecules26061718] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
682 Gomes TNF, de Azevedo FS, Argollo M, Miszputen SJ, Ambrogini O Jr. Clinical and Demographic Profile of Inflammatory Bowel Disease Patients in a Reference Center of São Paulo, Brazil. Clin Exp Gastroenterol 2021;14:91-102. [PMID: 33762838 DOI: 10.2147/CEG.S288688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
683 Iurciuc Tincu CE, Atanase LI, Jérôme C, Sol V, Martin P, Popa M, Ochiuz L. Polysaccharides-Based Complex Particles' Protective Role on the Stability and Bioactivity of Immobilized Curcumin. Int J Mol Sci 2021;22:3075. [PMID: 33802882 DOI: 10.3390/ijms22063075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
684 Yu T, Chu S, Liu X, Li J, Chen Q, Xu M, Wu H, Li M, Dong Y, Zhu F, Zhou H, Hu D, Fan H. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Stem Cell Res Ther 2021;12:181. [PMID: 33722292 DOI: 10.1186/s13287-021-02232-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
685 Chanchlani N, Russell RK. Life expectancy in patients with inflammatory bowel disease: time will tell if biologics are the answer. CMAJ 2021;193:E380. [PMID: 33722831 DOI: 10.1503/cmaj.78144] [Reference Citation Analysis]
686 Ichikawa M, Negoro R, Kawai K, Yamashita T, Takayama K, Mizuguchi H. Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells. Mol Ther Methods Clin Dev 2021;20:463-72. [PMID: 33614822 DOI: 10.1016/j.omtm.2021.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
687 Jin QW, Wang XD. Progress in research of vedolizumab in treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2021; 29(5): 248-255 [DOI: 10.11569/wcjd.v29.i5.248] [Reference Citation Analysis]
688 Xie Y, Zhuang T, Ping Y, Zhang Y, Wang X, Yu P, Duan X. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Clin Chim Acta 2021;517:122-6. [PMID: 33662359 DOI: 10.1016/j.cca.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
689 Mak JWY, Lok Tung Ho C, Wong K, Cheng TY, Yip TCF, Leung WK, Li M, Lo FH, Ng KM, Sze SF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Ng SC. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry. J Crohns Colitis 2021;15:401-8. [PMID: 32914171 DOI: 10.1093/ecco-jcc/jjaa181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
690 Schineis C, Ullrich A, Lehmann KS, Holmer C, Lauscher JC, Weixler B, Kreis ME, Seifarth C. Microscopic inflammation in ileocecal specimen does not correspond to a higher anastomotic leakage rate after ileocecal resection in Crohn's disease. PLoS One 2021;16:e0247796. [PMID: 33661983 DOI: 10.1371/journal.pone.0247796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
691 Zhang W, Fu X, Xie J, Pan H, Han W, Huang W. miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways. Mol Ther Nucleic Acids 2021;24:264-73. [PMID: 33815939 DOI: 10.1016/j.omtn.2021.02.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
692 Feng D, Yang Y, Wang Z, Wei W, Li L. Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies. Transl Androl Urol 2021;10:1332-41. [PMID: 33850767 DOI: 10.21037/tau-20-1358] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
693 Szántó KJ, Balázs T, Schrempf DM, Farkas K, Molnár T. Does inflammatory bowel disease have different characteristics according to stage of adolescence? Therap Adv Gastroenterol 2021;14:1756284820986670. [PMID: 33717208 DOI: 10.1177/1756284820986670] [Reference Citation Analysis]
694 Dhaliwal J, Walters TD, Mack DR, Huynh HQ, Jacobson K, Otley AR, Debruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Seidman E, Jantchou P, Ricciuto A, Rashid M, Muise AM, Wine E, Carroll M, Lawrence S, Van Limbergen J, Benchimol EI, Church P, Griffiths AM. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network. J Crohns Colitis 2020;14:445-54. [PMID: 31136648 DOI: 10.1093/ecco-jcc/jjz106] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
695 Yu Y, Wu Z, Han Y, Yuan Y, Fan H, Wei X, Yu Y. Comparison of the Effects of Essential Oil Obtained from the Crude and Bran-Processed Atractylodes lancea on Lipopolysaccharide-Induced Inflammatory Injury of Human Colonic Epithelial Cells by Downregulating the IKK/NF-κB Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:5219129. [PMID: 33628299 DOI: 10.1155/2021/5219129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
696 Miller AL, Bessho S, Grando K, Tükel Ç. Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases. Front Immunol 2021;12:638867. [PMID: 33717189 DOI: 10.3389/fimmu.2021.638867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
697 Riemschneider S, Hoffmann M, Slanina U, Weber K, Hauschildt S, Lehmann J. Indol-3-Carbinol and Quercetin Ameliorate Chronic DSS-Induced Colitis in C57BL/6 Mice by AhR-Mediated Anti-Inflammatory Mechanisms. Int J Environ Res Public Health 2021;18:2262. [PMID: 33668818 DOI: 10.3390/ijerph18052262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
698 Tan CXW, Brand HS, Kalender B, De Boer NKH, Forouzanfar T, de Visscher JGAM. Dental and periodontal disease in patients with inflammatory bowel disease. Clin Oral Investig 2021;25:5273-80. [PMID: 33619633 DOI: 10.1007/s00784-021-03835-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
699 Salem G, Ding K, Sakuraba A, Cohen R. Role of topical tacrolimus in the management of proctitis, perianal manifestations in Crohn's disease, and chronic pouchitis: a systematic review. J Investig Med 2021:jim-2020-001699. [PMID: 33622709 DOI: 10.1136/jim-2020-001699] [Reference Citation Analysis]
700 Wu Y, Murray GK, Byrne EM, Sidorenko J, Visscher PM, Wray NR. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun 2021;12:1146. [PMID: 33608531 DOI: 10.1038/s41467-021-21280-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
701 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
702 Bonfiglio R, Galli F, Varani M, Scimeca M, Borri F, Fazi S, Cicconi R, Mattei M, Campagna G, Schönberger T, Raymond E, Wunder A, Signore A, Bonanno E. Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development. Int J Mol Sci 2021;22:2028. [PMID: 33670766 DOI: 10.3390/ijms22042028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
703 Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol 2021;8:e000573. [PMID: 33597152 DOI: 10.1136/bmjgast-2020-000573] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
704 Kelm M, Anger F, Eichlinger R, Brand M, Kim M, Reibetanz J, Krajinovic K, Germer CT, Schlegel N, Flemming S. Early Ileocecal Resection Is an Effective Therapy in Isolated Crohn's Disease. J Clin Med 2021;10:731. [PMID: 33673222 DOI: 10.3390/jcm10040731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
705 Wang X, Khoshaba R, Shen Y, Cao Y, Lin M, Zhu Y, Cao Z, Liao DF, Cao D. Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. Front Cell Dev Biol 2021;9:632805. [PMID: 33644071 DOI: 10.3389/fcell.2021.632805] [Reference Citation Analysis]
706 Park J, Cheon JH. Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Med J 2021;62:99-108. [PMID: 33527789 DOI: 10.3349/ymj.2021.62.2.99] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
707 Xu L, Zhang J, Wang Y, Zhang Z, Wang F, Tang X. Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification. Biosci Rep 2021;41:BSR20203565. [PMID: 33409535 DOI: 10.1042/BSR20203565] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
708 Li C. Unfolded Protein Response and Crohn’s Diseases: A Molecular Mechanism of Wound Healing in the Gut. GastrointestDisord 2021;3:31-43. [DOI: 10.3390/gidisord3010004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
709 Du H, Xia H, Liu T, Li Y, Liu J, Xie B, Chen J, Liu T, Cao L, Liu S, Li S, Wang P, Wang D, Zhang Z, Li Y, Guo X, Wu A, Li M, You F. Suppression of ELF4 in ulcerative colitis predisposes host to colorectal cancer. iScience 2021;24:102169. [PMID: 33665583 DOI: 10.1016/j.isci.2021.102169] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
710 Sun W, Fennimore B, Beaulieu DB, Arsenescu R, Stein AC, Chen J, Lin T, McKnight S, Kadali H, Rosario M, Lirio RA. Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease. Clin Pharmacokinet 2021;60:811-8. [PMID: 33544318 DOI: 10.1007/s40262-021-00985-4] [Reference Citation Analysis]
711 Gearry RB, McCombie AM, Vatn M, Rubin DT, Steinwurz F, Loftus EV, Kruis W, Tysk C, Colombel JF, Ng SC, Van Assche G, Bernstein CN. What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries. Inflamm Intest Dis 2021;6:78-86. [PMID: 34124179 DOI: 10.1159/000512310] [Reference Citation Analysis]
712 Banfi D, Moro E, Bosi A, Bistoletti M, Cerantola S, Crema F, Maggi F, Giron MC, Giaroni C, Baj A. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:1623. [PMID: 33562721 DOI: 10.3390/ijms22041623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
713 Kim YN, Ji YK, Kim NH, Van Tu N, Rho JR, Jeong EJ. Isoquinolinequinone Derivatives from a Marine Sponge (Haliclona sp.) Regulate Inflammation in In Vitro System of Intestine. Mar Drugs 2021;19:90. [PMID: 33557170 DOI: 10.3390/md19020090] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
714 Ferreira-Duarte M, Rodrigues-Pinto T, Menezes-Pinto D, Esteves-Monteiro M, Gonçalves-Monteiro S, Capas-Peneda S, Magro F, Dias-Pereira P, Morato M, Duarte-Araújo M. 2,4,6-trinitrobenzenesulfonic acid-induced colitis in Rattus norgevicus: a categorization proposal. Exp Anim 2021;70:245-56. [PMID: 33536378 DOI: 10.1538/expanim.20-0113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
715 Meima-van Praag EM, Buskens CJ, Hompes R, Bemelman WA. Surgical management of Crohn's disease: a state of the art review. Int J Colorectal Dis 2021;36:1133-45. [PMID: 33528750 DOI: 10.1007/s00384-021-03857-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
716 Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
717 Hu S, Vich Vila A, Gacesa R, Collij V, Stevens C, Fu JM, Wong I, Talkowski ME, Rivas MA, Imhann F, Bolte L, van Dullemen H, Dijkstra G, Visschedijk MC, Festen EA, Xavier RJ, Fu J, Daly MJ, Wijmenga C, Zhernakova A, Kurilshikov A, Weersma RK. Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD. Gut 2021;70:285-96. [PMID: 32651235 DOI: 10.1136/gutjnl-2019-319706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
718 Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links. Gut 2021;70:408-17. [PMID: 33067333 DOI: 10.1136/gutjnl-2020-322429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 18.0] [Reference Citation Analysis]
719 Zhong YB, Kang ZP, Zhou BG, Wang HY, Long J, Zhou W, Zhao HM, Liu DY. Curcumin Regulated the Homeostasis of Memory T Cell and Ameliorated Dextran Sulfate Sodium-Induced Experimental Colitis. Front Pharmacol 2020;11:630244. [PMID: 33597887 DOI: 10.3389/fphar.2020.630244] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
720 Villanacci V, Reggiani-Bonetti L, Salviato T, Leoncini G, Cadei M, Albarello L, Caputo A, Aquilano MC, Battista S, Parente P. Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica 2021;113:39-53. [PMID: 33686309 DOI: 10.32074/1591-951X-235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
721 Yokoyama M, Kimura MY, Ito T, Hayashizaki K, Endo Y, Wang Y, Yagi R, Nakagawa T, Kato N, Matsubara H, Nakayama T. Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease. Front Immunol 2020;11:594297. [PMID: 33584659 DOI: 10.3389/fimmu.2020.594297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
722 Pudipeddi A, Liu J, Kariyawasam V, Borody TJ, Cowlishaw JL, McDonald C, Katelaris P, Chapman G, Corte C, Lemberg DA, Lee CH, Keshava A, Napoli J, Clancy R, Chan W, Paramsothy S, Leong R. High prevalence of Crohn disease and ulcerative colitis among older people in Sydney. Med J Aust 2021;214:365-70. [PMID: 33502004 DOI: 10.5694/mja2.50910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
723 Tinh NTT, Sitolo GC, Yamamoto Y, Suzuki T. Citrus limon Peel Powder Reduces Intestinal Barrier Defects and Inflammation in a Colitic Murine Experimental Model. Foods 2021;10:240. [PMID: 33503995 DOI: 10.3390/foods10020240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
724 Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, Malinska N, Mankowska-Wierzbicka D, Eder P, Dobrowolska A, Slomski R, Skrzypczak-Zielinska M. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study. Sci Rep 2021;11:2166. [PMID: 33495479 DOI: 10.1038/s41598-021-81628-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
725 Chen H, Chen L, Wang X, Ge X, Sun L, Wang Z, Xu X, Song Y, Chen J, Deng Q, Xie H, Chen T, Chen Y, Ding K, Wu J, Wang J. Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium-induced colitis in mice. J Cell Mol Med 2021;25:2679-90. [PMID: 33491282 DOI: 10.1111/jcmm.16297] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
726 Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. J Clin Med 2021;10:377. [PMID: 33498197 DOI: 10.3390/jcm10030377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
727 Fang H, Fu L, Li X, Lu C, Su Y, Xiong K, Zhang L. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Microb Cell Fact 2021;20:18. [PMID: 33468164 DOI: 10.1186/s12934-021-01513-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
728 Zhang L, Gui S, Xu Y, Zeng J, Wang J, Chen Q, Su L, Wang Z, Deng R, Chu F, Liu W, Jin X, Lu X. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with Musca domestica cecropin for ulcerative colitis therapy. Theranostics 2021;11:3417-38. [PMID: 33537095 DOI: 10.7150/thno.53105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
729 Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease. Pharmacol Rep 2021;73:700-11. [PMID: 33462754 DOI: 10.1007/s43440-020-00213-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
730 Naqvi SA, Taylor LM, Panaccione R, Ghosh S, Barkema HW, Hotte N, Shommu N, Kaur S, Reimer RA, Madsen KL, Raman M. Dietary patterns, food groups and nutrients in Crohn's disease: associations with gut and systemic inflammation. Sci Rep 2021;11:1674. [PMID: 33462267 DOI: 10.1038/s41598-020-80924-8] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
731 Zhang MH, Wang H, Wang HG, Wen X, Yang XZ. Effective immune-inflammation index for ulcerative colitis and activity assessments. World J Clin Cases 2021; 9(2): 334-343 [PMID: 33521101 DOI: 10.12998/wjcc.v9.i2.334] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
732 Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World J Clin Cases 2021; 9(2): 321-333 [PMID: 33521100 DOI: 10.12998/wjcc.v9.i2.321] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
733 Zaltman C, Parra RS, Sassaki LY, Santana GO, Ferrari MLA, Miszputen SJ, Amarante HMBS, Kaiser Junior RL, Flores C, Catapani WR, Parente JML, Bafutto M, Ramos O, Gonçalves CD, Guimaraes IM, da Rocha JJR, Feitosa MR, Feres O, Saad-Hossne R, Penna FGC, Cunha PFS, Gomes TN, Nones RB, Faria MAG, Parente MPPD, Scotton AS, Caratin RF, Senra J, Chebli JM. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil. World J Gastroenterol 2021; 27(2): 208-223 [PMID: 33510560 DOI: 10.3748/wjg.v27.i2.208] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
734 Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, Yoo HW, Choi JH. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr 2021;21:35. [PMID: 33446154 DOI: 10.1186/s12887-021-02496-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
735 Ratajczak AE, Szymczak-Tomczak A, Zawada A, Rychter AM, Dobrowolska A, Krela-Kaźmierczak I. Does Drinking Coffee and Tea Affect Bone Metabolism in Patients with Inflammatory Bowel Diseases? Nutrients 2021;13:216. [PMID: 33451170 DOI: 10.3390/nu13010216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
736 de Campos RJDS, Lucchetti G, Lucchetti ALG, Chebli LA, Schettino Pereira L, Chebli JMF. Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study. J Crohns Colitis 2021;15:55-63. [PMID: 32582934 DOI: 10.1093/ecco-jcc/jjaa130] [Reference Citation Analysis]
737 Shen Z, Zheng K, Zou J, Gu P, Xing J, Zhang L, Zhu L, Shen H. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial. Trials 2021;22:55. [PMID: 33441157 DOI: 10.1186/s13063-020-05012-8] [Reference Citation Analysis]
738 Miyazaki T, Shirakami Y, Mizutani T, Maruta A, Ideta T, Kubota M, Sakai H, Ibuka T, Genovese S, Fiorito S, Taddeo VA, Epifano F, Tanaka T, Shimizu M. Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis. Sci Rep 2021;11:492. [PMID: 33436792 DOI: 10.1038/s41598-020-79916-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
739 Ko JZ, Johnson S, Dave M. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.Biomolecules. 2021;11. [PMID: 33440772 DOI: 10.3390/biom11010082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
740 Miao Z, Chen L, Feng H, Gu M, Yan J, Xu Y, Ye B. Baitouweng Decoction Ameliorates Ulcerative Colitis in Mice Partially Attributed to Regulating Th17/Treg Balance and Restoring Intestinal Epithelial Barrier. Front Pharmacol 2020;11:531117. [PMID: 33597862 DOI: 10.3389/fphar.2020.531117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
741 Murray FR, Morell B, Biedermann L, Schreiner P. Protein-losing enteropathy as precursor of inflammatory bowel disease: a review of the literature. BMJ Case Rep 2021;14:e238802. [PMID: 33431540 DOI: 10.1136/bcr-2020-238802] [Reference Citation Analysis]
742 Wang Y, Gao X, Zhang X, Xiao F, Hu H, Li X, Dong F, Sun M, Xiao Y, Ge T, Li D, Yu G, Liu Z, Zhang T. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease. Gut Microbes 2021;13:1-18. [PMID: 33430702 DOI: 10.1080/19490976.2020.1865708] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
743 Liang H, Yang M, Zeng C, Wu W, Zhao L, Wang Y. Perfluorooctane sulfonate exerts inflammatory bowel disease-like intestinal injury in rats. PeerJ 2021;9:e10644. [PMID: 33510972 DOI: 10.7717/peerj.10644] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
744 Zhang X, Tong Y, Lyu X, Wang J, Wang Y, Yang R. Prevention and Alleviation of Dextran Sulfate Sodium Salt-Induced Inflammatory Bowel Disease in Mice With Bacillus subtilis-Fermented Milk via Inhibition of the Inflammatory Responses and Regulation of the Intestinal Flora. Front Microbiol 2020;11:622354. [PMID: 33519783 DOI: 10.3389/fmicb.2020.622354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
745 Andersen V, Pedersen AK, Möller S, Green A. Chronic Inflammatory Diseases - Diabetes Mellitus, Rheumatoid Arthritis, Coeliac Disease, Crohn's Disease, and Ulcerative Colitis Among the Offspring of Affected Parents: A Danish Population-Based Registry Study. Clin Epidemiol 2021;13:13-20. [PMID: 33442298 DOI: 10.2147/CLEP.S286623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
746 Farsi F, Ebrahimi-Daryani N, Barati M, Janani L, Karimi MY, Akbari A, Irandoost P, Mesri Alamdari N, Agah S, Vafa M. Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial. Med J Islam Repub Iran 2021;35:3. [PMID: 33996654 DOI: 10.47176/mjiri.35.3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
747 Maronek M, Gromova B, Liptak R, Konecna B, Pastorek M, Cechova B, Harsanyova M, Budis J, Smolak D, Radvanszky J, Szemes T, Harsanyiova J, Kralova Trancikova A, Gardlik R. Extracellular DNA Correlates with Intestinal Inflammation in Chemically Induced Colitis in Mice. Cells 2021;10:E81. [PMID: 33418977 DOI: 10.3390/cells10010081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
748 Nam K, Park SH, Oh JH, Lee HS, Noh S, Park JC, Kim JY, Oh EH, Kim J, Ham NS, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study. BMC Gastroenterol 2021;21:13. [PMID: 33407193 DOI: 10.1186/s12876-020-01597-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
749 Cushing K, Higgins PDR. Management of Crohn Disease: A Review. JAMA 2021;325:69-80. [PMID: 33399844 DOI: 10.1001/jama.2020.18936] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 38.0] [Reference Citation Analysis]
750 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
751 Wark G, Samocha-Bonet D, Ghaly S, Danta M. The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review. Nutrients 2020;13:E135. [PMID: 33396537 DOI: 10.3390/nu13010135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
752 Gavrilescu O, Prelipcean CC, Dranga M, Soponaru C, Mihai C. The specialized educational and psychological counseling in inflammatory bowel disease patients - a target or a challenge? Turk J Gastroenterol 2020;31:760-6. [PMID: 33361038 DOI: 10.5152/tjg.2020.19669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
753 Weidner J, Kern I, Manuwald U, Kugler J, Rothe U. Study protocol epidemiology of inflammatory bowel disease in childhood and adolescence: a systematic review. BMJ Open 2020;10:e037669. [PMID: 33372067 DOI: 10.1136/bmjopen-2020-037669] [Reference Citation Analysis]
754 Kitahara T, Sato Y, Oshiro T, Matsunaga R, Nagashima M, Okazumi S. Risk factors for postoperative stoma outlet obstruction in ulcerative colitis. World J Gastrointest Surg 2020; 12(12): 507-519 [PMID: 33437402 DOI: 10.4240/wjgs.v12.i12.507] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
755 Shivaji UN, Bazarova A, Critchlow T, Smith SCL, Nardone OM, Love M, Davis J, Ghosh S, Iacucci M. Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy. Therap Adv Gastroenterol 2020;13:1756284820981216. [PMID: 34104206 DOI: 10.1177/1756284820981216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
756 Comeche JM, Gutierrez-Hervás A, Tuells J, Altavilla C, Caballero P. Predefined Diets in Patients with Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Nutrients 2020;13:E52. [PMID: 33375314 DOI: 10.3390/nu13010052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
757 Edigin E, Asotibe J, Eseaton PO, Busari OA, Achebe I, Kichloo A, Jamal S, Patel A. Coexisting psoriasis is associated with an increased risk of hospitalization for patients with inflammatory bowel disease: an analysis of the National Inpatient Sample database. J Investig Med 2020:jim-2020-001689. [PMID: 33361402 DOI: 10.1136/jim-2020-001689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
758 Chen L, Yang J, Fang L, Wu W, Feng B, Shi Y, Sun M, Sun X, Liu Z. The Degree of Ulcerative Colitis Burden of Luminal Inflammation score is superior to predicting medium- to long-term prognosis in patients with active ulcerative colitis. Therap Adv Gastroenterol 2020;13:1756284820981210. [PMID: 33425012 DOI: 10.1177/1756284820981210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
759 Wang W, Wu L, Wu X, Li K, Li T, Xu B, Liu W. Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC. Clin Chim Acta 2021;514:8-14. [PMID: 33333044 DOI: 10.1016/j.cca.2020.12.014] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
760 Becker W, Alrafas HR, Busbee PB, Walla MD, Wilson K, Miranda K, Cai G, Putluri V, Putluri N, Nagarkatti M, Nagarkatti PS. Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis 2021;15:1032-48. [PMID: 33331878 DOI: 10.1093/ecco-jcc/jjaa253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
761 Collyer R, Clancy A, Agrawal G, Borody TJ. Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review. World J Gastrointest Endosc 2020; 12(12): 542-554 [PMID: 33362907 DOI: 10.4253/wjge.v12.i12.542] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
762 Xu Z, Tang H, Huang F, Qiao Z, Wang X, Yang C, Deng Q. Algal Oil Rich in n-3 PUFA Alleviates DSS-Induced Colitis via Regulation of Gut Microbiota and Restoration of Intestinal Barrier. Front Microbiol 2020;11:615404. [PMID: 33391246 DOI: 10.3389/fmicb.2020.615404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
763 Tsai YW, Fu SH, Dong JL, Chien MW, Liu YW, Hsu CY, Sytwu HK. Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E9564. [PMID: 33334069 DOI: 10.3390/ijms21249564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
764 Tian J, Zhu Q, Zhang Y, Bian Q, Hong Y, Shen Z, Xu H, Rui K, Yin K, Wang S. Olfactory Ecto-Mesenchymal Stem Cell-Derived Exosomes Ameliorate Experimental Colitis via Modulating Th1/Th17 and Treg Cell Responses. Front Immunol 2020;11:598322. [PMID: 33362781 DOI: 10.3389/fimmu.2020.598322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
765 Yang H, Cai R, Kong Z, Chen Y, Cheng C, Qi S, Gu B. Teasaponin Ameliorates Murine Colitis by Regulating Gut Microbiota and Suppressing the Immune System Response. Front Med (Lausanne) 2020;7:584369. [PMID: 33363184 DOI: 10.3389/fmed.2020.584369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
766 Jacob EM, Borah A, Pillai SC, Kumar DS. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials (Basel) 2020;10:E2460. [PMID: 33316984 DOI: 10.3390/nano10122460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
767 Ng SC, Mak JWY, Pal P, Banerjee R. Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020;5:1089-100. [PMID: 33181088 DOI: 10.1016/S2468-1253(20)30298-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
768 Banerjee R, Pal P, Mak JWY, Ng SC. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020;5:1076-88. [PMID: 33181087 DOI: 10.1016/S2468-1253(20)30299-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
769 Zheng L, Luo M, Kuang G, Liu Y, Liang D, Huang H, Yi X, Wang C, Wang Y, Xie Q, Zhi F. Capsular Polysaccharide From Bacteroides fragilis Protects Against Ulcerative Colitis in an Undegraded Form. Front Pharmacol 2020;11:570476. [PMID: 33364945 DOI: 10.3389/fphar.2020.570476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
770 Gioxari A, Amerikanou C, Papada E, Zioga E, Georgoulis AD, Bamias G, Kaliora AC. Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases. Nutrients 2020;12:E3734. [PMID: 33291539 DOI: 10.3390/nu12123734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
771 Hosseini-Asl SK, Mehrabani D, Karimi-Busheri F. Therapeutic Effect of Mesenchymal Stem Cells in Ulcerative Colitis: A Review on Achievements and Challenges. J Clin Med 2020;9:E3922. [PMID: 33287220 DOI: 10.3390/jcm9123922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
772 Alexandrino TD, Moya AMTM, de Medeiros TDM, Morari J, Velloso LA, Leal RF, Maróstica MR, Pastore GM, Cazarin CBB, Bicas JL. Anti-inflammatory effects of monoterpenoids in rats with TNBS-induced colitis. PharmaNutrition 2020;14:100240. [DOI: 10.1016/j.phanu.2020.100240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
773 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
774 Limsrivilai J, Lee CK, Prueksapanich P, Harinwan K, Sudcharoen A, Cheewasereechon N, Aniwan S, Sripongpan P, Wetwittayakhlang P, Pongpaibul A, Sanpavat A, Pausawasdi N, Charatcharoenwitthaya P, Higgins PDR, Ng SC. Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia. PLoS One 2020;15:e0242879. [PMID: 33253239 DOI: 10.1371/journal.pone.0242879] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
775 Qiu Y, Zhang YF, Zhu LR, He JS, Tan JY, Tan ND, Lin SN, Lin XQ, Ghosh S, Chen MH, Mao R. Impact of COVID-19 on the Healthcare of Patients With Inflammatory Bowel Disease: A Comparison Between Epicenter vs. Non-epicenter Areas. Front Med (Lausanne) 2020;7:576891. [PMID: 33330534 DOI: 10.3389/fmed.2020.576891] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
776 Miao F, Shan C, Shah SAH, Akhtar RW, Geng S, Ning D, Wang X. The protective effect of walnut oil on lipopolysaccharide-induced acute intestinal injury in mice. Food Sci Nutr 2021;9:711-8. [PMID: 33598156 DOI: 10.1002/fsn3.2035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
777 Everhov ÅH, Bruze G, Söderling J, Askling J, Halfvarson J, Westberg K, Malmborg P, Nordenvall C, Ludvigsson JF, Olén O. Women's Earnings are more Affected by Inflammatory Bowel Disease than Men's: A Register-Based Swedish Cohort Study. J Crohns Colitis 2021;15:980-7. [PMID: 33245360 DOI: 10.1093/ecco-jcc/jjaa238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
778 Qian B, Wang C, Zeng Z, Ren Y, Li D, Song JL. Ameliorative Effect of Sinapic Acid on Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in Kunming (KM) Mice. Oxid Med Cell Longev 2020;2020:8393504. [PMID: 33312339 DOI: 10.1155/2020/8393504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
779 Dickson K, Malitan H, Lehmann C. Imaging of the Intestinal Microcirculation during Acute and Chronic Inflammation. Biology (Basel) 2020;9:E418. [PMID: 33255906 DOI: 10.3390/biology9120418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
780 Hodges P, Kelly P. Inflammatory bowel disease in Africa: what is the current state of knowledge? Int Health 2020;12:222-30. [PMID: 32133502 DOI: 10.1093/inthealth/ihaa005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
781 Rajbhandari R, Blakemore S, Gupta N, Adler AJ, Noble CA, Mannan S, Nikolli K, Yih A, Joshi S, Bukhman G. Crohn’s disease in low and lower-middle income countries: A scoping review. World J Gastroenterol 2020; 26(43): 6891-6908 [PMID: 33268969 DOI: 10.3748/wjg.v26.i43.6891] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
782 Liu F, Wang X, Li D, Cui Y, Li X. Apple polyphenols extract alleviated dextran sulfate sodium-induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosis. Phytother Res 2021;35:1468-85. [PMID: 33215776 DOI: 10.1002/ptr.6910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
783 Hisamatsu T, Suzuki Y, Kobayashi M, Hagiwara T, Kawaberi T, Ogata H, Matsui T, Watanabe M, Hibi T. Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study. Intest Res 2021;19:408-18. [PMID: 33207857 DOI: 10.5217/ir.2020.00025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
784 Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.Dtsch Arztebl Int. 2020;117:564-574. [PMID: 33148393 DOI: 10.3238/arztebl.2020.0564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
785 Karmiris K. Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners? Inflamm Bowel Dis 2020;26:1878-9. [PMID: 32144931 DOI: 10.1093/ibd/izaa022] [Reference Citation Analysis]
786 da Cunha VP, Preisser TM, Santana MP, Machado DCC, Pereira VB, Miyoshi A. Mycobacterial Hsp65 antigen delivered by invasive Lactococcus lactis reduces intestinal inflammation and fibrosis in TNBS-induced chronic colitis model. Sci Rep 2020;10:20123. [PMID: 33208841 DOI: 10.1038/s41598-020-77276-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
787 Song D, Lai L, Ran Z. Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease. Front Immunol 2020;11:580467. [PMID: 33193381 DOI: 10.3389/fimmu.2020.580467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
788 Hao X, Feng T, Yang Y, Shi Y, Jing R, Liu S, Luo Y, Qiao Y, Zhong M, Yu M. Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn's disease: a randomised, controlled, open-label trial. BMJ Open 2020;10:e038429. [PMID: 33199421 DOI: 10.1136/bmjopen-2020-038429] [Reference Citation Analysis]
789 Wu Y, Shen J. Innate Lymphoid Cells in Crohn's Disease. Front Immunol 2020;11:554880. [PMID: 33329513 DOI: 10.3389/fimmu.2020.554880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
790 Meyers TJ, Weiner AB, Graff RE, Desai AS, Cooley LF, Catalona WJ, Hanauer SB, Wu JD, Schaeffer EM, Abdulkadir SA, Kundu SD, Witte JS. Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study. Int J Cancer 2020;147:2735-42. [PMID: 32399975 DOI: 10.1002/ijc.33048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
791 Poddighe D, Telman A, Tuleutayev E, Ibrayeva A. Pediatric Ulcerative Colitis in Kazakhstan: First Case Series from Central Asia and Current Clinical Management. Gastroenterology Insights 2020;11:27-35. [DOI: 10.3390/gastroent11020006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
792 Mahajna H, Barash Y, Ungar B, Soffer S, Albshesh A, Levartovsky A, Ben-Horin S, Klang E, Kopylov U. Prediction of Recurrent Emergency Department Visits among Patients with Crohn's Disease: A Retrospective Study. J Clin Med 2020;9:E3651. [PMID: 33202843 DOI: 10.3390/jcm9113651] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
793 Kumar A, Brookes MJ. Iron Therapy in Inflammatory Bowel Disease. Nutrients 2020;12:E3478. [PMID: 33198376 DOI: 10.3390/nu12113478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
794 Lv H, Jin M, Zhang H, Chen X, Wu M, Guo M, Zhou R, Wang Z, Yang H, Qian J. Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre. BMC Gastroenterol 2020;20:377. [PMID: 33183228 DOI: 10.1186/s12876-020-01527-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
795 Richard L, Noller G, Derrett S, Sullivan T, Doolan-Noble F, McCombie A, Schultz M, Ho C, Stokes T. Patients' accounts of living with and managing inflammatory bowel disease in rural Southern New Zealand: a qualitative study. BMJ Open 2020;10:e041789. [PMID: 33184085 DOI: 10.1136/bmjopen-2020-041789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
796 Qiu X, Zhao X, Cui X, Mao X, Tang N, Jiao C, Wang D, Zhang Y, Ye Z, Zhang H. Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn's disease. Therap Adv Gastroenterol 2020;13:1756284820971202. [PMID: 33240394 DOI: 10.1177/1756284820971202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
797 Wei C, Wang JY, Xiong F, Wu BH, Luo MH, Yu ZC, Liu TT, Li DF, Tang Q, Li YX, Zhang DG, Xu ZL, Jin HT, Wang LS, Yao J. Curcumin ameliorates DSS‑induced colitis in mice by regulating the Treg/Th17 signaling pathway. Mol Med Rep 2021;23:34. [PMID: 33179078 DOI: 10.3892/mmr.2020.11672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
798 Chen Y, Li H, Lai L, Feng Q, Shen J. Identification of Common Differentially Expressed Genes and Potential Therapeutic Targets in Ulcerative Colitis and Rheumatoid Arthritis. Front Genet 2020;11:572194. [PMID: 33262784 DOI: 10.3389/fgene.2020.572194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
799 Coad J, Pedley K. Nutrition in New Zealand: Can the Past Offer Lessons for the Present and Guidance for the Future? Nutrients 2020;12:E3433. [PMID: 33182406 DOI: 10.3390/nu12113433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
800 Dibley L, Khoshaba B, Artom M, Van Loo V, Sweeney L, Syred J, Windgassen S, Moffatt G, Norton C; and members of the IBD-BOOST PPI team. Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support. Dig Dis Sci 2021;66:3330-42. [PMID: 33164146 DOI: 10.1007/s10620-020-06698-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
801 Miranda EF, Nones RB, Kotze PG. Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn's disease: a narrative review. Intest Res 2021;19:255-64. [PMID: 33147899 DOI: 10.5217/ir.2020.00029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
802 Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep 2020;10:19273. [PMID: 33159156 DOI: 10.1038/s41598-020-76361-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
803 Truffi M, Sevieri M, Morelli L, Monieri M, Mazzucchelli S, Sorrentino L, Allevi R, Bonizzi A, Zerbi P, Marchini B, Longhi E, Sampietro GM, Colombo F, Prosperi D, Colombo M, Corsi F. Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease. Int J Nanomedicine 2020;15:8537-52. [PMID: 33173291 DOI: 10.2147/IJN.S264513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
804 Khaloian S, Rath E, Hammoudi N, Gleisinger E, Blutke A, Giesbertz P, Berger E, Metwaly A, Waldschmitt N, Allez M, Haller D. Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn's disease recurrence. Gut 2020;69:1939-51. [PMID: 32111634 DOI: 10.1136/gutjnl-2019-319514] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 21.0] [Reference Citation Analysis]
805 Lei Y, Chen Y, Lin Z, Tian D, Han P. Comprehensive analysis of key biomarkers, immune infiltration and potential therapeutic agents for ulcerative colitis. Life Sci 2020;260:118437. [PMID: 32950577 DOI: 10.1016/j.lfs.2020.118437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
806 Allocca M, Chaparro M, Gonzalez HA, Bosca-Watts MM, Palmela C, D'Amico F, Zacharopoulou E, Kopylov U, Ellul P, Bamias G, Ntelis V, Lahat A, Mantzaris GJ, Papaconstantinou I, Katsanos K, Uspenskaya Y, Christodoulou D, Ben Horin S, Peyrin-Biroulet L, Torres J, Sebastian S, Gisbert JP, Danese S, Fiorino G. Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study. J Clin Med. 2020;9. [PMID: 33142843 DOI: 10.3390/jcm9113533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
807 Wang S, Tsou HK, Chiou JY, Wang YH, Zhang Z, Wei JC. Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study. Front Immunol 2020;11:578732. [PMID: 33123163 DOI: 10.3389/fimmu.2020.578732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
808 Chen L, Li J, Ye Z, Sun B, Wang L, Chen Y, Han J, Yu M, Wang Y, Zhou Q, Seidler U, Tian D, Xiao F. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice. Front Immunol 2020;11:585094. [PMID: 33193406 DOI: 10.3389/fimmu.2020.585094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
809 Chong Y, Han C, Li J, Long X. Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019. J Int Med Res 2020;48:300060520965824. [PMID: 33115290 DOI: 10.1177/0300060520965824] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
810 Nelson A, Stewart CJ, Kennedy NA, Lodge JK, Tremelling M, Probert CS, Parkes M, Mansfield JC, Smith DL, Hold GL, Lees CW, Bridge SH, Lamb CA; UK IBD Genetics Consortium. The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation. J Crohns Colitis 2021;15:800-12. [PMID: 33119074 DOI: 10.1093/ecco-jcc/jjaa220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
811 Dai C, Huang YH, Jiang M, Sun MJ. Nonclostridium difficile enteric infection and the risk of developing inflammatory bowel disease: A systematic review and meta-analysis. Saudi J Gastroenterol 2020. [PMID: 33154203 DOI: 10.4103/sjg.SJG_231_20] [Reference Citation Analysis]
812 Ding JH, Jin Z, Yang XX, Lou J, Shan WX, Hu YX, Du Q, Liao QS, Xie R, Xu JY. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol 2020; 26(40): 6141-6162 [PMID: 33177790 DOI: 10.3748/wjg.v26.i40.6141] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
813 Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal 2020; 8(5): 383-399 [DOI: 10.13105/wjma.v8.i5.383] [Reference Citation Analysis]
814 Ruiz MA, Junior RLK, Piron-Ruiz L, Saran PS, Castiglioni L, Quadros LG, Pinho TS, Burt RK. Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn’s disease in Brazil. World J Stem Cells 2020; 12(10): 1113-1123 [PMID: 33178395 DOI: 10.4252/wjsc.v12.i10.1113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
815 Karadag P, Morris B, Woolfall K. The information and support needs of patients living with inflammatory bowel disease: A qualitative study. Chronic Illn 2020;:1742395320968617. [PMID: 33106026 DOI: 10.1177/1742395320968617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
816 Choi YI, Park SJ, Chung JW, Kim KO, Cho JH, Kim YJ, Lee KY, Kim KG, Park DK. Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study.J Clin Med. 2020;9:3427. [PMID: 33114505 DOI: 10.3390/jcm9113427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
817 Hong SW, Ye BD. The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia. Intest Res 2020;18:345-6. [PMID: 33131230 DOI: 10.5217/ir.2020.00121] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
818 James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
819 Hu JE, Bojarski C, Branchi F, Fromm M, Krug SM. Leptin Downregulates Angulin-1 in Active Crohn's Disease via STAT3. Int J Mol Sci 2020;21:E7824. [PMID: 33105684 DOI: 10.3390/ijms21217824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
820 Ortega Moreno L, Sanz-Garcia A, Fernández de la Fuente MJ, Arroyo Solera R, Fernández-Tomé S, Marin AC, Mora-Gutierrez I, Fernández P, Baldan-Martin M, Chaparro M, Gisbert JP, Bernardo D. Serum adipokines as non-invasive biomarkers in Crohn's disease. Sci Rep 2020;10:18027. [PMID: